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      Uridine-rich small nuclear RNAs (U snRNAs) play essential roles in eukaryotic gene 
expression by facilitating the removal of introns from mRNA precursors and the processing of 
the replication-dependent histone pre-mRNAs. Formation of the 3’ end of these snRNAs is 
carried out by a poorly characterized, twelve-membered protein complex named Integrator 
Complex. 
      In the effort to understand Integrator Complex function in the formation of the snRNA 3’ 
end, we performed a functional RNAi screen in Drosophila S2 cells to identify protein factors 
required for snRNA 3’ end formation. This screen was conducted by using a fluorescence-
based reporter that elicits GFP expression in response to a deficiency in snRNA processing. 
Besides scoring the known Integrator subunits, we identified Asunder and CG4785 as 
additional core members of the Integrator Complex. Additionally, we also found a conserved 
requirement for Cyclin C and Cdk8 in both fly and human snRNA 3’ end processing. We have 
further demonstrated that the kinase activity of Cdk8 is critical for snRNA 3’ end processing 
and is likely to function independent of its well-documented function within the Mediator Cdk8 
module. Taken together, this work functionally defines the Drosophila Integrator Complex and 
demonstrates a novel function for Cyclin C/Cdk8 in snRNA 3’ end formation. 
      This thesis work has also characterized an important functional interaction mediated by a 
microdomain within Integrator subunit 12 (IntS12) and IntS1 that is required for the activity of 
the Integrator Complex in processing the snRNA 3’ end. Through the development of a 
reporter-based functional RNAi-rescue assay in Drosophila S2 cells, we analyzed domains 
within IntS12 required for snRNA 3’ end formation. This analysis unexpectedly revealed that 
an N-terminal 30 amino acid region and not the highly conserved central PHD finger domain, 
is required for snRNA 3’ end cleavage. The IntS12 microdomain (1-45) functions 
autonomously, and is sufficient to interact and stabilize the putative scaffold protein IntS1.  
       Our findings provide more details of the Integrator Complex for understanding the 
molecular mechanism of snRNA 3’ end processing. Moreover, these results lay the foundation 
for future studies of the complex through the identification of a novel functional domain within 
one subunit and the identification of additional subunits.  
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Chapter 1. Introduction 
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INTRODUCTION AND BACKGROUND 
 
Overview: Cellular functions and biogenesis of uridine-rich small nuclear RNA (U 
snRNA).  
      U snRNAs are a population of non-coding small RNAs in eukaryotic cells that are highly 
expressed, non-polyadenylated, and function in the nucleoplasm. Based on consensus 
sequence features and bound protein cofactors, U snRNAs are grouped into two different 
classes. The Sm-class contains a tri-methylguanosine cap at the 5’ end, a stem-loop structure 
at the 3’ end, and a central consensus protein binding site that serves as a binding platform for 
the heteroheptameric Sm ring (Sm site) (Figure 1.1A). The Lsm-class, in contrast, have a 5’ 
mono-methylphosphate cap, a 3′ stem-loop, and a stretch of uridines at the 3’ end that serves 
as a binding site for a distinct heptameric ring of Lsm proteins (Figure 1.1B). 
      The Sm-class snRNAs are transcribed by RNA polymerase II (RNAPII) and include U1, 
U2, U4, U5, U7, U11, U12, and U4atac. In contrast, the Lsm-class snRNAs are RNA 
polymerase III (RNAPIII) transcripts and include U6 and U6atac. U snRNAs are best known for 
their function in forming the RNA core of the spliceosome to facilitate the removal of introns 
from mRNA precursors (pre-mRNA). During the splicing reaction, specific and dynamic 
complementary interactions between the substrate and snRNA take place in the context of 
over a hundred of accessory proteins (Figure 1.2A). Accurate removal of intronic sequences is 
achieved by sequential synergistic actions of distinct small nuclear ribonucleoproteins 
(snRNPs). The early interactions in the splicing reaction include the U1 snRNP recognition of 
the 5’-splice sites of the pre-mRNA by base pairing, the U2 snRNP recognition of the branch 
point sequences, and identification of the 3’ splice site by the U2 auxiliary factors. Once these 
recognition events have been established, the U4/U6/U5 tri-snRNP enters the complex to 
ultimately form the catalytic spliceosome (Will and Luhrmann 2011). The aforementioned 
snRNAs are the components of the cellular major spliceosome, whereas the U11, U12, U4atac 
and U6atac are found in the minor spliceosome and catalyze the removal of the non-canonical 
“atac” introns (Will and Luhrmann 2005). One exception within this snRNA group is the U7 
snRNA, which is required for histone pre-mRNA 3′ processing and plays no role in pre-mRNA 
splicing. The U7 snRNP can basepair with the histone downstream element (HDE) that is 
located downstream of the cleavage site, and facilitates the 3’ end endonucleolytic cleavage of 
the histone pre-mRNA (Figure 1.2B) (Marzluff et al. 2008).  
      Recent studies of the U1 snRNP reveal that it also functions beyond pre-mRNA splicing. 
The U1 snRNP is shown to activate gene transcription through a combination of interactions 
with the pre-mRNA transcript and with the transcription initiation machinery (Kwek et al. 2002). 
It is also found to repress the levels of viral transcripts by suppression of RNA 
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Figure 1.1 Anatomical features of Sm- and Lsm-class small nuclear RNAs. (A). Sm-class 
small nuclear RNAs are transcribed by RNAPII, and have a 5’ trimethylguanosine (TMG) cap, 
a 3’ stem loop and a Sm protein binding site in the middle. The U7 snRNA has a noncanonical 
Sm site that is bound by a U7 Sm core. (B). Lsm-class snRNAs are transcribed by RNAPIII 
and have a 5’ monomethylphosphate (MMP) cap, a 3′ stem loop, and a stretch of uridines at 
the very 3’ end that serve as a binding site for a distinct heptameric ring of Lsm proteins. 
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Figure 1.2 Cellular functions of spliceosomal snRNP and U7 snRNP. 
 
A. snRNPs function in pre-mRNA splicing  
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Figure 1.2 Cellular functions of spliceosomal snRNP and U7 snRNP. (A). Schematic 
representation of the spliceosome assembly pathway during pre-mRNA splicing. Introns are 
excised from pre-mRNA by the spliceosome that is assembled by stepwise integration of U1, 
U2, and U4/U6.U5 snRNPs. (B). Schematic representation of U7 snRNP involved in histone 
mRNA 3’ end formation. The U7 snRNP binds histone downstream element (HDE) through 
basepairing between 5’ U7 snRNA and HDE sequence, and the stem loop binding protein 
(SLBP) binds the 3’ stem-loop, together with ZFP100 and FLASH to stabilize the U7 snRNP 
and help recruiting the endonuclease to cleave the histone pre-mRNA. 
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polyadenylation (West 2012), and in human cells, it has been shown to protect the widespread 
premature cleavage and polyadenylation of pre-mRNA transcripts through U1 snRNA binding 
to the 5’-splice site-like sequences present in primary transcripts (Kaida et al. 2010). These 
studies are all consistent with the fact that the U1 snRNA is expressed at significantly higher 
levels than other snRNAs. 
 
The Lifecycle of the snRNP.     
 
Introduction.    The biogenesis of snRNPs is an extensively studied research topic. The 
primary focus of these investigations has been to determine how snRNPs are assembled as 
well as how the mature snRNPs function in pre-mRNA splicing. In contrast, less is known 
about the events that precede snRNP incorporation into the spliceosome. The biogenesis of 
the functional Sm-class snRNPs includes a sophisticated nuclear-cytoplasmic life cycle (Figure 
1.3A), while the Lsm-class snRNPs are only subject to a nuclear maturation process (Figure 
1.3B).  
 
snRNA Transcription.      Transcription of the RNAPII transcribed snRNA genes is related in 
several ways to other transcription reactions but also possesses several important distinctions 
from mRNA-encoding genes (for more comprehensive reviews, see (Hernandez 2001; Egloff 
et al. 2008)). The RNAPII-transcribed snRNA genes have a TATA-less promoter that is 
featured by the presence of a well-conserved DNA element called the proximal sequence 
element (PSE). Transcription initiation at snRNA genes is mediated by a group of snRNA 
gene-specific proteins that have been referred to differently in the literature: the snRNA 
activating protein complex (SNAPc), the PSE-binding transcription factor (PTF), PSE-binding 
protein (PBP) (Hung and Stumph 2011). The SNAPc complex is thought to recruit RNAPII to 
the snRNA promoter by binding to the PSE element, similar to how general transcription 
factors recruit RNAPII, but the events that follow are snRNA-specific. For protein-encoding 
genes, transcription initiates from the recruitment of RNAPII by transcription factors, and is 
followed by phosphorylation of Ser5 within C-terminal domain of the heptad repeat 
(YSPTS5PS) of the RNAPII large subunit (Rpb1) by the cyclin-dependent kinase 7 (Cdk7) of 
transcription factor IIH (TFIIH), which is critical for promoter clearance (reviewed in (Phatnani 
and Greenleaf 2006; Buratowski 2009)). Subsequent to promoter clearance there is an 
increase in the phosphorylation of Ser2 within the CTD heptad repeat by CDK9 of the positive 
transcription elongation factor-b complex (P-TEFb) that is concomitant with a reduction in the 
levels of pSer5. This change in phosphorylation status is thought to increase elongation 
efficiency and facilitate the loading of RNA-processing factors onto the RNAPII  
! 8 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Sm-class and Lsm-class snRNP biogenesis pathways. 
Adapted from Nucleic Acids Research, Patel S and Bellini M, The assembly of a spliceosomal 
small nuclear ribonucleoprotein particle. 2008, Vol. 36, No. 20, 6482–6493. 
 
A. 
B. 
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Figure 1.3 Sm-class and Lsm-class snRNP biogenesis pathways. (A). The biogenesis of 
Sm-class snRNPs occurs both in the nucleus and the cytoplasm. The snRNA primary 
transcripts are generated by RNAPII, cleaved by the Integrator complex and then exported to 
the cytoplasm by the PHAX-containing snRNA export complex. In the cytoplasm, the SMN 
complex recruits the heteroheptameric Sm proteins ring and tethers it to snRNA to form the 
Sm-core RNP. Following assembly of the Sm core, the 7-methylguanosine (m7G) cap is 
hypermethylated and the 3' end is trimmed. The newly formed TMG cap serves as a signal for 
assembling the import complex containing the import adaptor Snurportin-1 (SPN) and the 
import receptor Importin-β (Imp-β). Once returned to the nucleus, the Sm-class snRNPs are 
targeted to Cajal bodies for snRNA-based modification, which is requisite for spliceosomal 
function. The matured snRNPs then leave the Cajal bodies and either are stored in the splicing 
factor compartments (SFCs) or participate in transcription-coupled pre-mRNA splicing at 
perichromatin fibrils (PFs). (B). The biogenesis of Lsm-class snRNP (U6 snRNP) is an 
exclusively nuclear process. The U6 snRNA are transcribed by RNAPIII and the 3’ end is 
formed by transcription termination with stretch of uridines. The newly transcribed U6 snRNA 
is bound by the La antigen at both 5’ and 3’ ends and then is targeted to nucleoli, where its 5’ 
cap and 3’ end are modified. The modification discharges La protein binding and enables Lsm 
protein binding. Once the Lsm core is assembled onto U6 snRNA, the U6 snRNP is targeted 
to Cajal bodies for further maturation. The mature U6 snRNP either are stored in the splicing 
factor compartments (SFCs) or participate in transcription-coupled pre-mRNA splicing 
process. 
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CTD in order to catalyze downstream RNA processing reactions (Zhang et al. 2005; Zhang 
and Gilmour 2006). Unlike its role in protein-encoding genes, P-TEFb is found to be 
dispensable for efficient elongation of snRNA genes, which is not unexpected given the 
relative short length and lack of polyadenylate tails in snRNAs (Medlin et al. 2005). 
Surprisingly, however, phosphorylation of Ser2 in the heptad repeat of the RNAPII CTD has 
been reported to be required for proper snRNA 3′ end formation, thereby implicating a distinct 
requirement for P-TEFb in snRNA 3’ end formation (Medlin et al. 2005). Recently, an 
additional phosphorylation at Ser7 of the RNAPII CTD has been reported by the Murphy 
laboratory to be essential for snRNA processing (Chapman et al. 2007; Egloff et al. 2007), 
and, surprisingly, TFIIH has been found to phosphorylate Ser7 of the CTD, expanding its 
established substrate specificity beyond Ser5 (Akhtar et al. 2009). 
       
snRNA nuclear export.    The primary snRNA transcript is cleaved at the 3’ end to facilitate 
RNAPII termination and recycling. This cleavage event is governed by a poorly conserved cis-
regulatory element called the 3′-box, which is located several nucleotides downstream the 
cleavage site (Hernandez 1985). The 3′ box is likely to serve as a recognition site for the 
Integrator Complex (described in more detail below) that is responsible for the nascent snRNA 
cleavage from the elongating polymerase. Once the snRNA is cleaved from the DNA template, 
it is exported to the cytoplasm by an snRNA-specific export complex for maturation.  
      The cytoplasmic export of snRNA is carried out by a protein complex that is comprised of 
the snRNA-specific phosphorylated adaptor for RNA export (PHAX), the cap-binding complex 
(CBC), the chromosome region maintenance-1 (CRM1/Xpo1), and RanGTP (Ohno et al. 
2000). The 5′ mono-methylguanosine cap structure and length of the snRNA are key 
determinants in snRNA nuclear export while the compartmentalized phosphorylation status of 
PHAX controls the directionality of export (Ohno et al. 2000). Phosphorylated PHAX is 
localized in the nucleus and together with CBC complex bridges the snRNA to CRM1/Xpo1 for 
export. Once PHAX enters into the cytoplasm it is dephosphorylated causing export complex 
disassembly and PHAX is then recycled to the nucleus through the import receptor importin-β 
(Segref et al. 2001). The nuclear kinase and cytoplasmic phosphatase that regulate this 
process have been identified to be Casein Kinase 2 (CK2) and protein phosphatase 2A, 
respectively (Kitao et al. 2008). There have been no PHAX orthologues found in fungal 
genomes suggesting that either the fungal snRNAs are not exported to cytoplasm or they use 
a different system for snRNA export. 
       
SMN and snRNP assembly. Once exported to the cytoplasm, the snRNAs are loaded onto 
the Sm-core particles under the facilitation of the Survival of Motor Neuron (SMN) protein 
! 11 
complex.  Proper function of SMN is critical, as loss or mutation of SMN1 gene is known to 
cause selective dysfunction of motor neurons leading to Spinal Muscular Atrophy (SMA) 
(Burghes and Beattie 2009; Coady and Lorson 2011; Workman et al. 2012). Given the 
importance of SMN in snRNP biogenesis, one explanation is that mutation of SMN results in 
splicing alterations of specific genes that are required for neuromuscular junction function. The 
SMN complex (SMN, Germin2-8 and UNR-interacting protein) bridges the heptameric Sm 
protein ring and the newly exported snRNA precursors to form the snRNPs. The binding 
specificity of SMN complex to snRNAs is mediated through the interaction between the 
Germin5 WD repeat and Sm site of snRNA (Lau et al. 2009; Yong et al. 2010). It is noteworthy 
that the U7 snRNA has a nonconsensus Sm site, which determines the inclusion of two 
alternative Sm-like proteins (Lsm10 and Lsm11) in the U7 core (Figure 1.1A). It is still not 
known how the SMN complex facilitates loading the alternative heptameric Sm core onto the 
U7 snRNA. 
      Once the Sm core/SMN complex are assembled on the Sm sites, the cap structure of 
snRNA is hypermethylated by the tri-methylguanosine synthase-1 (TGS1) to form a 2,2,7-
trimethylguanosine (TMG) cap (Mouaikel et al. 2002). The snRNA 3’ end is then further 
trimmed several nucleotides by a yet-to-be identified cytoplasmic exonuclease. The newly 
formed TMG cap serves as a nuclear import signal that is recognized by the adaptor protein 
Snurportin-1, and together with the SMN complex, the snRNP is re-imported into the nucleus 
through the import receptor importin-β (Imp-β), which directly interacts both Snurportin-1 and 
SMN complex (Segref et al. 2001). 
      Once imported back into the nucleus, the Sm-class snRNPs are sorted into Cajal bodies 
for further maturation through site-specific modification and assembly of snRNP-specific 
proteins (Matera et al. 2007; Patel and Bellini 2008). A recent study also indicates that the 
production of snRNAs is a critical event for maintaining the integrity of the nuclear Cajal bodies 
in human cells (Takata et al. 2012). This suggests that there is an interplay between the 
formation of the Cajal Body and the levels of snRNAs that transit through the Cajal Body. 
Functional snRNPs then leave the Cajal bodies and function in splicing at perichromatin fibrils 
(PFs) or are stored in splicing factor compartments (SFCs) for later use. 
      The RNAPIII-transcribed U snRNAs (U6 and U6atac) use a unique extragenic RNAPIII 
type III promoter for transcription (Schramm and Hernandez 2002) and their 3’ ends terminate 
with a run of uridines that serves as the Lsm-binding site (Figure 1.1B) as well as the Pol III 
transcription terminator. These snRNAs remain in the nucleus for maturation (Figure 1.3B) 
(detailed review, see (Patel and Bellini 2008)).  
 
3’ end formation of RNAPII transcripts 
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Introduction.   In eukaryotes, RNA polymerase II transcribes a variety of RNA transcripts that 
serve distinct functions within the cell. The three major types of RNAPII-transcribed RNA are: 
the polyadenylated mRNAs, the nonpolyadenylated histone mRNAs, and the small nuclear 
RNAs. The presence of a poly(A) tail at the 3’ end is a prominent feature of the eukaryotic 
mRNAs, which is important for mRNA export, stability and translation. However, the metazoan 
replication-dependent histone mRNAs and the ubiquitously expressed snRNAs have a stem-
loop structure at their 3’ end. These non-polyadenylated RNAs utilize mechanisms to form 
their 3’ ends that are distinct from poly(A)+ mRNA but they also share certain similarities for 
the 3’ end formation that include the arrangement of cis-regulatory sequence elements and the 
chemistry of the cleavage event itself (Reviewed in (Chen and Wagner 2010)). 
 
The polyadenylated messenger RNA.    The 3’ end formation of polyadenylated mRNAs is 
carried out by the cleavage/polyadenylation machinery and initially requires recognition of the 
two cis-regulatory 3’ end processing signals and then cleavage of the pre-mRNA (Figure 1.4). 
The initial binding of the highly conserved AAUAAA polyadenylation signal (PAS) is carried out 
by the 160 kDa subunit of the five membered Cleavage and Polyadenylation Specificity Factor 
(CPSF) complex (Murthy and Manley 1995). This occurs in parallel or in concert with the 
recognition of the downstream G/U-rich sequence element (DSE) through the 64 kDa subunit 
of the trimeric Cleavage Stimulation Factor (CstF) complex (MacDonald et al. 1994). 
Recognition of these two conserved sequence elements by the CPSF and CstF complexes 
facilitates the recruitment of a cleavage factor that then cleaves the pre-mRNA at the cleavage 
site, which is preferably a CA dinucleotide located between the PAS and DSE. The cleavage 
factor for polyadenylated mRNA comprises of the endonuclease CPSF73, the catalytically 
inactivated CPSF100, and a large scaffold protein called Symplekin (Mandel et al. 2006). The 
crystal structure of CPSF73 demonstrates that it belongs to the metallo-β-lactamase (MBL) 
and metallo-β-lactamase-associated CPSF, Artemis, SNM1/PSO2 (β-CASP) subfamily 
chelating zinc ions, and cleavage assay further revealed that it is a hydrolase capable of 
cleaving single stranded RNA substrates in vitro (Mandel et al. 2006). Interestingly, the crystal 
structure of CPSF100 clearly demonstrates that it adopts the same fold as CPSF73, but it 
does not coordinate zinc ions in its active site and cleavage analysis shows that it has no 
endonuclease activity to RNA tested in vitro, consistent with the observation that it lacks 
critical amino acids thought to be required for catalytic activity. Symplekin is an ARM/HEAT 
repeats containing protein and data from its crystal structure indicates that its HEAT domain is 
likely to function as a scaffold for protein-protein interactions essential to the mRNA maturation 
process in mammalian cells (Andrade et al. 2001). Besides the factors mentioned above, 
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cleavage factor I (CFIm) and cleavage factor II (CFIIm) complexes have also been implicated 
in the cleavage reaction of pre-mRNAs lacking the canonical PAS signal by stimulating binding 
of the CPSF complex to the pre-mRNA through a functional interaction with Fip1 (Brown and 
Gilmartin 2003; Venkataraman et al. 2005). Finally, the C-terminal domain (CTD) of the largest 
subunit of RNA polymerase II (Rpb1) is required for the pre-mRNA cleavage step likely 
through its ability to recruit cleavage factors to sites of transcription. Tightly coupled to the 
cleavage step is the addition of a poly(A) tail to the newly formed mRNA 3’ end by the poly(A) 
polymerase (PAP) to form the mature mRNA with a 200-250 nucleotide poly(A) tail. 
 
The replication-dependent histone mRNA.     The mature replication-dependent metazoan 
histone mRNAs terminate with a 3’ end stem-loop structure that is generated by single 
endonucleolytic cleavage but it is distinctly not followed by polyadenylation. Histone genes are 
intronless, thus this single cleavage reaction is the only RNA processing event required to 
form mature histone mRNAs. The 3’ end of histone mRNA is formed by a distinct processing 
machinery that recognizes two conserved sequence elements present in histone pre-mRNAs: 
the 3’ end stem-loop and a purine-rich histone downstream element (HDE) (Dominski and 
Marzluff 2007) (Figure 1.4). The stem-loop sequence is highly conserved throughout evolution 
and consists of a 6-base pair stem and a 4-nucleotide loop. In contrast, the HDE sequence of 
vertebrate histone pre-mRNAs is less conserved but all contains a purine-rich core, which has 
a typical sequence of PuAAAGAGCTG (Pu, purine) located 15-20 nucleotides downstream of 
the 3’ end stem-loop. The conserved stem-loop structure in histone pre-mRNA is recognized 
by the stem-loop binding protein (SLBP) through its central RNA binding domain (RBD) (Wang 
et al. 1996), and the downstream HDE sequence is a binding site for the U7 snRNP where the 
5’ end of U7 snRNA basepairs with HDE sequence (Mowry and Steitz 1987; Dominski et al. 
2003). Recognition of these two elements by SLBP and U7 snRNP recruits other protein 
factors, including the cleavage factor CPSF73/CPSF100 and Symplekin, to cleave the histone 
pre-mRNA at the cleavage site, typically an adenosine between the stem-loop and the HDE 
sequences. Thus the unique histone mRNA 3’ end processing machinery includes at least the 
U7 snRNP, SLBP, a 100-kDa zinc-finger protein (ZFP100) and a same large complex 
consisting of CPSF and CstF complexes as the effector of RNA cleavage. 
      The U7 snRNA has an unstructured 5’ terminus that is involved in formation of a duplex 
with the histone HDE sequence, and thus is essential for histone pre-mRNA 3’ end formation. 
In contrast, the 3’ end of U7 snRNA folds into a stem-loop structure, which has been shown to 
be resistant to alterations at the sequence level suggesting that the structure itself is important 
rather than the content. The central region of the U7 snRNA contains its noncanonical Sm 
protein-binding site that guides inclusion of a different Sm core called the U7 core. Instead of 
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the classical Sm core consisting of seven Sm proteins: B, D1, D2, D3, E, F and G, the U7 core 
forms a heptameric ring by replacing the SmD1, D2 proteins with Lsm10 and Lsm11, 
respectively (Pillai et al. 2001; Pillai et al. 2003). Lsm10 resembles other Sm proteins in size 
and structure and shares the highest sequence homology to SmD1 but is not observed to be 
included in spliceosomal snRNPs and is required for U7 snRNP function. Interestingly, Lsm11 
has an unusual large size with a long N-terminus, and it has been shown to directly participate 
in recruiting an essential processing factor for histone pre-mRNA 3’ end formation (Yang et al. 
2012). The U7 snRNP that contains either N-terminal truncated Lsm11 or N-terminal mutated 
Lsm11 is defective in histone pre-mRNA 3’ end processing (Pillai et al. 2003). Recognition of 
the HDE sequence by the U7 snRNP is an essential event for histone pre-mRNA 3’ end 
processing and has been proposed to serve as a molecular ruler that specifies the site of 
cleavage. Mutations introduced into the HDE sequence that compromise U7 snRNA 
complimentary base paring consistently lead to complete inhibition of the 3’ end cleavage 
reaction and alteration of the distance between the stem-loop and the HDE sequence shifts 
the location of the cleavage site (Mowry et al. 1989; Scharl and Steitz 1994).  
     Mutation of the stem-loop (SL) sequence or genetic loss of SLBP leads to misprocessing of 
histone pre-mRNA underscoring the essential nature of this element and its RNA binding 
protein (Wang et al. 1996).  However, mutations introduced into the stem-loop sequence in the 
context of an HDE that has very high complementarity with the U7 snRNA does not 
significantly affect the efficiency of 3’ end processing tested in vitro (Dominski et al. 1999). 
This suggests that the recognition of the stem-loop by SLBP is used to stabilize binding of U7 
snRNP to the HDE, especially in histone pre-mRNAs with relatively weak complementarity of 
the HDE sequence to U7 snRNA 5’ end. This notion is further supported by the evidence that 
ZFP100 interacts with the SL/SLBP complex and Lsm11 thus bridging both factors (Dominski 
et al. 2002; Azzouz et al. 2005). Additional interactions have been identified with the recent 
finding that binding between a 220 kDa proapoptotic protein FLASH and Lsm11 in the U7 
snRNP is essential for histone pre-mRNA 3’ end processing (Yang et al. 2009). The N-terminal 
regions of these two proteins interact and form a platform for a unique combination of 
polyadenylation factors including all CPSF subunits, Symplekin and CstF subunits, providing a 
molecular mechanism for recruitment the similar cleavage factor containing the endonuclease 
CPSF73 to histone pre-mRNAs (Burch et al. 2011; Yang et al. 2012). Finally, in stark contrast 
to its role in protein-encoding genes, the CTD of Rpb1 is likely not required for coupling 
transcription and 3’ end processing of histone pre-mRNA. Evidence shows that inhibition of the 
CTD Ser2 kinase Cdk9 affects neither transcription of histone genes nor 3’ end processing of 
histone pre-mRNAs (Medlin et al. 2005). 
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The uridine-rich small nuclear RNAs.     U snRNA primary transcripts made by RNAPII are 
very similar to their histone pre-mRNA counterparts in that both transcripts are short, 
intronless, and contain a stem-loop structure at their 3’ end. For snRNA, however, the size and 
content of this 3’ stem-loop is not well conserved, and the 3’ end processing signal 
downstream of the cleavage site is an AU-rich cis-regulatory sequence element termed “3’ 
box” (Hernandez 1985). The 3’ box is located 9-19 nucleotides downstream of the 3’ end of 
mature snRNA and has a typical sequence of GTTTN0-3AAAPuN2AGA (N, any nucleotide; Pu, 
purine). Unlike the rigid requirement for the HDE element in 3’ end processing of the histone 
pre-mRNAs, the snRNA 3’ box is required but more tolerant to mutation in that no single point 
mutation significantly compromises efficient snRNA 3’ end processing (Ach and Weiner 1987; 
Ezzeddine et al. 2011). This suggests that other mechanisms are likely to contribute to the 
cleavage specificity. Indeed, mutagenesis analysis of Drosophila U7 snRNA reveals that its 3’ 
end stem-loop structure is also required for efficient 3’ end formation, which is analogous to 
the role of the 3’ end stem-loop in histone pre-mRNA 3’ end formation (Ezzeddine et al. 2011). 
Accurate 3’ end formation of pre-snRNA in metazoan cells also requires that transcription 
initiates from the unique TATA-less snRNA promoters. Replacing the snRNA promoter with 
other RNAPII promoters completely abolishes proper pre-snRNA 3’ end formation, indicating 
that unique factors important for accurate 3’ end processing must load onto the snRNA 
promoter early in the transcription cycle (de Vegvar et al. 1986; Hernandez and Weiner 1986; 
Ezzeddine et al. 2011).  
      In addition to the promoter-coupled 3’ end formation is the fact that the CTD of Rpb1 is 
also required for snRNA gene expression. Inhibition of Cdk9 activity by kinase inhibitors does 
not affect snRNA gene transcription but abolishes their RNA 3’ end processing suggesting that 
phosphorylation of serine 2 of the CTD is selectively required for snRNA 3’ end processing but 
is dispensable for transcription elongation (Medlin et al. 2003; Jacobs et al. 2004). Indeed, 
follow-up studies in mammalian cells demonstrate that a double phosphorylation mark on the 
RNAPII CTD, pSer2 and pSer7 is required for recruitment of the snRNA specific 3’ end 
processing machinery-the Integrator complex to snRNA gene promoters (Egloff et al. 2007; 
Egloff et al. 2010).  
 
The snRNA 3’ -end processing complex: Integrator Complex 
     The Integrator complex was serendipitously discovered by Baillat et al from the Shiekhattar 
laboratory to associate with the CTD of RNAPII and serves as the 3’ end processing 
machinery for metazoan RNAPII transcribed U snRNAs (Baillat et al. 2005). The name 
“Integrator” refers to integrating the CTD of RNAPII largest subunit with the 3’ end processing 
of small nuclear RNAs U1 and U2. The original biochemical purification and mass 
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spectrometric analysis identified twelve different polypeptides that exhibited very little 
homology with known proteins. A domain schematic of all 12 known human Integrator proteins 
analyzed by Pfam is shown in Figure 1.5 and well-defined domains are shown in black and 
regions with high sequence conservation are marked in grey. Proteins in the complex are 
annotated in numerical order based on migration size on the SDS-PAGE gel, with Integrator 1 
(IntS1) migrating the slowest with a molecular weight of ~ 244 kDa and IntS12 migrating as the 
fastest at ~48 kDa. The majority of proteins in the Integrator complex were not studied at the 
time of purification, and none of the proteins have an identifiable RNA-binding domain. 
However, a close examination reveals the presence of a von Willebrand factor type A (VWA) 
domain in IntS6, Armadillo repeats (ARM) in IntS4 and IntS7, and a plant homeodomain (PHD) 
finger in IntS12. IntS11/RC-68 and IntS9/RC-74 both contain the MBL/β-CASP domains and 
display high sequence similarity to the cleavage and polyadenylation specificity factor CPSF73 
and CPSF100, which are known to function in the cleavage reaction of other RNAPII 
transcripts (Dominski et al. 2005a; Dominski et al. 2005b). Interestingly, IntS11 is predicted to 
be the catalytically active endonuclease analogous to CPSF73 that enables to cleave single 
strand RNA, and IntS9 analogous to CPSF100 has critical residues required for the activity of 
the MBL/β-CASP domain mutated, making it catalytically inactive (Mandel et al. 2006). As 
predicted, IntS9 and IntS11 have been shown to form heterodimer through their C-terminal 
regions using yeast two-hybrid analysis and pulldown assays and this interaction is important 
for snRNA 3’ end formation in vivo (Albrecht and Wagner 2012). Based on these results, 
IntS9/11 are proposed to form the core that performs the catalytic cleavage reaction of the pre-
snRNA. An in vitro RNA cleavage assay or a co-crystallization of the snRNA substrate and the 
endonuclease will provide final evidence to support this model. The details of the Integrator 
Complex molecular mechanism remain to be determined. More specifically, it is not known 
which Integrator subunit is responsible for recognition of the 3’ box or the 3’ stem-loop 
structure and which subunit facilitates complex recruitment to the snRNA promoter to couple 
transcription with 3’ end formation. 
      Several studies have emerged to provide cellular and biological details of the Integrator 
complex in different organisms. Some of these studies are consistent with a function of snRNA 
biogenesis, whereas others suggest that Integrator proteins may function beyond that. 
Targeted disruption of mouse IntS1/KIAA1440 causes embryonic lethality at the blastocyst 
stage, demonstrating a fundamental role of IntS1 in mouse development that is not 
compensated by other genes (Hata and Nakayama 2007). The observation of accumulation of 
unprocessed, primary U2 snRNA transcript but decrease of the mature U2 snRNA transcript in 
IntS1 null embryos implies that the developmental role of IntS1 in mouse is likely through 
controlling snRNA biogenesis pathway. 
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Figure 1.5 Schematic representations of domains and motifs found in Integrator protein. 
Protein domain and conserved motif search is conducted by using Pfam analysis, and protein 
domains are labeled in black whereas conserved motif (>80%) over a stretch of ten amino 
acids are labeled in grey. The species used for conservation analysis are human, cow, 
chicken, Drosophila and zebrafish. Abbreviations: ARM, Armadillo-fold repeats; MBL, metallo-
β-lactamase domain; β-CASP, metallo-β-lactamase-associated CPSF Artemis SNM1/PSO2; 
DEAD, RNA helicase DEAD box; DUF, domain of unknown function; HEAT, HEAT repeat 
units; PHD, plant homeodomain finger; TPR repeats, tetratricopeptide repeats; VWA, von 
Willebrand factor type A domain; IntS, Integrator subunit; * represents that certain critical 
residues are altered that renders the domain inactive. 
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Similarly, IntS4 or IntS7/deflated null flies exhibit various developmental defects at early 
stages and in both cases die at the stage of late second instar larvae. Elevated levels of 
unprocessed primary U snRNAs are also observed in these Integrator null flies, suggesting 
that an essential developmental role of the snRNA biogenesis controlled by the Integrator 
complex (Rutkowski and Warren 2009; Ezzeddine et al. 2011). Moreover, antisense 
morpholino-mediated depletion of IntS5 (or IntS9 and IntS11) in zebrafish embryos causes 
specific red blood cell differentiation arrest. This is reported to be a requirement of the 
Integrator complex for the bone morphogenetic protein (BMP) signaling pathway, a pathway 
essential for the specification and proliferation of blood progenitors. Depletion of the Integrator 
subunits affects snRNA processing, which in turn leads to aberrant splicing of smad1 and 
smad5 pre-mRNAs, two downstream effectors of BMP signaling important for hematopoiesis 
(Tao et al. 2009). The observed developmental defect in zebrafish is surprisingly specific and 
one possible explanation is that splicing of these particular pre-mRNAs at specific 
developmental stage is sensitive to the levels of functional snRNA in cells.  
      Recent studies from several different laboratories have identified IntS3 as DNA damage 
response gene as IntS3 localizes to DNA damage foci once human cells are subject to 
genotoxic stress (Huang et al. 2009; Li et al. 2009; Skaar et al. 2009). It is found to be one 
component of the heterotrimeric sensor of single-stranded DNA (SOSS) complex that is likely 
involved in maintenance of genome stability. IntS3 may function as a platform to form the 
complex and its N-terminal region including the highly conserved DUF domain shown in Figure 
1.5 is required for both interactions with other two components in the complex (Huang et al. 
2009). The SOSS complex appears to be distinct from the known Integrator complex, as 
SOSS subunits other than IntS3 were neither found in the original Integrator purification nor in 
the recent high-throughout proteomic analysis of Integrator immunoprecipitations 
(Malovannaya et al. 2010; Malovannaya et al. 2011). Recently, a DNA damage response 
screen also identified IntS7 as one candidate protein that is recruited to the sites of DNA 
damage (Cotta-Ramusino et al. 2011). But it is still unknown how IntS7 participates in the DNA 
damage response. IntS6/DICE1 (deleted in cancer 1) is the only member in the Integrator 
complex that had been functionally studied before the purification of the Integrator complex 
(Wieland et al. 1999; Han et al. 2006; Filleur et al. 2009). IntS6 is a putative tumor suppressor 
gene, as it is often found to be deleted or downregulated in the majority of non-small cell lung 
carcinomas and prostate cancers and overexpression of IntS6 in prostate cancer cells or 
human non-small cell lung carcinoma cells inhibits colony formation and causes a cell-cycle 
arrest (Wieland et al. 1999; Filleur et al. 2009). No mutations in IntS6 were reported in human 
non-small cell lung carcinomas and prostate cancers, and the reduced levels of expression in 
prostate cancers is due to CpG hypermethylation of the IntS6 promoter (Ropke et al. 2005). It 
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is unexpected that loss or downregulation of a specific Integrator protein, which would 
presumably affect snRNA biosynthesis, correlates to tumorigenesis. The possible explanation 
is that IntS6 may form different complexes that function in different pathways. IntS6 contains 
an N-terminal well-conserved VWA (von Willebrand factor type A) domain, which is present in 
both extracellular and intracellular proteins. The extracellular VWA domains are found to 
mediate adhesion via metal ion-dependent adhesion sites (MIDAS), and the intracellular VWA 
proteins are commonly found in multiprotein complexes, which are involved in a variety of 
functions such as transcription, DNA repair and the proteasome (Whittaker and Hynes 2002). 
Absence of a signal motif and association with the RNAPII CTD suggests that IntS6 plays an 
intracellular function. Work on the worm orthologue of IntS6 (DIC-1) however, suggests that 
DIC-1 is a mitochondrial protein located in the inner membrane of mitochondria, and is 
required for formation of the normal morphology of mitochondria. DIC-1 is required for worm 
development as RNAi-mediated depletion of DIC-1 leads to defective oogenesis and inviable 
embryos (Han et al. 2006). This observation is unexpected, as Integrator proteins have been 
shown to function in the nucleus in snRNA 3’ end formation. Finally, IntS4 (or IntS11) has 
been found to be required for the Integrity of the nuclear Cajal bodies as RNAi-mediated 
depletion of IntS4 significantly abolishes Cajal body formation in HeLa cells (Takata et al. 
2012). Given the importance of the Integrator complex in snRNA 3’ end formation, it is very 
likely that Integrator complex contributes to nuclear Cajal body formation through controlling 
snRNA maturation. 
      Besides the known Integrator subunits, a recent high-throughput proteomic analysis of 
immunoprecipitates from human cells using specific antibodies against different Integrator 
subunits confirms the presence of all 12 Integrator proteins in the complex and demonstrates 
the existence of additional protein factors that form an expanded complex (Malovannaya et al. 
2010; Malovannaya et al. 2011). However, no functional studies have been done to determine 
the importance of these factors, especially their roles in snRNA 3’ end formation, making their 
importance to snRNA biogenesis unknown. 
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SIGNIFICANCE OF THE STUDY 
      RNA processing is a major engine driving diversity within the proteome that is absent in 
the comparatively simpler genome. Not surprisingly, mutations in many of the genes involved 
in RNA processing can lead to human diseases manifesting in almost any tissue type. One of 
the most dramatic examples of such a disease is SMA, which is caused by attenuation in the 
activity of the SMN protein that is responsible for snRNP assembly (Coady and Lorson 2011; 
Workman et al. 2012). SMA and a host of other splicing-related diseases underscore the need 
for further understanding of snRNA biogenesis. 
      The combined efforts of several laboratories have created the paradigm that the 3’ end 
formation of metazoan RNAPII-transcribed snRNA requires the snRNA promoter itself as well 
as the 3’ box and the potential 3’ stem-loop structure (Hernandez 1985; Ezzeddine et al. 
2011). It is clear that the 3’ box is not a termination site as RNAPII has been found to 
transcribe much further downstream (Cuello et al. 1999). Rather, it is a cis-regulatory element 
that likely binds a complex of proteins that carry out the 3’ end cleavage reaction but the 
components of this complex had remained unknown until 2005. 
      The identification of the Integrator complex as the snRNA 3’ end processing machinery 
represents a significant advancement in our knowledge of how snRNA 3’ end formation occurs 
(Baillat et al. 2005). The Integrator subunits were purified due to their association with the CTD 
of the large subunit RNAPII. The initial purification identified twelve polypeptides that bear little 
resemblance to the 3’ processing factors known to participate in both poly(A) mRNA and 
histone mRNA 3’ end formation with the exception of IntS9/11. The predicted snRNA 3’ end 
processing model (Figure 1.4), which is analogous to the counterpart for poly(A) mRNA or 
histone mRNA 3’ end processing, involves recognition of the 3’ box and 3’ stem-loop elements 
by Integrator proteins, which subsequently recruit the endonuclease IntS11 to perform the 
cleavage reaction.  
      Since no identifiable RNA-binding domain is present in the original purified Integrator 
complex and a more expanded biochemical Integrator complex has been identified, we set out 
to identify the candidate protein factors that are functionally required for snRNA 3’ end 
formation by a genome-wide functional RNAi screen in Drosophila S2 cells. Chapter 3 
describes the genome-wide screen data and it shows that a majority of the known Integrator 
subunits (10/12) are required for reporter U7 snRNA 3’ end formation. Importantly, this screen 
identified Asunder and CG4785 as two additional core Integrator subunits that are functional 
required for snRNA 3’ end formation and biochemically interact with the known Integrators. 
The screen also identified a conserved requirement for Cyclin C/Cdk8 in snRNA 3’ end 
formation. This work is important for understanding snRNA 3’ end formation because it 
provides genome-wide analysis from a functional perspective, and thus complements the 
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existing biochemical data. This work also lays the foundation to further understand the 
mechanism of the snRNA 3’ end machinery through the identification of additional critical 
factors required for cis-regulatory sequence element recognition and cleavage complex 
assembly. 
      The work described in Chapter 4 characterizes the role of one of the Integrator subunits, 
IntS12, in snRNA 3’ end formation.  IntS12 is the smallest subunit in the Integrator Complex 
and contains a centrally located and well-conserved plant homeodomain (PHD) finger. Data in 
Chapter 4 demonstrate the surprising finding that there is an N-terminal “microdomain” within 
IntS12 that is capable of mediating its function in snRNA 3’ end formation. The IntS12 
microdomain mediates its function through an interaction with IntS1, while the centrally located 
conserved PHD finger is functionally dispensable. These results suggest that IntS12 
contributes to snRNA 3’ end formation through a requisite binding to IntS1, which is the largest 
Integrator subunit. Chapter 5 further characterizes the biochemical features of IntS12, focusing 
specifically on its PHD finger and its affinity toward histones. Data in this chapter show that 
though functionally not required for processing of the reporter snRNA 3’ end, the IntS12 PHD 
finger avidly binds histone H3 in vitro, and enhances interaction with other Integrators in cells. 
The cellular function of these biochemical interactions is not known yet, but we speculate that 
the PHD finger is playing a role beyond snRNA processing. 
      At the beginning of my doctoral research, very little was known about the human Integrator 
Complex and essential nothing was known about the fly complex. Taken together, data 
presented in these studies functionally define the Drosophila Integrator complex to comprise of 
fourteen core subunits (IntS 1-12, Asu/IntS13, IntS14), and of a regulatory CycC/Cdk8 kinase. 
These features are likely conserved in other metazoan species. This work also provides the 
first detailed structural-functional analysis of the smallest Integrator subunit and reveals an 
unexpected autonomous microdomain mediating the activation of the Integrator complex in 
snRNA 3’ end formation. All of the work presented here provides a foundation for future 
studies to characterize the network of interactions within the Integrator Complex that are 
important for snRNA 3 end formation. 
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Plasmids and Cell Lines Used 
 
      Plasmids and oligonucleotides (Sigma) used in these studies are described in Table 2.1 
and Table 2.2, respectively. The pUB-Myc/HA/FLAG Drosophila expression vector was 
generated by cloning the ubiquitin 63E promoter (ubi-p63E) and the viral OpIE2 
polyadenylation signal into the bacterial plasmid pUC19 backbone. The Green Fluorescent 
Protein (GFP) based snRNA readthrough reporters were constructed by cloning the snRNA 
gene (including the promoter, coding sequence and 3’ flanking sequence) upstream of the 
EGFP Open Reading Frame (ORF) into the promoterless pUB (Drosophila snRNA-GFP 
reporter) or pcDNA6 (human U7-GFP reporter) vectors as described in detail previously 
(Ezzeddine et al. 2011; Albrecht and Wagner 2012). The GFP-based histone H3 reporter and 
Actin5C promoter driven H3 reporter were described in detail earlier (Wagner et al. 2007; 
Yang et al. 2009). The Drosophila expression clones (pUB-Myc/HA/FLAG), the yeast two 
hybrid clones (pGADT7 and pGBKT7) and bacterial recombinant protein clones (pET49) were 
constructed by standard PCR cloning procedures. Site-directed mutation-containing clones 
were created using the QuickChange method (Stratagene).  
      All cell lines and bacterial and yeast strains used in these studies are listed in Table 2.3.  
D.mel-2 (S2) cells from Invitrogen (Catalog No. 10831-014) were used for most of studies 
described here. S2 stable cell lines were generated by co-transfection of the plasmids 
expressing FLAG-tagged protein with a Blastocidin expressing plasmid (w/w,19:1) and 
selection was performed in Drosophila media (Invitrogen) containing 10%FBS and 25 ug/mL 
blastocidin. Escherichia coli XL-1 blue was used for standard cloning, and E.coli BL-21 (DE3) 
was used for expression of recombinant IntS12 proteins. Yeast strain AH109 (a/α) was used to 
perform the yeast two-hybrid assay (Clontech, Matchmaker 3). 
 
Cell Culture and RNA Interference 
      S2 cells were maintained in Sf-900 II SFM medium (Invitrogen) unless otherwise 
mentioned following the manufacture’s instructions. Double-stranded RNA (dsRNA) used for 
the RNA interference (RNAi) experiment in S2 cells were created by in vitro transcription of the 
T7 DNA templates using T7 RNA polymerase (Fermentas). All T7 DNA templates were 
created by PCR amplification of targeted genes off of genomic DNA using primers containing 
T7 promoters at the 5’ end. In all cases, PCR primers were designed to amplify exons to 
preclude the inclusion of intronic sequences in the dsRNA. To minimize off-target effects 
(OTEs), the online dsRNA design tools “Snapdragon” (http://www.flyrnai.org/cgi-
bin/RNAi_find_primers.pl) and “Find OTEs” (http://www.flyrnai.org/RNAi_find_frag_free.html) 
!
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Table 2.1: Plasm
ids used 
 
 
N
am
e 
D
escription 
M
arker 
O
rigin 
pU
B
 
pU
C
19 backbone, ubi-63E
 prom
oter, O
pIE
2 polyA
 site 
A
m
p 
W
agner lab 
pIZ-U
7G
FP
 
P
rom
oterless pIZ vector, U
7 prom
oter, coding region, 3' U
TR
 follow
ed by 
eG
FP
 coding sequence (ref) 
Zeo 
W
agner lab 
pU
B
-U
4G
FP
 
P
rom
oterless pU
B
 vector, U
4 prom
oter, coding region, 3' U
TR
 follow
ed by 
eG
FP
 O
R
F 
A
m
p 
W
agner lab 
pcD
N
A
-hU
7G
FP
 
D
escribed by A
lbrecht and W
agner 2012 (ref) 
A
m
p 
W
agner lab 
pIZ-H
3G
FP
 
D
escribed by W
agner and M
arzluff 2007 (R
ef) 
Zeo 
W
agner lab 
pIZ-A
ctH
3G
FP
 
D
escribed by E
zzeddine and W
agner 2011 (ref) 
Zeo 
W
agner lab 
pU
B
-M
yc-C
dk8 
U
bi-p63E
 prom
oter, D
rosophila C
dk8 O
R
F 
A
m
p 
C
O
3, C
O
4 
pU
B
-M
yc-C
dk8(D
N
) 
U
bi-p63E
 prom
oter, D
rosophila kinase activity dead C
dk8 O
R
F (D
173A
) 
A
m
p 
W
O
127, W
O
128 
pU
B
-M
yc-IntS
12 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12 O
R
F 
A
m
p 
C
O
63, C
O
20 
pU
B
-M
yc-IntS
12* 
U
bi-p63E
 prom
oter, M
yc, D
rosophila R
N
A
i-resistant IntS
12 O
R
F 
A
m
p 
C
O
13, C
O
20 
pU
B
-M
yc-Δ
C
 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 2-251 
A
m
p 
C
O
13, C
O
14 
pU
B
-M
yc-N
P
 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 2-185 
A
m
p 
C
O
13, C
O
21 
pU
B
-M
yc-N
 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 2-130 
A
m
p 
C
O
13, C
O
15 
pU
B
-M
yc-C
 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 184-328 
A
m
p 
C
O
20, C
O
22 
pU
B
-M
yc-P
C
 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 124-328 
A
m
p 
C
O
16, C
O
20 
pU
B
-M
yc-Δ
N
 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 46-328 
A
m
p 
C
O
17, C
O
20 
pU
B
-M
yc-P
 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 124-185 
A
m
p 
C
O
16, C
O
21 
pU
B
-M
yc-Δ
P
 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 2-130 and 184-328 
A
m
p 
C
O
13-C
O
18, 
C
O
19-C
O
20, 
C
O
13-C
O
20 
pU
B
-M
yc-Δ
N
15 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 16-328 
A
m
p 
C
O
41, C
O
20 
pU
B
-M
yc-Δ
N
30 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 31-328 
A
m
p 
C
O
23, C
O
20 
pU
B
-M
yc-N
45 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 2-45 
A
m
p 
C
O
13, C
O
24 
pU
B
-M
yc-IntS
12*M
t1 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* (16D
P
V
LK
20->A
A
A
A
A
) 
A
m
p 
C
O
25, C
O
26 
pU
B
-M
yc-IntS
12*M
t2 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* (21K
A
IK
L25->A
A
A
A
A
) 
A
m
p 
C
O
27, C
O
28 
pU
B
-M
yc-IntS
12*M
t3 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* (26LH
S
S
N
30->A
A
A
A
A
) 
A
m
p 
C
O
29, C
O
30 
pU
B
-M
yc-IntS
12*M
t4 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* (31P
TS
A
A
35->A
A
A
A
A
) 
A
m
p 
C
O
31, C
O
32 
!
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Table 2.1: Plasm
ids used (continued) 
 
 
N
am
e 
D
escription 
M
arker 
O
rigin 
pU
B
-M
yc-IntS
12*M
t5 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* (36E
LR
LL40->A
A
A
A
A
) 
A
m
p 
C
O
33, C
O
34 
pU
B
-M
yc-IntS
12*M
t6 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* (41LD
E
A
L45->A
A
A
A
A
) 
A
m
p 
C
O
35, C
O
36 
pU
B
-M
yc-IntS
12*N
M
t1 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12*N
 (16D
P
V
LK
20->A
A
A
A
A
) 
A
m
p 
C
O
25, C
O
26 
pU
B
-M
yc-IntS
12*N
M
t2 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12*N
 (21K
A
IK
L25->A
A
A
A
A
) 
A
m
p 
C
O
27, C
O
28 
pU
B
-M
yc-IntS
12*N
M
t3 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12*N
 (26LH
S
S
N
30->A
A
A
A
A
) 
A
m
p 
C
O
29, C
O
30 
pU
B
-M
yc-IntS
12*N
M
t4 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12*N
 (31P
TS
A
A
35->A
A
A
A
A
) 
A
m
p 
C
O
31, C
O
32 
pU
B
-M
yc-IntS
12*N
M
t5 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12*N
 (36E
LR
LL40->A
A
A
A
A
) 
A
m
p 
C
O
33, C
O
34 
pU
B
-M
yc-IntS
12*N
M
t6 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12*N
 (41LD
E
A
L45->A
A
A
A
A
) 
A
m
p 
C
O
35, C
O
36 
pU
B
-M
yc-N
S
2829 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 1-129 (S
2829A
 ) 
A
m
p 
C
O
37, C
O
38 
pU
B
-M
yc-N
S
33 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 1-129 (S
33A
 ) 
A
m
p 
C
O
39, C
O
40 
pU
B
-M
yc-N
T56 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 1-129 (T56A
 ) 
A
m
p 
C
O
47, C
O
48 
pU
B
-M
yc-N
T76 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 1-129 (T76A
 ) 
A
m
p 
C
O
51, C
O
52 
pU
B
-M
yc-N
T91 
U
bi-p63E
 prom
oter, M
yc, D
rosophila IntS
12* residues 1-129 (T91A
 ) 
A
m
p 
C
O
49, C
O
50 
pU
B
-H
A
-IntS
12 
U
bi-p63E
 prom
oter, H
A
, D
rosophila IntS
12 
A
m
p 
C
O
5, C
O
6 
pU
B
-FLA
G
-A
su 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila A
sunder O
R
F 
A
m
p 
C
O
80, C
O
81 
pU
B
-FLA
G
-C
G
4785 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila C
G
4785 O
R
F 
A
m
p 
C
O
82, C
O
83 
pU
B
-FLA
G
-m
C
herry 
U
bi-p63E
 prom
oter, FLA
G
, m
C
herry O
R
F 
A
m
p 
C
O
53, C
O
54 
pU
B
-FLA
G
-C
dk8 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila C
dk8 O
R
F 
A
m
p 
C
O
3, C
O
4 
pU
B
-FLA
G
-C
ycC
 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila C
yclin C
 O
R
F 
A
m
p 
C
O
1, C
O
2 
pU
B
-FLA
G
-IntS
12* 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila IntS
12* 
A
m
p 
C
O
13, C
O
20 
pU
B
-FLA
G
-M
t3 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila IntS
12* (26LH
S
S
N
30->A
A
A
A
A
) 
A
m
p 
C
O
29, C
O
30 
pU
B
-FLA
G
-M
t5 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila IntS
12* (36E
LR
LL40->A
A
A
A
A
) 
A
m
p 
C
O
33, C
O
34 
pU
B
-FLA
G
-Δ
N
 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila IntS
12* residues 46-328 
A
m
p 
C
O
17, C
O
20 
pU
B
-FLA
G
-N
45 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila IntS
12* residues 1-45 
A
m
p 
C
O
13, C
O
24 
pU
B
-FLA
G
-N
45C
h 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila IntS
12* residues 1-45 fused to 
m
C
herry 
A
m
p 
C
O
13-C
O
55, 
C
O
53-C
O
54 
pU
B
-FLA
G
-12N
m
C
h 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila IntS
12 residues 1-129, m
C
herry 
A
m
p 
C
O
13-C
O
56, 
C
O
53-C
O
54 
pU
B
-FLA
G
-12N
T76m
C
h 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila IntS
12 residues 1-129 (T76A
), m
C
he 
A
m
p 
C
O
61, C
O
62 
!
27 
Table 2.1: Plasm
ids used (continued) 
 
 
N
am
e 
D
escription 
M
arker 
O
rigin 
pU
B
-FLA
G
-12N
P
m
C
h 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila IntS
12 residues 1-185, m
C
herry 
A
m
p 
C
O
13-C
O
57, 
C
O
53-C
O
54 
pU
B
-FLA
G
-12N
P
Lm
C
h 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila IntS
12 residues 1-185 (L145A
), 
m
C
herry 
A
m
p 
C
O
74, C
O
75 
pU
B
-FLA
G
-12N
P
E
m
C
H
 
U
bi-p63E
 prom
oter, FLA
G
, D
rosophila IntS
12 residues 1-185 (E
147A
), 
m
C
herry 
A
m
p 
W
O
811, W
O
812 
pU
B
-FLA
G
-m
C
h12C
 
U
bi-p63E
 prom
oter, FLA
G
, m
C
herry,  D
rosophila IntS
12 residues 184-328 
A
m
p 
C
O
58-C
O
20, 
C
O
59-C
O
60 
pG
A
D
T7-A
su 
A
D
H
1 prom
oter, G
A
L4 activation dom
ain, H
A
 epitope tag, D
rosophila 
A
sunder O
R
F 
A
m
p, 
LE
U
2 
W
O
, W
O
 
pG
A
D
T7-C
G
4785 
A
D
H
1 prom
oter, G
A
L4 activation dom
ain, H
A
 epitope tag, D
rosophila 
C
G
4785 O
R
F 
A
m
p, 
LE
U
2 
W
O
, W
O
 
pG
A
D
T7-IntS
12 
A
D
H
1 prom
oter, G
A
L4 activation dom
ain, H
A
 epitope tag, D
rosophila IntS
12 
A
m
p, 
LE
U
2 
C
O
76, C
O
77 
pG
A
D
T7-IntS
12M
t3 
A
D
H
1 prom
oter, G
A
L4 activation dom
ain, H
A
 epitope tag, D
rosophila IntS
12 
(26LH
S
S
N
30->A
A
A
A
A
) 
A
m
p, 
LE
U
2 
C
O
76, C
O
77 
pG
A
D
T7-IntS
12M
t5 
A
D
H
1 prom
oter, G
A
L4 activation dom
ain, H
A
 epitope tag, D
rosophila IntS
12 
(36E
LR
LL40->A
A
A
A
A
) 
A
m
p, 
LE
U
2 
C
O
76, C
O
77 
pG
A
D
T7-IntS
12Δ
N
 
A
D
H
1 prom
oter, G
A
L4 activation dom
ain, H
A
 epitope tag, D
rosophila IntS
12 
residues 46-328 
A
m
p, 
LE
U
2 
C
O
78, C
O
77 
pG
A
D
T7-IntS
12N
45 
A
D
H
1 prom
oter, G
A
L4 activation dom
ain, H
A
 epitope tag, D
rosophila IntS
12 
residues 1-45 
A
m
p, 
LE
U
2 
C
O
76, C
O
79 
pG
B
K
T7-IntS
1 
A
D
H
1 prom
oter, G
A
L4 D
N
A
 binding dom
ain, c-M
yc epitope tag, D
rosophila 
IntS
1 O
R
F 
K
an, 
TR
P
1 
W
arren lab 
pG
B
K
T7-IntS
2 
A
D
H
1 prom
oter, G
A
L4 D
N
A
 binding dom
ain, c-M
yc epitope tag, D
rosophila 
IntS
2 O
R
F 
K
an, 
TR
P
1 
W
arren lab 
pG
B
K
T7-IntS
3 
A
D
H
1 prom
oter, G
A
L4 D
N
A
 binding dom
ain, c-M
yc epitope tag, D
rosophila 
IntS
3 O
R
F 
K
an, 
TR
P
1 
W
arren lab 
pG
B
K
T7-IntS
4 
A
D
H
1 prom
oter, G
A
L4 D
N
A
 binding dom
ain, c-M
yc epitope tag, D
rosophila 
IntS
4 O
R
F 
K
an, 
TR
P
1 
W
arren lab 
pG
B
K
T7-IntS
5 
A
D
H
1 prom
oter, G
A
L4 D
N
A
 binding dom
ain, c-M
yc epitope tag, D
rosophila 
IntS
5 O
R
F 
K
an, 
TR
P
1 
W
arren lab 
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Table 2.1: Plasm
ids used (continued) 
N
am
e 
D
escription 
M
arker 
O
rigin 
pG
B
K
T7-IntS
6 
A
D
H
1 prom
oter, G
A
L4 D
N
A
 binding dom
ain, c-M
yc epitope tag, D
rosophila 
IntS
6 O
R
F 
 K
an, 
TR
P
1 
 W
arren lab 
pG
B
K
T7-IntS
7 
A
D
H
1 prom
oter, G
A
L4 D
N
A
 binding dom
ain, c-M
yc epitope tag, D
rosophila 
IntS
7 O
R
F 
K
an, 
TR
P
1 
W
arren lab 
pG
B
K
T7-IntS
8 
A
D
H
1 prom
oter, G
A
L4 D
N
A
 binding dom
ain, c-M
yc epitope tag, D
rosophila 
IntS
8 O
R
F 
K
an, 
TR
P
1 
W
arren lab 
pG
B
K
T7-IntS
9 
A
D
H
1 prom
oter, G
A
L4 D
N
A
 binding dom
ain, c-M
yc epitope tag, D
rosophila 
IntS
9 O
R
F 
K
an, 
TR
P
1 
W
arren lab 
pG
B
K
T7-IntS
10 
A
D
H
1 prom
oter, G
A
L4 D
N
A
 binding dom
ain, c-M
yc epitope tag, D
rosophila 
IntS
10 O
R
F 
K
an, 
TR
P
1 
W
arren lab 
pG
B
K
T7-IntS
11 
A
D
H
1 prom
oter, G
A
L4 D
N
A
 binding dom
ain, c-M
yc epitope tag, D
rosophila 
IntS
11 O
R
F 
K
an, 
TR
P
1 
W
arren lab 
pG
B
K
T7-IntS
12 
A
D
H
1 prom
oter, G
A
L4 D
N
A
 binding dom
ain, c-M
yc epitope tag, D
rosophila 
IntS
12 O
R
F 
K
an, 
TR
P
1 
W
arren lab 
pE
T49b(+) 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag 
K
an 
N
ovagen 
pE
T49-IntS
12P
H
D
 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 P
H
D
 finger, 
residues 120-193 
K
an 
C
O
9, C
O
10 
pE
T49-hIntS
12P
H
D
 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, hum
an IntS
12 P
H
D
 finger, residues 
130-224 
K
an 
C
O
11, C
O
12 
pE
T49-IntS
12 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 
K
an 
C
O
5, C
O
6 
pE
T-12P
H
D
V
 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 P
H
D
 finger, 
residues 120-193 (V
133A
) 
K
an 
W
O
803, W
O
804 
pE
T-12P
H
D
M
 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 P
H
D
 finger, 
residues 120-193 (M
137A
) 
K
an 
W
O
805, W
O
806 
pE
T-12P
H
D
N
 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 P
H
D
 finger, 
residues 120-193 (N
143A
) 
K
an 
W
O
807, W
O
808 
pE
T-12P
H
D
L 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 P
H
D
 finger, 
residues 120-193 (L145A
) 
K
an 
C
O
74, C
O
75 
pE
T-12P
H
D
E
 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 P
H
D
 finger, 
residues 120-193 (E
147A
) 
K
an 
W
O
811, W
O
812 
pE
T-12P
H
D
Y
 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 P
H
D
 finger, 
residues 120-193 (Y
155A
) 
K
an 
W
O
813, W
O
814 
!
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Table 2.1: Plasm
ids used (continued) 
 
 
N
am
e 
D
escription 
M
arker 
O
rigin 
pE
T-12P
H
D
H
 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 P
H
D
 finger, 
residues 120-193 (H
160A
) 
K
an 
C
O
7, C
O
8 
pE
T-12P
H
D
P
 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 P
H
D
 finger, 
residues 120-193 (P
162A
) 
K
an 
C
O
72, C
O
73 
pE
T-12P
H
D
D
 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 P
H
D
 finger, 
residues 120-193 (D
171A
) 
K
an 
C
O
64, C
O
65 
pE
T-12P
H
D
W
 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 P
H
D
 finger, 
residues 120-193 (W
177A
) 
K
an 
C
O
66, C
O
67 
pE
T-12P
H
D
C
C
H
 
T7 prom
ter,N
-term
inal G
S
T-tag, H
is-tag, D
rosophila IntS
12 P
H
D
 finger, 
residues 120-193 (C
148A
,C
151A
,H
156A
) 
K
an 
C
O
68-C
O
69, 
C
O
70-C
O
71 
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Table 2.2: Oligonucleotides used 
Cloning Oligos Sequence 
CO1 GATGAATTCTGGCGGGCAATTTTTGGCAG 
CO2 GATTCTAGACTAACGCTGAGGCGGTGG 
CO3 GCGACTAGTCGACTACGATTTCAAGATGAAAAC 
CO4 GCGTCTAGAGTTGAAGCGCTGGAAGTTC 
CO5 GCGTCTAGAATGGCCGCAAATATAGCC 
CO6 GCGAAGCTTTTACTGCTTGGATCTGCG 
CO9 GTAGAATTCTACCGGTGACACCGGCGAC 
CO10 GCGAAGCTTTTATGTTGTCCTCCCGCTGCT 
CO11 GCGGAATTCTGCTGATGATTTTGCCATG 
CO12 CGCAAGCTTTTACTGAGTTTTTTGAGCCAT 
CO13 GCGGAATTCTGGCGGCCAACATCGCGGC 
CO14 CGCTCTAGAGCTGCTACTGCTGCTGGC 
CO15 GCGTCTAGACAGATCTCCGAAATCTCC 
CO16 CGCGAATTCTGGGAGATTTCGGAGATCTG 
CO17 GATGAATTCTGCTGAAAGCCCGCTTCGGC 
CO18 CGTTGGCTTGTTCAGATCTCCGAAATCTCC 
CO19 TTCGGAGATCTGAACAAGCCAACGAGCAGC 
CO20 CGCTCTAGATTACTGCTTGGATCTGCG 
CO21 CGCTCTAGACTTGTTGCAGCACGTGTC 
CO22 GCGGAATTCTGAACAAGCCAACGAGCAGC 
CO23 GATGAATTCTGCCGACGAGCGCCGCGGAG 
CO24 CGCTCTAGACAGGGCTTCATCCAGCAG 
CO53 CATGCGGCCGCTGTGAGCAAGGGCGAGGAG 
CO54 CGCTCTAGATTACTTGTACAGCTCGTCCATG 
CO55 CATGCGGCCGCCAGGGCTTCATCCAGCAG 
CO56 CATGCGGCCGCCAGATCTCCGAAATCTCC 
CO57 CATGCGGCCGCCTTGTTGCAGCACGTGTC 
CO58 CATGCGGCCGCTAACAAGCCAACGAGCAGC 
CO59 GCGGAATTCTGGTGAGCAAGGGCGAGGAG 
CO60 CATGCGGCCGCCTTGTACAGCTCGTCCATG 
CO63 GCGGAATTCTGATGGCCGCAAATATAGCC 
CO76 GATGAATTCGCGGCCAACATCGCGGCG 
CO77 GCGGGATCCTTACTGCTTGGATCTGCGC 
CO78 GCGGAATTCCTGAAAGCCCGCTTCGGC 
CO79 CGCGGATCCTTACAGGGCTTCATCCAGCAG 
CO80 GGCCACTAGTCATGTTCGAACGCAACCAGAAG 
CO81 GGCCGAATTCTTAACTACGTACGGATTCCTCC 
CO82 GGCCGGATCCCATGCTGCGCCCGGTGCCGGG 
CO83 GGCCGAATTCTCAATACATGTATGCAGGAGC 
QuickChange Oligos 
CO7 GGTGCCATGTACGCTCAGGAGTGCCAC 
CO8 GTGGCACTCCTGAGCGTACATGGCACC 
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CO25 CGCGCAGGAGGTCGCCGCGGCCGCCGCAAAAGCGATTAAAC 
CO26 GTTTAATCGCTTTTGCGGCGGCCGCGGCGACCTCCTGCGCG 
CO27 CCGGTCCTCAAAGCAGCGGCTGCAGCGCTCCATAGCTCC 
CO28 GGAGCTATGGAGCGCTGCAGCCGCTGCTTTGAGGACCGG 
CO29 GCGATTAAACTGGCCGCTGCCGCCGCCCCGACGAGCGCC 
CO30 GGCGCTCGTCGGGGCGGCGGCAGCGGCCAGTTTAATCGC 
CO31 CATAGCTCCAACGCGGCGGCCGCCGCGGAGCTC 
CO32 GAGCTCCGCGGCGGCCGCCGCGTTGGAGCTATG 
CO33 CGAGCGCCGCGGCGGCCGCCGCCGCGCTGGATGAAGC 
CO34 GCTTCATCCAGCGCGGCGGCGGCCGCCGCGGCGCTCG 
CO35 CTCCGCCTCCTGGCGGCTGCAGCCGCGAAAGCCCGCTTC 
CO36 GAAGCGGGCTTTCGCGGCTGCAGCCGCCAGGAGGCGGAG 
CO37 AAGTTGCTGCACGCGGCTAATCCCACCTCG 
CO38 CGAGGTGGGATTAGCCGCGTGCAGCAACTT 
CO39 AGTAATCCCACCGCGGCGGCCGAACTG 
CO40 CAGTTCGGCCGCCGCGGTGGGATTACT 
CO47 GAGAAAAGTTTGGCCAACAACATGACG 
CO48 CGTCATGTTGTTGGCCAAACTTTTCTC 
CO49 ATCATCAATTTGGCCAACTCACCGGAC 
CO50 GTCCGGTGAGTTGGCCAAATTGATGAT 
CO51 GGACGTGCTGCCGCGCCCCCGCAGCAG 
CO52 CTGCTGCGGGGGCGCGGCAGCACGTCC 
CO61 GGGCCGCGCCGCGGCCCCGCCCCAACAAC 
CO62 GTTGTTGGGGCGGGGCCGCGGCGCGGCCC 
CO64 AAGGAGGAGGCGGCCGCTGACCAGGAGCAGAAC 
CO65 GTTCTGCTCCTGGTCAGCGGCCGCCTCCTCCTT 
CO66 GACCAGGAGCAGAACGCGCAGTGCGACACGTGC 
CO67 GCACGTGTCGCACTGCGCGTTCTGCTCCTGGTC 
CO68 ATGTACGCTCAGGAGGCCCACAAGCCGCCCATA 
CO69 TATGGGCGGCTTGTGGGCCTCCTGAGCGTACAT 
CO70 AATCGGCTGATTGAGGCCTCCAAGGCCGGTGCC 
CO71 GGCACCGGCCTTGGAGGCCTCAATCAGCCGATT 
CO72 CAGGAGTGCCACAAGGCGCCCATAACCAAGGAG 
CO73 CTCCTTGGTTATGGGCGCCTTGTGGCACTCCTG 
CO74 ACGGCCACCAATCGGGCGATTGAGTGCTCCAAG 
CO75 CTTGGAGCACTCAATCGCCCGATTGGTGGCCGT 
WO811 CCAATCGGCTGATTGCGTGCTCCAAGTGCGG 
WO812 CCGCACTTGGAGCACGCAATCAGCCGATTGG 
WO127 GCCGCGTAAAAATCGCCGcCATGGGTTTCGCGCGGCTC 
WO128 GAGCCGCGCGAAACCCATGGCGGCGATTTTTACGCGGC 
WO803 CGACCTCAATTGCTGCGCGTGCGGCGAGATGG 
WO804 CCATCTCGCCGCACGCGCAGCAATTGAGGTCG 
WO805 CTGCGTGTGCGGCGAGGCGGTTTTCACGGCCAC 
WO806 GTGGCCGTGAAAACCGCCTCGCCGCACACGCAG 
WO807 GGTTTTCACGGCCACCGCTCGGCTGATTGAGTGC 
! 32 
WO808 GCACTCAATCAGCCGAGCGGTGGCCGTGAAAACC 
WO813 CAAGTGCGGTGCCATGGCCCATCAGGAGTGCCAC 
WO814 GTGGCACTCCTGATGGGCCATGGCACCGCACTTG 
  PCR Oligos for endogenous misprocessed/unprocessed snRNA 
U1-pF GCTGAGTTGACCTCTGCGATTA 
U1-pR CTTTTAAAATTTATTGCAGATGTCGG 
U2 pF CCCGGTATTGCAGTACCGCCGGGA 
U2 pR CAAAGGACACTTTCGACATGTC 
U4 pF GGTGGCAATACCGTAACCAAT 
U4 pR GGCTAAGACAACCGTCATATTAA 
U5 pF CGCCTTTTACTAAAGATTTCCGTGG 
U5 pR CCATGTATATGACCACCAGACC 
Rps17 for CGAACCAAGACGGTGAAGAAG 
Rps17 rev CCTGCAACTTGATGGAGATACC 
  Realtime PCR Oligos for Integrator mRNAs 
IntS2-1-f GAGCTGAAGAAGGAGCTGCAG 
IntS2-1-r CAGATCCTCGGGATGCTTGAG 
IntS3-1-f GAGATGCATGATATGTTGTCAC 
IntS3-1-r GGCGTACAAAATCTCTTCCTAG 
IntS4-1-f CGTCAACAGGTGTCATCG 
IntS4-1-2-r GCTCGAGTCCTGCGAGTC 
IntS5-2-f CGGAAAATCGCGAGAACC 
IntS5-2-r CAGTGCGCGCAGTAGCAC 
IntS6-1-f CGCTGGGATCAGCGCTTG 
IntS6-1-r GACGGGGAAGCTGCGCAC 
IntS7-1-f CATCTGGACAAGATCCTCAAC 
IntS7-1-r GTATGCGTACTGGTGTCC 
IntS8-2-f CTGCTGGAGAAGTTCCAGC 
IntS8-2-r CTTGGAGTGACACATCCAGTC 
IntS10-1-1-f GTTGTACATGGTCAAGGAG 
IntS10-1-2-r CAGATTTGGCGAAAGTTCC 
IntS13-1-f CTCCAAGAAGGGACTGGTC 
IntS13-1-2-r GCTGGAGTTGGCGTTCTG 
IntS14-2-f CACGAACGTGATTCCCTGG 
IntS14-2-r GTAAACACAGTCTTAAAGTAAGGAC 
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from Harvard Drosophila RNAi Screening Center (DRSC) were used. In vitro transcribed 
dsRNA was purified using TRIzol reagent (Invitrogen) and the quality of dsRNA was assessed 
by electrophoresis or using the Nanodrop spectrophotometer (Thermo Scientific). To perform 
RNAi in S2 cells, 5x104 cells per 96 well in 100µl of Sf-900 II media or 3x105 cells per 24 well 
in 300µl medium were plated in each well and supplemented with 1µg (96-well) or 3µg (24-
well) dsRNA. The next day, an additional 1µg or 3µg of dsRNA was added and then cells were 
harvested in the fourth day for qRT-PCR or Western blot analysis. Cells were harvested for 
analysis using TRIzol for total RNA extraction or radioimmunoprecipitation assay (RIPA) buffer 
[50 mM Tris-HCl pH 8, 150 mM NaCl, 1% NP-40, 0.5% Na deoxycholate, 0.1% SDS] for 
protein lysates.  
      HeLa cells were cultured in Dulbecco’s modified Eagle medium (DMEM) (Invitrogen, 
Carlsbad CA) supplemented with 1% penicillin-streptomycin (pen/strep) (Invitrogen) and 10% 
fetal bovine serum (FBS; Phenix Research, NC). RNAi experiments in HeLa cells were 
performed by the use of the manufacturer’s instructions for Lipo-fectamine 2000 with minor 
modifications. Briefly, 3µl of 20 µM siRNAs were mixed with 47µl of Opti-MEM (Invitrogen) in 
tube A, and 12µl of Opti-MEM and 3µl of Lipofectamine 2000 were mixed in Tube B. Both 
tubes were incubated at room temperature for 7 min, and then the contents were mixed and 
incubated at room temperature (RT) for an additional 25 min. After this incubation, 38µl of 
Opti-MEM was added and the mixture (100µl/tube) was pipetted dropwise into the wells. For 
siRNA transfection, 8.5x104 cells per well were initially plated in 24-well plates, and in second 
day after the RNAi treatment, cells were re-plated into a 6-well plate for each well containing 2 
ml DMEM complete media. The next day, the same amount of siRNA and 500 ng human U7-
GFP reporter cells were co-transfected into each well under the conditions described above. 
Two days after the second siRNA transfection, cells were harvested for Western blot analysis.  
 
Quantitative Real Time-PCR (qRT-PCR) Analysis 
      Total RNA was isolated from Drosophila S2 cells using TRIzol reagent, and 2 µg of 
RNA was treated with DNase I (Fermentas, Burlington, ON, Canada) in accordance 
with the manufacturer’s recommendations. Reverse transcription was performed on the 
2 µg of RNA using random hexamer primers and MMLV reverse transcriptase 
(Invitrogen) in a total volume of 20µl at 37°C for 1 h, followed by incubation at 95°C for 
5 min. In each case, 2µl of the reverse transcription product was used for real-time 
PCR reaction using SYBR green master mix (Fermentas) and specific primers to each 
amplicon tested (for oligonucleotides, see Table 2.2). Data were acquired using a 
Stratagene Mx3000P real-time PCR machine, and were analyzed by the ΔΔCT (CT, 
threshold cycle) method using the equation fold change = 2-[(CTGOI – CTnorm)control – (CTGOI – 
CT
norm
)
treated
], where CTGOI is the CT for the gene of interest and CTnorm is the normalized 
CT. Triplicate experiments were performed for each Integrator knockdown, and data 
are plotted as fold increases in amplicon CT values normalized to the reference gene 
RpS17 versus those for the control dsRNA-treated cells, which were also normalized to 
RpS17. (An excerpt from: Ezzeddine, N., et al. (2011). "A subset of Drosophila 
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integrator proteins is essential for efficient U7 snRNA and spliceosomal snRNA 3'-end 
formation." Mol Cell Biol 31(2): 328-341.) 
 
Immunoprecipitation 
      For immunoprecipitation of FLAG-tagged protein, 1 mg nuclear extracts were 
incubated with 10 µl of anti-FLAG antibody-conjugated agarose beads (anti-FLAG M2 
affinity gel, Sigma) with constant rotation for 2 hrs at 4 °C in buffer D [20 mM HEPES 
pH7.9, 20% glycerol, 0.1 M KCl, 0.2 mM EDTA, 0.5 mM PMSF] plus 0.1% Triton X- 
100. Beads were washed twice with 1XTris Buffered Saline [50 mM TrisHCl pH 7.4, 
150 mM NaCl] and then twice with buffer D plus 0.1% Triton X-100. During last wash, 
switch to new tube. For immunoprecipitation of endogenous protein, 2 µg antigen 
purified antibody was pre-incubated with 20 µl Protein A/G beads (Santa Cruz 
Biotechnology, Inc.) with constant rotation in buffer D at 4 °C for 1 hr, and then 400 µg 
nuclear extracts were added and incubated with rotation for another 2 hrs at 4 °C. 
Wash condition is same as above mentioned. Finally 50 µl of 1XSDS loading buffer 
was added to the beads and boil at 95 °C for 3 minutes and resolved in 12.5% SDS-
PAGE gel. Western blot analysis was performed using standard procedure. (An 
excerpt from: Chen, J., et al. (2012). "An RNAi screen identifies additional members of 
the Drosophila Integrator complex and a requirement for cyclin C/Cdk8 in snRNA 3'-
end formation." RNA.) 
 
Yeast Two-Hybrid Analysis 
      Full-length coding regions of the twelve Drosophila Integrator subunits were 
obtained from the Drosophila Genomics Resource Center and cloned in frame into the 
pGBKT7 vector (BD), Asu/Ints13 and CG4785/Ints14 were cloned into pGADT7 (AD). 
IntS12 full length, first 45 amino acid microdomain (N45), N-terminal truncation (ΔN), 
and functional deficient alanine-scanning mutants Mt3 and Mt5 were cloned into 
pGADT7 (AD) using standard methods.  Pairwise co-transformations of AD and BD 
constructs into yeast strain AH109 were according to manufacturer’s instructions 
(Matchmaker 3 system, Clontech). Empty vectors were co-transformed to control for 
construct autoactivation. Positive interactions were analyzed using nutritional selection 
by spotting four serial ten-fold dilutions on SD- plates lacking Leucine/Tryptophan 
(vector control), or additionally Histidine (medium stringency) and Histidine/Adenine 
(high stringency). Images were taken after three or five days incubation at 30 °C. To 
determine the HA-tagged protein expression, yeast transformants were harvested at 
OD600 of ~0.8 in SC-Leu liquid culture, lysed using the glass beads method and 
tagged proteins were detected by western blotting using anti-HA antibody (Covance, 
Princeton NJ). (An excerpt from: Chen, J., et al. (2012). "An RNAi screen identifies 
additional members of the Drosophila Integrator complex and a requirement for cyclin 
C/Cdk8 in snRNA 3'-end formation." RNA.) 
 
Genome-wide RNAi Screen in S2 Cells 
      The dsRNA library was purchased from Open Biosystems (Thermo Scientific, 
Waltham, MA) as 5 µg per well resuspended in 100 µl of water. The dsRNA was 
realiquoted into 167 96-well plates (Greiner Bio-One, Monroe, NC) at 1µg per well and 
allowed to dry down. Then 5x104 cells were plated into each well and allowed to 
incubate for three days. On the fourth day, the 30 ng of U7-GFP reporter was 
transfected into each well using Effectene according to manufacturer’s instructions 
(Qiagen, Hilden, Germany). Two days following reporter transfection, cells were 
imaged live using a Cellomics Array Scan V highthroughput automated microscope 
(Thermo Scientific). Exposure times were calculated on a plate-to-plate basis and 
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fluorescence levels were calculated using pre-written algorithms incorporated into the 
manufacturer’s software. The two algorithms used in the data presentation are the 
standard deviation in fluorescence intensity and the mean differential intensity as these 
two methods were most effective in blindly identifying positive controls in pilot assays. 
(An excerpt from: Chen, J., et al. (2012). "An RNAi screen identifies additional 
members of the Drosophila Integrator complex and a requirement for cyclin C/Cdk8 in 
snRNA 3'-end formation." RNA.) 
 
S2 Cell Nuclear Extracts Preparation 
      S2 cell nuclear extracts were prepared using previously described methods (Dignam et al. 
1983) with minor modifications. In brief, harvested S2 cells were washed twice with cold 
1xPBS and resuspended in 5 times packed cell volume (PCV) of ice-cold buffer A [10 mM 
HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 0.5 mM PMSF] for 30 min on ice to 
swell. Swollen cells were further disrupted by grinding 35 strokes using the glass dounce 
tissue grinder and then cell nuclei were pelleted by centrifuging at 2000 rpm for 5 min. The 
crude nuclei pellet were further resuspended in ½ pellet volume of buffer C [20 mM HEPES pH 
7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF] 
and incubated 1 hr at 4 °C with rotation for extraction. Extracted supernatants were collected 
by centrifugation at 14000 rpm for 30 min and final nuclear extracts were dialyzed overnight in 
buffer D [20 mM HEPES pH7.9, 20% glycerol, 0.1 M KCl, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM 
PMSF]. Dialyzed nuclear extracts were stored at -80 °C for future use. 
 
Site-directed Mutagenesis 
      Site-directed mutations of Cdk8 and IntS12 were generated using QuickChange Kit 
(Stratagene) protocol. In brief, 25 ng of template plasmids were used for PCR amplification 
using quickchange oligos listed in Table 2.2 in a total volume of 50 µl reaction, and 1 µl 
FastDigest DpnI (Fermentas) was used to digest the methylated template DNA at 37 °C for 30 
min. 1 µl of DpnI treated PCR product was used for transformation, and the right clones were 
screened and confirmed by direct sequencing. 
 
S2 Cell Immunofluorescence Microscopy 
      The method to prepare S2 cells for immunofluorescence microscopy was described by 
Rogers & Rogers (Rogers and Rogers 2008).  Briefly, 1x105 S2 cells in 100 µl Sf-900 II 
medium were allowed to attach to the Concanavalin A coated round coverslips for 1hr at 28 
°C, and followed by two washes with 1xPBS. Cells were fixed by treating with 10% 
paraformaldehyde diluted in 1xPBS for 10 min at room temperature. Fixed cells were then 
permeabilized by washing three times with 1xPBS supplemented with 0.1% Triton X-100. 
Permeabilized cells were then blocked in 1xPBST containing 5% normal goat serum, and 
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probed by anti-FLAG M2 antibodies (Sigma) with 1:1000 dilutions in the blocking buffer for 1hr 
at room temperature. Cells were washed using 1xPBST three times for 10 min each, and 
probed with light sensitive Cy3-conjugated anti-mouse secondary antibodies (1:1000) for 45 
min. Cells were washed again twice in 1xPBST and the final wash was supplemented with 
4',6-diamidino-2-phenylindole! (DAPI) (1:1000). Finally, washed coverslips were mounted 
facing down on glass slides using fluoro-gel mounting medium (Electron Microscopy Sciences, 
PA) and then imaged using fluorescence microscopy. FLAG tagged proteins were visualized 
at excitation wavelength 550 nm, and the nuclear DAPI staining was observed at 350 nm. 
 
GST Recombinant Protein Preparation 
      pET49 clones expressing GST, GST-tagged full-length IntS12, or various IntS12 PHD 
fingers were transformed into E.coli BL-21(DE3). Bacterial culture were grown at 37 °C in 1liter 
of LB medium [1% tryptone, 0.5% yeast extract, and 1% NaCl] supplemented with Kanamycin 
(50 µg/ml) to OD600 of ~0.6. To induce the expression of GST-tagged recombinant protein, 
isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the cultures to at a final 
concentration of 1mM, and continued to culture for another 2 hrs at 37 °C. Induced cultures 
were pelleted and resuspended in 30 ml of cold PBS [140 mM NaCl, 2.7 mM KCl, 10 mM 
Na2PO4, 1.8 mM KH2PO4, supplemented with10 mM DTT, and 1 mM phenylmethylsulfonyl 
fluoride (PMSF), 1% Triton X-100, pH 8]. Culture suspensions were lysed by using EF-C3 
high-pressure homogenizer (Avestin, Germany), and crude lysates were cleared by 
centrifuging 15 min at 12,000xg at 4 °C. Cleared lysates were incubated with 0.5 ml 
glutathione agarose beads with rotation at 4 °C for 1 hr. Protein bound beads were pelleted 
and washed three times for 15 min each with cold PBS. To elute the recombinant GST-tagged 
proteins, washed beads were resuspended in 1ml Elution buffer [50 mM Tris HCl pH 8, 10 mM 
reduced glutathione] and incubated at room temperature for 10 min. The supernatants were 
collected after centrifugation and the concentration of recombinant proteins were determined 
by Bio-rad protein assay (Bio-rad Laboratory, California). The purified recombinant proteins 
were supplemented with glycerol to 50% [v/v] and stored at -80 °C for later use. 
 
GST Pulldown Assay 
      The assay for GST-tagged recombinant protein pulldown of histones was carried out by 
incubation of 2 µg of purified GST-tagged proteins with 10 µg of global histones (Worthington, 
NJ) for 3 hrs at 4 °C in 300 µl incubation buffer [50 mM Tris-HCl pH7.5, 500 mM NaCl, 1% NP-
40, 0.5 mM EDTA, 1mM PMSF]. Then 20 µl glutathione beads were added and incubated for 1 
hr. Beads were collected by centrifugation and washed three times for 5 min each with 1 ml 
incubation buffer. Washed beads were resuspended in 50 µl 1xSDS loading buffer and boiled 
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for 3 min at 95 °C. Boiled samples were centrifuged and 20 µl of supernatant were resolved in 
15% SDS-PAGE. Western blot analysis was conducted using the standard procedure. Anti-
GST serum were generated by injection of Guinea pig with recombinant GST proteins and 
anti-histone antibodies [H2A (Upstate 07-146), H2B (Upstate 07-371), H3 (Abcam ab1791) 
and H4 (Activemotif 39269), H1 (Upstate 05-457)] were kindly provided by Dr. Barton’s Lab at 
the University of Texas MD Anderson Cancer Center. 
 
Biotin-labeled Histone Peptide Pulldown Assay 
      Biotinylated histone peptide pulldown of recombinant GST-tagged IntS12 PHD finger 
proteins was carried out by incubation of 1 µg GST-tagged proteins with 1 µg of biotinylated 
histone peptides for 4 hrs at 4 °C in 300 µl binding buffer [50 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 0.05% NP-40]. Then 15 µl Streptavidin sepharose beads (Amersham) were added to the 
binding reaction and incubated for another hour. Beads were collected by centrifugation and 
wash three times for 5 min each with 1 ml binding buffer. Washed beads were resuspended in 
60 µl 1xSDS loading buffer and boiled for 3 min at 95 °C. Boiled samples were centrifuged and 
10 µl supernatant were resolved in 12.5% SDS-PAGE gel. Biotinylated histone peptides (H3, 
1-21; H3, 22-44; H3, 66-88; H4, 1-25; H3K4, K9, K27, K36, K79 and H4K20 mono-, di- or tri- 
methylated peptide) were kindly provided by Dr. Shi’s Lab at the University of Texas MD 
Anderson Cancer Center.  
 
Chromatin Immunoprecipitation (CHIP) 
      Cultured S2 cells were crosslinked with 1% formaldehyde for 7 min at room temperature 
and the crosslinking reaction was quenched by adding glycine to a final concentration of 125 
mM for 10 min. Fixed S2 cells were collected and washed twice with ice-cold PBS and 
resuspended in cold sonication buffer [0.5% SDS, 20 mM Tris-HCl pH 8, 2 mM EDTA, 0.5 mM 
EGTA, 0.5 mM PMSF] in a ratio 108 cells per 1 ml buffer for 10 min on ice. Lysed cells were 
further sonicated for 12 min (30 sec on/2.5 min off) using the Ultrasonic Converter C5749 and 
clarified by centrifugation at 14 000 rpm for 10 min. The clarified supernatant was used 
immediately for immunoprecipitation or stored at -80 °C. 
      75 µl sonicated chromatin was diluted in 1 ml IP buffer [0.5% Triton X-100, 2 mM EDTA, 
20 mM Tris-HCl pH 8, 150 mM NaCl, 10% glycerol] and pre-cleared by incubating with 30 µl 
50% Protein A/G beads slurry for 2 hrs at 4 °C on a rotator before overnight incubation with 2 
µg of antigen purified IntS12 antibodies or the M2 resin. The bound materials were washed 
rigorously once with Low Salt buffer [0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-
HCl pH 8, 150 mM NaCl], three times with High Salt buffer [0.1% SDS, 1% Triton X-100, 2 mM 
EDTA, 20 mM Tris-HCl pH 8, 500 mM NaCl], once with LiCl buffer [2 mM EDTA, 20 mM Tris-
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HCl pH 8, 1% Sodium Deoxycholate, 1% NP-40, 250 mM LiCl], twice with Tris-EDTA buffer 
[10 mM Tris-HCl pH 8, 1 mM EDTA], and eluted 15 min at room temperature with 500 µl 
Elution buffer [1% SDS, 0.1% NaHCO3]. Eluted fractions were reverse crosslinked by adding 
20 µl of 5 M NaCl and incubate at 65 °C in the water bath for at least 4 hrs, and then treated 
with proteinase K and purified by phenol/chloroform extraction followed by ethanol 
precipitation. Finally, purified DNA is resuspended in 150 µl ddH2O, and 2 µl was used for 
qPCR analysis. 
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Chapter 3. A Functional RNAi Screen Identifies Drosophila Genes Required for snRNA 
3’ End Formation. 
 
(Partial contents described in this chapter have been published in Mol. Cell. Biol. 31, 2011, 
328-341, doi:10.1128/MCB.00943-10 and RNA December 2012 18: 2148-2156, and usage 
permissions have been granted from the publishers.) 
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INTRODUCTION 
 
      RNA processing is a fundamental biological process required to generate mature RNA 
species. The U snRNA are non-coding transcripts that play important roles in different RNA 
processing events. They form the RNA core of spliceosome to help remove introns from 
mRNA precursors and the U7 snRNA is involved in the 3’ end processing of the replication-
dependent histone pre-mRNA (Reviewed in (Matera et al. 2007; Marzluff et al. 2008)). Most 
snRNAs are transcribed by RNA polymerase II, and their 3’ end is formed by a single 
endonucleolytic cleavage at the 3’ end cleavage site from the elongating polymerase to allow 
for release and subsequent export to the cytoplasm (Reviewed in (Egloff et al. 2008)). 
      Studies in the past decades have established the requirement of three features for snRNA 
3’ end processing: an snRNA promoter, a 3’ box sequence element located 9-19 nt 
downstream of the mature snRNA 3’ end, and the CTD of RNAPII largest subunit Rpb1 
(Hernandez 1985; de Vegvar et al. 1986; Hernandez and Weiner 1986; Medlin et al. 2003; 
Jacobs et al. 2004; Egloff et al. 2007; Egloff et al. 2010)). Promoter-swap experiments reveal 
that replacement of either human or Drosophila snRNA promoters with other RNAPII 
promoters significantly compromises proper snRNA 3’ end formation (de Vegvar et al. 1986; 
Hernandez and Weiner 1986; Ezzeddine et al. 2011)). The 3’ end formation of viral-encoded 
snRNA-like transcripts in Herpesvirus saimiri has recently been reported to be highly 
dependent on the snRNA promoter as well (Cazalla et al. 2011), further supporting the 
importance of the snRNA promoter for their 3’ end formation. Conserved promoter coupling 
indicates that the 3’ end processing machinery is loaded onto the snRNA promoter early in the 
transcription cycle. The 3’ box sequence element has been determined to be required for 
proper snRNA 3’ end processing though was found to be highly tolerant to mutation (Ach and 
Weiner 1987; Ezzeddine et al. 2011). It very likely serves as a binding site for the protein 
complex that carries out the cleavage process for snRNA. Finally, phosphorylation of the Ser2 
and Ser7 but not Ser5 in the heptad repeats of the Rpb1 CTD is reported to be important for 
snRNA 3’ end formation (Egloff et al. 2007; Egloff et al. 2010). 
      Biochemical purification and functional identification of the Integrator complex in snRNA 3’ 
end formation provides new insight into the snRNA 3’ end processing events (Baillat et al. 
2005; Ezzeddine et al. 2011). Twelve different members were initially identified in the complex 
associated with the RNAPII CTD and two of them (IntS1 and IntS11) were shown to be 
functionally required for U1 and U2 snRNA 3’ end formation. Among the twelve members, 
IntS9 and IntS11 are homologous to the poly(A)+ mRNA and poly(A)- histone mRNA 3’ end 
processing factors CPSF100 and CPSF73 (Mandel et al. 2006; Sullivan et al. 2009). IntS9/11 
have been shown to form a heterodimer through their unique C-terminal regions and this 
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interaction is required for the endonucleatytic cleavage activity of the Integrator complex 
(Albrecht and Wagner 2012). Other than these two proteins, the remainder of the ten founding 
members in the complex display insignificant similarity with the known factors involved in 
either poly(A)+ mRNA or histone mRNA 3’ end formation, making their role in 3’ end formation 
of snRNA difficult to anticipate. Recent high-throughput mass spectrometry analysis of 
Integrator immunoprecipitations from mammalian cells has identified a number of additional 
factors associated with the core Integrator subunits (Malovannaya et al. 2010; Malovannaya et 
al. 2011), and these include additional RNAPII subunits, a group of phosphatases, OB-fold 
nucleic acid binding proteins, zinc-finger proteins and many others either uncharacterized 
and/or not previously known to be involved in snRNA biogenesis. Functional validation of 
these factors has not been done, making their importance to snRNA 3’ end formation unclear. 
      In this chapter, I describe a functional RNAi screen in Drosophila S2 cells to identify genes 
required for snRNA 3’ end formation by utilizing the U7-GFP readthrough reporter assay 
(Ezzeddine et al. 2011). Our screen scored ten of the twelve known Integrator subunits, and 
also identified four new non-Integrator subunits necessary for snRNA 3’ end formation. Follow-
up systematic functional analysis confirmed the functional requirement for 10 of the 12 known 
Integrator subunits. We also determined that the four novel factors CG4785, Asunder (Asu), 
cyclin C (CycC), and Cdk8, are required for snRNA 3’ end formation. Further analysis 
demonstrates that Asunder and CG4785 are additional core components of the known 
Integrator complex, and the Cdk8 kinase activity is required for proper snRNA 3’ end 
processing. We further discovered that CycC/Cdk8 play a conserved role in both fly and 
human snRNA 3’ end formation and it is likely that this cognate CycC/Cdk8 pair exerts it 
function through a novel pathway independent of the canonical Mediator Cdk8 module. Taken 
together, this study redefines the Drosophila Integrator complex as comprising of fourteen core 
subunits and demonstrates a novel role of CycC/Cdk8 in snRNA 3’ end formation unrelated to 
its known function in the mediator complex. 
 
  
! 43 
RESULTS 
(Excerpts in Results section are from: Chen, J., et al. (2012). "An RNAi screen identifies 
additional members of the Drosophila Integrator complex and a requirement for cyclin C/Cdk8 
in snRNA 3'-end formation." RNA.) 
Genome-wide RNAi screen for Drosophila snRNA 3’ end Processing Factors  
      We previously developed a cell-based reporter that expresses green fluorescent 
protein (GFP) in response to misprocessing of U7 snRNA, allowing for non-invasive 
and sensitive detection of misprocessing in vivo (Figure 3.1A; (Ezzeddine et al. 2011)). 
To determine whether this reporter would be suitable for use in a genome-wide RNAi 
screen, we treated S2 cells with dsRNA targeting either the Polypyrimidine Tract 
Binding Protein (PTB) (negative control) or IntS12 (positive control) and in both 
instances found no overt effects on growth. Three days following the dsRNA treatment, 
cells were transfected with the U7-GFP reporter and fluorescence was assessed 48 
hrs later. Robust GFP expression was clearly observed after IntS12 depletion, relative 
to a low level of background fluorescence in cells treated with PTB dsRNA (Figure 
3.1A). Western blot analysis confirmed that only after significant reduction in IntS12 
expression was GFP expression observed (Figure 3.1A). 
      Using the U7-GFP reporter we performed a genome-wide RNAi screen in 
Drosophila S2 cells using a library consisting of 15,881 unique dsRNAs targeting >90% 
of the annotated fly genome. U7-GFP reporter expression in cells grown in 96 well 
plates was imaged via automated high throughput microscopy and plotted as a function 
of fluorescence variance. We observed that in ~7% of the wells the dsRNA targeted 
essential genes, resulting in no viable cells at the time of image acquisition. The 
imaging of nearly all plates of the dsRNA screen revealed a relatively homogenous 
level of background fluorescence in practically all wells. Representative graphs of two 
plates are shown in Figure 3.1B. A small number of wells displayed strong GFP 
fluorescence, for example on plate 25, cells treated with dsRNA targeting CG5859 
identified the fly orthologue of IntS8 as a ‘strong hit’. In addition, a modest number of 
moderately fluorescent wells were also identified, as evidenced by the GFP signal and 
cell images presented for plate 54 (Figure 3.1B). The levels of GFP expression after 
knockdown of either CG10572 or CG10583 were clearly above plate background, yet 
were below the signal of the positive control dsRNA (targeting Drosophila IntS9). 
      In total, our RNAi screen identified 89 genes that, when subjected to RNAi 
knockdown, resulted in detectable levels of GFP expression from the U7-GFP reporter 
(Figure 3.1C and Table 3.1). The screen identified ten of the twelve annotated 
Drosophila Integrator subunits, as well as genes involved in RNA binding, 
chromatin/DNA function, and UTP biosynthesis. To determine the reproducibility of the 
data, we regenerated dsRNAs corresponding to each of the 89 target genes identified 
in the initial screen and performed iterative RNAi followed by transfection of the U7-
GFP reporter. From this, the initial list of 89 genes was reduced down to 21 that either 
scored as high or modest with regards to their GFP expression (Figure 3.1D). Ten of 
these were Integrator genes that encode proteins previously found in the twelve-
membered Integrator complex. Since only IntS1 and IntS11 were functionally validated 
in the initial study that is required for U1 and U2 snRNA 3’ end processing, here we 
comprehensively investigated the importance of each Integrator subunit in U7 and 
spliceosomal snRNAs 3’ end formation. Importantly, eleven genes scored in our 
functional screen were not previously known to be involved in snRNA biogenesis. As 
depletion of four of these genes (CG4785, Asu, cyclin C, and Cdk8) produced high 
levels of GFP expression comparable to that observed after depletion of known 
Integrator subunits, we then focused the remainder of our analysis on these genes.  
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Figure 3.1 Using the U7-GFP reporter to conduct a genome-wide RNAi screen. (A). 
Schematic of U7-GFP reporter and the results from transient transfection of the reporter into 
S2 cells treated with dsRNA targeting PTB (-control) or IntS12 (+control). Fluorescence and 
brightfield images are on the left and Western blot analysis on the right. (B). Bar graph 
representing quantification of screen results for plate 25 and 54. The figure insets are taken 
from the acquired image collection. (C). Pie graph representing results of RNAi screen 
categorically. (D). Trimmed down list of non-Integrator genes that reproducibly scored as 
strong or modest by secondary screening. 
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Table 3.1 Genes required for snRNA 3’ end processing identified from functional RNAi screen 
Gene number Fly gene name 
Human 
orthologue Function/domains 
CG3173  Integrator 1 Integrator 1 snRNA 3'-end processing 
CG8211  Integrator 2 Integrator 2 snRNA 3'-end processing 
CG12113  Integrator 4 Integrator 4 snRNA 3'-end processing 
CG9591  Integrator 5 Integrator 5 snRNA 3'-end processing 
CG3125 Integrator 6 Integrator 6 snRNA 3'-end processing 
CG18176  Integrator 7 Integrator 7 snRNA 3'-end processing 
CG5859  Integrator 8 Integrator 8 snRNA 3'-end processing 
CG5222  Integrator 9 Integrator 9 snRNA 3'-end processing 
CG1972  Integrator 11 Integrator 11 snRNA 3'-end processing 
CG5491  Integrator 12 Integrator 12 snRNA 3'-end processing 
CG6233  UFD1-like UFD1L ubiquitin-specific protease activity 
CG3593  Rudimentary like UMPS UMP biosynthetic process 
CG1743  Gs2 GLUL glutamine synthesis 
CG42797 Novel HECW1 
(HECT, C2 and WW domain) protein 
ubiquitination  
CG3307  pr-Set7 SETD8 chromatin modification 
CG3931  Rrp4 EXOSC2 deadenylation-dependent decay 
CG4482  mol DUOXA1 protein transport 
CG4467  Novel TRHDE metallopeptidase 
CG6437 GLcT-1 UGCG Glycosyl transferase 
CG6721  Gap1 RASA2 Ras GTPase activator 
CG7281   CycC CCNC Cyclin 
CG34401 novel KIAA0913 zinc finger protein 
CG7610 ATPsyn-gamma ATP5C1 ATP biosynthetic process 
CG7487  RecQ4 NA ATP-dependent DNA helicase 
CG7940  Arp5 ACTR5 DNA repair 
CG8114  pebble ECT2 guanyl-nucleotide exchange factor 
CG8274  Megator TPR protein import into nucleus 
CG8344  RpIII128 POLR3B RNA polymerase III 
CG34389 crossveinless c STARD13 GTPase activator 
CG9428   ZIP1 SLC39A1 metal ion transport 
CG10572 Cyclin-dependent kinase 8 CDK8 cyclin-dependent protein kinase 
CG10583  Separase  ESPL1 peptidase activity 
CG13345  tumbleweed RACGAP1 Rac GTPase activator 
CG18525  Serine protease inhibitor 5 SERPINC1 erine-type endopeptidase inhibitor 
CG4260  α-Adaptin AP2A2 Adaptor protein complex AP-2 
CG10911  Novel  NA NA 
CG30184   Novel NA phospholipase A2 activity 
CG7608  Ecdysone-induced gene 71Ec NA defense response to bacterium 
CG3181   thymidylate synthase TYMS dTMP biosynthetic process 
CG42670 pasilla NOVA1 RNA splicing 
CG10134  beat-Va NA NA 
CG5614   Novel (LisH dimerisation motif) NA NA 
CG11504  Novel  (MADF domain) NA NA 
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Table 3.1 (continued) 
Gene number Fly gene name 
Human 
orthologue Function/domains 
CG43374 Cht6 CHI3L2 Chitinase II 
CG1030  Sex combs reduced HOXB5 
sequence-specific DNA binding 
transcription factor 
CG1258  pavarotti KIF23 microtubule motor 
CG3924  Chip LDB2 LIM domain binding 2 
CG4021  Novel KHDRBS 
KH domain containing, RNA binding 
protein 
CG4079   TBP-associated factor 11 TAF11 transcription coactivator 
CG4082   Minichromosome maintenance 5 MCM5 DNA helicase 
CG4567  iconoclast GFM1 Translation elongation factor 
CG4785  Novel C15orf44 NA 
CG4798  lethal (2) k01209 UCKL1 uridine kinase 
CG34420 Novel DPEP2 peptidase activity 
CG5941  Novel MCTS1 RNA binding 
CG6147  Tsc1 TSC1 kinase binding 
CG6196  novel TRAPPC6B vesicle-mediated transport 
CG6814 asunder ASUN spermatogenesis regulator 
CG6939   SET domain binding factor SBF2 SET binding factor 
CG7108  DNA polymerase α 50kD PRIM1 DNA primase 
CG7109  microtubule star PPP2CB protein serine/threonine phosphatase 
CG7538   Minichromosome maintenance 2 MCM2 DNA replication 
CG8372  Novel TMEM222 transmembrane protein 
CG8388  novel NA DNA binding 
 CG9504   Ecdysone oxidase CHDH choline dehydrogenase activity 
CG9667   ISY like splicing factor ISY1 RNA splicing 
CG9741  Dihydroorotate dehydrogenase DHODH UMP biosynthetic process 
CG9755   pumilio PUM2 RNA binding 
CG9945  Novel (WD40 repeat) DCAF11 protein ubiquitination 
CG9943 Surfeit 1 SURF1 cytochrome-c oxidase activity 
CG9951  novel CCDC22 coiled-coil domain containing 22 
CG10399   novel HMGCL leucine metabolic process 
CG10463  novel DUS3L tRNA-dihydrouridine synthase 
CG11352  jim NA regulation of chromatin silencing 
CG11207   fascetto PRC1 cytokinesis 
CG11247   novel NA Zinc finger protein 
CG11291  Novel PGP 4-nitrophenylphosphatase activity 
CG42568 novel NA NA 
CG32239 
Guanine nucleotide 
exchange factor GEF64C NET1 guanyl-nucleotide exchange factor 
CG13604  novel (SH3 domain) UBASH3 NA 
CG14325  novel (Leucine-rich repeat) TCTE1 carboxy-lyase activity 
CG14105  Novel (Tetratricopeptide repeat) TTC36 NA 
CG10395   Novel INO80B DNA repair 
CG32845  Novel PIN1 isomerase activity 
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Table 3.1 (continued) 
Gene number Fly gene name 
Human 
orthologue Function/domains 
CG14339   Novel (Tetratricopeptide repeat) NA NA 
CG32198    Novel NA NA 
CG14024  Novel CHST carbohydrate biosynthetic process 
CG10342 neuropeptide F NA neuropeptide hormone 
CG7837 
Novel (Armadillo and 
BTB domain) ARMC5 ATP hydrolysis coupled proton transport 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1 Positive hits from RNAi screen. Color coding describes relative intensity of GFP 
signal to background within the plate. Red font denotes the strongest scoring hits, blue are 
medium, and purple are the weakest scoring hits. Column one denotes the CG number 
present in flybase (www.flybase.net). Column two gives the fly gene name while column three 
is the putative human orthologue according to ensemble (www.ensembl.org). The fourth 
column is a short description of known function or putative domains in the absence of known 
function. Novel means that no characterization of the gene has been found and “NA” means 
that no orthologue or function is known at this time. 
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Knockdown of different Integrator components results in differential 3’ end processing 
defects of U7 reporter and endogenous spliceosomal snRNAs. 
      To systematically assess the importance of individual Integrator subunit for the 
requirement in snRNA biosynthesis, we measured snRNA misprocessing by using the U7-
GFP readthrough reporter in S2 cells depleted of each corresponding Integrator subunit. To 
accomplish this, we generated dsRNAs targeting all of the known Drosophila Integrator 
subunits using the method described in detail in Chapter 2 (Cell culture and RNAi Section). 
The dsRNA targeting PTB was used as a negative control. S2 cells were treated with dsRNA 
for two days before transfection with the U7-GFP reporter, and we observed no overt effect on 
cell growth in response to the dsRNAs treatment. To assess the knockdown efficiency of 
endogenous Integrator proteins in S2 cells, antibodies to Drosophila Integrator subunits IntS1, 
IntS9, IntS11 and IntS12 were successfully generated by injection of Guinea pigs with 
recombinant GST-fusion proteins. Western blot analysis demonstrated that dsRNA targeting 
each endogenous Integrator mRNA tested significantly reduced the corresponding Integrator 
protein levels in cells (Figure 3.2A). U7-GFP reporter expression was measured in these cells 
depleted of each Integrator subunit by both fluorescence microscopy (Figure 3.2B, D) and 
Western blot analysis (Figure 3.2C, E). Only background GFP fluorescence was observed in 
control dsRNA (PTB) treated cells while knockdown of nearly every Drosophila Integrator 
subunit gave rise to increased levels of GFP expression from the U7-GFP reporter with the 
highest level of GFP expression observed from IntS9 depleted cells. However, knockdown of 
IntS3 and IntS10 only gave rise to low levels of GFP expression equivalent to that observed in 
control dsRNA treated cells. 
      To further determine the effect of knockdown of each Integrator subunit on the 3’ end 
processing of endogenous spliceosomal snRNAs, a sensitive quantitative real-time PCR 
method was developed to measure the accumulation of endogenous premature snRNA 
species in Integrator knockdown cells. To accomplish this, each snRNA amplicon was 
designed with a forward primer priming to sequences within the snRNA coding region and 
reverse primer recognizing ~50 nucleotides downstream of the 3’ cleavage site. Therefore, by 
design, only premature or misprocessed snRNA transcripts would be specifically amplified and 
detected. PCR primer quality was verified by agarose gel electrophoresis followed by ethidium 
staining as well as an analysis of the dissociation curves. All amplicons identities were 
confirmed by sequencing. S2 cells were treated with dsRNA targeting each Integrator subunit 
or PTB (negative control) for two days, and on the fourth day, total RNA was isolated and 
subject to reverse transcription (RT). The levels of premature snRNAs were then determined 
by qRT-PCR analysis using primers specific for premature snRNAs, and data analysis was 
carried out by using the ΔΔCt method using Rps17 as the reference gene and PTB dsRNA 
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Figure 3.2 Knockdown of the Drosophila Integrator subunits causes misprocessing of 
the U7-GFP reporter.  
(Figure reprinted from Ezzeddine N, Chen J et al. Mol. Cell. Biol. 2011; 31:328-341)  
(A) Western blot analysis of lysates from Drosophila S2 cells treated with either control dsRNA 
targeting PTB or a specific dsRNA targeting Integrator 1, 11, or 12. RNAPII (center) or a cross-
reacting band (*) serves as a loading control. (B) Fluorescence images of cells treated with a 
specific dsRNA (labeled in white), then transfected with the U7-GFP reporter. (C) Western blot 
analysis of cell lysates from the cells shown in panel B. Lysates were probed with either anti-
GFP antibodies or with anti-Symplekin (αSym.) antibodies as a control. (D) Fluorescence 
images of cells treated with dsRNA targeting IntS5, 9 and 12 followed by transfection with the 
U7-GFP reporter. In this case the control dsRNA targeted LacZ and not PTB. (E) Western blot 
analysis of cell lysates from panel D. 
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treated cells as a control. Results (Figure 3.3A) were plotted as fold changes in the level of 
premature snRNA in Integrator knockdown cells versus control treated cells and the average 
presented was from three independent RNAi experiments. With the exception of Integrator 3 
dsRNA treatment, all knockdowns led to increase in the levels of premature spliceosomal 
snRNAs (Figure 3.3A). Notably, knockdown of Integrator 10 gave rise to the smallest increase, 
consistent with our observations from the U7-GFP reporter assay (Fig. 3.2B). For each 
knockdown, data garnered from our qPCR analysis were very consistent with those from our 
reporter assay where knockdown of Integrators 1, 4, and 9 led to a over 50-fold increase in the 
levels of premature snRNAs, and knockdowns of Integrators 11 and 7 resulted in a ~10 fold 
increase. Except for IntS3 and IntS10, knockdown of the remainder of the Integrator subunits 
led to a 2-10 fold increase in the levels of premature snRNAs. We measured Integrator protein 
knockdown efficiency in these cells by using antibodies for IntS1, 9, 11 and 12, and measured 
IntS3 and IntS10 mRNA levels in knockdown cells by qRT-PCR analysis using PTB and IntS9 
dsRNAs treated cells as negative and positive controls respectively (Figure 3.3B). We 
observed a 65%, 75% and ~90% reduction in the levels of IntS3, IntS9 and IntS10 mRNAs 
respectively, and these results suggest that dsRNAs targeting IntS3 or IntS10 was effective in 
depleting endogenous Integrator mRNA levels and it is likely that IntS3 and IntS10 are not 
required for efficient snRNA 3’ end formation. Taken together, functional analysis indicates 
that with the exception of IntS3 and IntS10, all known Integrators are functionally required for 
snRNA 3’ end processing. 
 
Asunder and CG4785 are specifically required for snRNA 3’ end formation. 
      In addition to the known Integrator proteins, our genome-wide RNAi screen also identified 
four non-Integrator proteins: Asunder, CG4785, cyclin C, and Cdk8.  
      To confirm that the observed snRNA misprocessing occurs as a consequence of 
knockdown of CG4785 and Asu, we designed a second set of dsRNA targeting a 
distinct region of each open reading frame. S2 cells were then treated with dsRNA 
targeting LacZ or the Stem Loop Binding Protein (SLBP) as negative controls, IntS9 
and IntS12 as positive controls, and either dsRNA targeting Asu or CG4785. We 
observed only background levels of GFP expression in negative control dsRNA treated 
cells while both dsRNA targeting Asu and CG4785 gave rise to robust and nearly 
identical levels of GFP expression comparable to those observed after depletion of 
IntS9 or IntS12 (Figure 3.4A and B). To determine the specificity of the misprocessing 
phenotype, we utilized two related GFP reporters that we developed previously to 
determine defects in histone pre-mRNA processing (Wagner et al. 2007; Yang et al. 
2009; Ezzeddine et al. 2011). The H3-GFP report is almost identical to the U7-GFP 
construct, except the histone H3 gene is used. In addition, the Act-H3-GFP reporter 
replaces the H3 promoter with the actin promoter, which was found to sensitize it to 
additional factors whose depletion normally extinguishes the histone promoter (Yang et 
al. 2009). We treated cells with the same series of positive control, negative control, 
! 51 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Knockdown of Integrator subunits causes various degrees of misprocessing 
of endogenous spliceosomal snRNAs.  
(Figure reprinted from Ezzeddine N, Chen J et al. Mol. Cell. Biol. 2011; 31:328-341) 
(A) Histogram of real-time PCR experimental data generated using primer pairs designed to 
detect the presence of misprocessed (mis.) spliceosomal U1, U2, U4, or U5 snRNAs. Results 
are plotted as fold increases relative to control-treated cells and reflect expression normalized 
to an internal control gene (RpS17). All results are derived from biological triplicates, with error 
bars indicative of the standard deviations of the triplicate quantification. (B) Histogram of qRT-
PCR quantitation of IntS3, IntS9, and IntS10 mRNA following dsRNA treatment. Levels 
represented are the averages of triplicate experiments normalized to an internal control 
(RpS17) and then normalized to control-treated cells. 
 
! 52 
and test dsRNA as described above followed by the transfection with either H3-GFP or 
Act-H3-GFP reporter. Using these other two constructs, we only observed GFP 
expression after depletion of SLBP, confirming that both Asu andCG4785 are 
specifically required for snRNA 3’ end processing. To characterize the role of Asunder 
and CG4785 in the processing of endogenous snRNA, we used a sensitive qRT-PCR 
assay designed to measure misprocessed U1 and U5 snRNA following RNAi depletion. 
Total cell RNA was isolated following several days of incubation with dsRNA targeting 
LacZ (negative control), IntS9 or IntS12 (positive controls) or dsRNAs targeting Asu 
and CG4785 (two separate dsRNAs each gene). We subjected total RNA to reverse 
transcription followed by real-time PCR analysis using primers specific for the 
misprocessed U1 and U5 snRNA (Ezzeddine et al. 2011). Relative to control treated 
cells, we observed a 5-10 fold increase in the level of misprocessed snRNA (Figure 
3.4C). The levels of misprocessed snRNA were consistent between the two individual 
dsRNAs for each target and comparable to that observed after depletion of IntS12. 
Taken together, these results demonstrate that Asu and CG4785 are required for both 
reporter and endogenous snRNA 3’ end formation. 
 
Cyclin C and Cdk8 are required for snRNA 3’ end formation.  
      The observation that both Cdk8 and CycC were independently isolated in our 
screen strongly suggests that they are involved in snRNA 3’ end formation, as they 
form a cognate cyclin/cdk pair (Leclerc et al. 1996).To address the possibility of any 
potential off-target effects and characterize their specificity towards snRNA 3’ end 
formation we created a second set of dsRNA targeting distinct regions of each ORF. 
Treatment of S2 cells with dsRNAs targeting Cdk8 or targeting CycC resulted in robust 
expression of GFP from the U7-GFP reporter (Figure 3.4D). We also tested the effect 
of CycC or Cdk8 depletion on both the histone H3-GFP and Actin-H3-GFP reporters. 
Neither the H3 nor Actin H3 reporters were found to produce GFP in response to Cdk8 
or CycC knockdown. In contrast, we observed robust expression of GFP from both 
reporters in response to treating cells with dsRNA targeting SLBP. These data 
implicate that CycC and Cdk8 are specifically involved in the process of snRNA 3’ end 
formation. 
      To test whether the kinase activity of Cdk8 is required for snRNA 3’ end formation, 
we cloned wild-type Drosophila Cdk8 and generated a kinase-dead (D173A) form 
analogous to a mutant human CDK8 shown previously to behave as a dominant-
negative (DN) (Akoulitchev et al. 2000). Both wild-type and DN cDNAs were expressed 
as N-terminal myc-tagged proteins in S2 cells co-transfected with the U7-GFP reporter. 
Despite the reduced accumulation of the catalytically inactive Cdk8 relative to the wild-
type protein, we observed potent misprocessing of U7-GFP reporter (Figure 3.4E). 
These data demonstrate that the kinase activity of the CycC/Cdk8 complex is essential 
for correct snRNA 3’ end processing. 
      One possible explanation for the observed phenotype is that CycC/Cdk8 fulfills a 
general requirement in the expression of one or more Integrator subunits and therefore 
CycC/Cdk8 plays an indirect role in snRNA 3’ end formation. To test this, we analyzed 
the expression of all twelve Integrator subunits as well as Asunder and CG4785 after 
depletion of CycC or Cdk8 using both Western blot analysis (Figure 3.5A) and qRT-
PCR (Figure 3.5B/C). We found no observable differences in the levels of Integrator 
subunit expression following CycC or Cdk8 knockdown. Therefore, we conclude that 
these two proteins are likely functioning directly in the 3’ end formation of Drosophila 
snRNA. 
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Figure 3.4 Validation of Asunder, CG4785, CycC, and Cdk8 as required for snRNA 3’ end 
formation. (Figure reprinted from Chen J et al. RNA. 2012. doi:10.1261/rna.035725.112) 
(A). Images from S2 cells transfected with U7-GFP reporter after dsRNA treatment targeting 
Asu or CG4785. (B). Western blot analysis of cell lysates from Panel A. (C). qRT-PCR 
analysis specific for misprocessed endogenous snRNA from knockdown cells. (D). Western 
blot analysis of S2 cells treated with dsRNA targeting CycC or Cdk8 followed by transient 
transfection with reporters measuring snRNA or histone mRNA 3’ end formation. (E). Western 
blot analysis of cells cotransfected withU7-GFP reporter and myc-tagged Cdk8 that is wild type 
or catalytically inactive. 
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Figure 3.5 Functional involvement of Cyclin C and Cdk8 in snRNA 3’ end formation is 
not through regulation of Integrator expression. 
(Figure reprinted from Chen J et al. RNA. 2012. doi:10.1261/rna.035725.112) 
(A). Western blot analysis of protein levels of Integrator subunits after treating cells with 
dsRNA targeting LacZ, CycC, or Cdk8. Cells were also transfected with the U7-GFP reporter 
to monitor snRNA misprocessing as a functional readout of knockdown of CycC/Cdk8. (B). 
Quantitative RT-PCR analysis using SYBR green staining of PCR products. RNA was isolated 
from S2 cells, treated with the three dsRNAs described in panel A and subjected to real-time 
PCR analysis using amplicons specific to Integrator subunits not tested by Western blot 
analysis in panel A. All measurements were normalized to RpS17 signals as a housekeeping 
internal control. (C). Ethidium bromide staining of agarose gel electrophoresis of the amplicons 
amplified in panel B. 
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Asunder and CG4785 associate with Integrator Subunits.  
      To determine if either CG4785 or Asunder biochemically associate with the other 
Integrator subunits, we cloned full-length cDNAs and generated stable S2 cell lines 
expressing either FLAG-tagged Asunder or FLAG-tagged CG4785. Western blot 
analysis of lysates from these cell lines using anti-FLAG antibodies demonstrates the 
expression of specific bands of the predicted molecular weight for both proteins (Figure 
3.6A). We analyzed the subcellular localization of both of the tagged proteins and 
observed a nuclear localization of CG4785 and a bimodal localization of Asu in both 
the nucleus and the cytoplasm (Figure 3.6B). Nuclear extracts were prepared from 
both stable cell lines from which epitope tagged proteins were immunoprecipitated 
using anti-FLAG agarose. A large majority of FLAG-tagged protein was recovered in 
each precipitate from both cell lines and we determined the levels of interacting 
endogenous Integrator subunits using antibodies to Drosophila IntS1, IntS9, IntS11, 
and IntS12 proteins (Figure 3.6C). A large proportion of all four Integrator subunits 
were detected specifically associating with Asu and CG4785, relative to control pull 
downs (Figure 3.6C). We did not detect SLBP in either immunoprecipitate, consistent 
with the observation that depletion of these two proteins does not affect histone mRNA 
3’ end formation. To confirm potential direct interactions with Drosophila Integrator 
subunits, we performed binary interaction tests using pairwise, directed yeast two-
hybrid analysis. This is an ideal assay to perform this analysis given the lack of 
endogenous yeast Integrator subunits. Under low and high stringency conditions, we 
did not observe any interaction between Asu and the known Integrator subunits (not 
shown). In contrast, we did observe a robust interaction between CG4785 and IntS10 
by Y2H (Figure 3.6D). Collectively, these data demonstrate that, in addition to their 
functional requirement in snRNA 3’ end formation, both Asu and CG4785 biochemically 
associate with the previously described members of the Drosophila Integrator complex 
(Baillat et al. 2005). While the interaction of CG4785 is most likely mediated through 
IntS10, the binding partner(s) of Asunder remain to be identified. 
 
Requirement for Cyclin C and Cdk8 in snRNA 3’ end formation is conserved and 
independent of its function in Mediator.  
      There has been extensive previous characterization of CycC and CDK8 as 
members of the Mediator CDK8 module in conjunction with Mediator 12 and 13 
(reviewed in (Galbraith et al. 2010)). Knockdown of these two Mediator subunits did not 
produce GFP expression in our screen, suggesting that either they are not required for 
snRNA processing or were not depleted effectively. To address the latter possibility, we 
created independent dsRNAs specific to Med12 and Med13 and observed that they 
elicited significant reduction in the levels of endogenous Med12 and Med13 yet failed 
to trigger misprocessing in the U7-GFP reporter (Figure 3.7A). These results imply that 
CycC and Cdk8 are required for snRNA 3’ end formation independent of Med12 and 
Med13. To determine if CycC or CDK8 play a conserved role in the 3’ end formation of 
human snRNA, we treated HeLa cells with two siRNAs targeting both transcripts and 
then transfected the human version of the U7-GFP reporter that we showed previously 
to express GFP in response to Integrator activity disruption (Albrecht and Wagner 
2012). We observed that both siRNAs resulted in efficient reduction of the levels of 
endogenous CycC and siRNA #2 resulted in significant depletion of CDK8 and gave 
rise to GFP expression comparable to those after depletion of IntS12 (Figure 3.7B). We 
noted that CDK8 siRNA#1 did not give rise to as much GFP expression as siRNA#2 
but the knockdown was not as effective and also not as effective as co-depleting CycC. 
These results demonstrate the requirement for CycC and CDK8 in snRNA 3’ end 
formation in metazoans. 
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Figure 3.6 Asunder and CG4785 biochemically associate with the fly Integrator 
Complex.  
(Figure reprinted from Chen J et al. RNA. 2012. doi:10.1261/rna.035725.112) 
(A). Western blot analysis of FLAG-tagged Asunder and CG4785 expression in S2 stable 
cells. (B). IF analysis of stable S2 cell lines expressing FLAG- tagged Asunder or CG4785. 
(C). Western blot analysis of FLAG immunoprecipitates from cell lines described in panel A. 
Input lanes represent 5% of input and IP represents 50% of the immunoprecipitate. (D). 
Directed yeast two-hybrid using fly Integrator subunits and CG4785 demonstrating an 
interaction with IntS10. 
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      The functional requirement for CycC/Cdk8 in fly snRNA 3’ end formation generates 
the question of whether these two proteins are associated with Integrator subunits. To 
test this possibility, we generated stable S2 cell lines expressing FLAG-mcherry 
(negative control), FLAG-Cdk8, or FLAG-CycC and performed immunoprecipitations 
from nuclear extracts prepared from these cell lines. We observed substantial amounts 
of endogenous Med12 and Med13 associating with both FLAG-CycC and FLAG-Cdk8 
as predicted, yet we also observed a reproducible interaction with the Integrator 
subunits (Figure 3.7C). The reduced levels of Integrator proteins in the co-IP suggest 
that the interaction is relatively weak or transient and that only a small pool of 
CycC/Cdk8 not associated with Med12 and Med13 binds to the Integrator subunits. To 
test these predictions, we used IntS12 antibodies to immunoprecipitate the Integrator 
complex from nuclear extract derived from S2 cells stably expressing FLAG-Cdk8. We 
observed significant amount of IntS11 and a portion of FLAG-Cdk8 associating with 
IntS12 (Figure 3.7D). Importantly, we did not detect Med13 interacting with IntS12. This 
reciprocal pulldown confirms the presence of a small amount of Cdk8 associating with 
the fly Integrator complex in the absence of Mediator. 
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Figure 3.7 CycC/Cdk8 function in snRNA 3’ end formation independent of Mediators 
12/13 and are associated with Integrator subunits.  
(Figure reprinted from Chen J et al. RNA. 2012. doi:10.1261/rna.035725.112) 
(A). Western blot analysis of lysates from S2 cells treated with dsRNA targeting members of 
the Drosophila Mediator Cdk8 module and transfected with the U7-GFP reporter. (B). Western 
blot analysis of lysates from HeLa cells treated with siRNA to CycC or CDK8 followed by 
transfection with a human version of the U7-GFP reporter. (C). Immunoprecipitations using 
αFLAG-agarose to detect interactions between CycC/Cdk8 and Integrator 1 and 9. Input lanes 
represent 2% of input and IP lanes represent 50% of immunoprecipitate. (D). Western blot 
analysis of immunoprecipitations using anti-IntS12 antibodies. 
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DISCUSSION 
 
      The functional genome-wide RNAi screen presented here has defined the Drosophila 
Integrator complex to comprise of fourteen core subunits. It is likely that the core members of 
the Integrator complex are conserved as the human orthologues of Asu and CG4785 were 
reported to be present in the human Integrator immunoprecipitations with the levels 
comparable to the known twelve Integrator members (Malovannaya et al. 2010). The 
conserved requirement for CycC/Cdk8 in the formation of both fly and human snRNA 3’ end 
suggests that besides the conserved core complex, the regulation of snRNA 3’ end formation 
is likely retained in metazoan species.  
 
U7-GFP reporter as a sensor for snRNA misprocessing 
      The snRNA-GFP reporter allows us to visually monitor snRNA 3’ end formation with great 
sensitivity. However, one limitation of the U7-GFP reporter is that for an RNAi-knockdown to 
be scored as a positive “hit”, the protein depleted must only disrupt snRNA 3’ end formation 
but not snRNA gene transcription. In this case, any factor that extinguishes snRNA 
transcription will be eliminated. This likely explains why members of the snRNA Activating 
Protein Complex (SNAPc) and the recently defined Little Elongation Complex were not scored 
in our RNAi screen (Hung and Stumph 2011; Smith et al. 2011). Depletion of any of these 
factors would compromise U7-GFP transcription and lead to no GFP expression. Developing 
an snRNA reporter that is able to visualize both snRNA transcription and 3’ end formation will 
significantly improve our understanding to the screen results by discriminating the effect 
resulted from transcription from 3’ end formation. Recently, RNA aptamers have been reported 
to lighten up modified RNAs in cells by forming the RNA aptamer/fluorophore complex, which 
produce a wide spectrum of fluorescence(Paige et al. 2011). A modified snRNA reporter that 
fuses these newly developed RNA aptamers to the snRNA genes will enable us to monitor 
snRNA transcription and 3’ end formation simultaneously by measuring the different spectrum 
of fluorescence, such as GFP and mCherry. Interestingly, the fly orthologue of RPAP2 
(CG34183), a protein factor recently proposed to mediate the interaction between Integrator 
complex and the RNAPII CTD (Egloff et al. 2012), was not scored in our screen either. One 
possible explanation of this is that RPAP2 may be required for snRNA gene transcription as 
well as 3’ end processing. Alternatively it may not be required in Drosophila. Considering the 
markedly distinct structure of fly RNAP II CTD (very few Ser7 within the heptad repeat), and 
the significantly smaller fly RPAP2 (143a.a.) versus its human counterpart (612a.a.), it is 
possible that RPAP2 may not be involved in Drosophila snRNA 3’ end formation. 
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Novel components identified to be required for snRNA 3’ end processing 
      Our functional screen identified Asu and CG4785 as two additional core components of the 
Integrator complex. Asu was initially named Mat89b, due to its maternal deposition in the 
Drosophila embryo (Stebbings et al. 1998). Later, it was characterized to be a substrate for 
PanGu kinase, and the reduction of Asu expression in the spermatocytes was reported to 
cause aberrant centrosome and spindle assembly (Anderson et al. 2009). Asu has a predicted 
molecular weight of 76kDa with a conserved yet uncharacterized DUF2151 domain. The 
CG4785 gene encodes a 65kDa protein with a less conserved (Pfam: E-value 0.022) von 
Willebrand Factor (vWF) type A (VWA) domain, which was observed in IntS6 as well. Previous 
studies show that the VWA domains in extracellular eukaryotic proteins are involved in cell 
surface adhesion via metal ion-dependent adhesion sites (MIDAS), and intracellular VWA 
domains containing proteins have been found to be involved in various functions such as 
transcription, DNA repair, ribosomal and membrane transport and the proteasome(Whittaker 
and Hynes 2002). The human orthologues of Asu and CG4785 have been found to be present 
in the human Integrator protein immunoprecipitations by large-scale mass spectrometry at the 
levels comparable to known Integrator proteins, suggesting that these two proteins are likely to 
play conserved roles in snRNA biogenesis (Malovannaya et al. 2010; Malovannaya et al. 
2011). Based on the existing evidence and our results, we suggest that Asu be known as 
Asu/IntS13 and CG4785 as IntS14.  
      This study also identified the functional requirement of CycC/Cdk8 in snRNA 3’ end 
formation, and suggests that CycC/Cdk8 are likely to function in a pathway independent of 
Mediator 12 and 13. Our results are consistent with previous observations that sex comb 
phenotypes of CycC– and Cdk8– clones are indistinguishable from each other but clearly 
distinct from the phenotypes of Med12– and Med13– clones (Loncle et al. 2007). Here we 
propose two potential functions for Cyclin C/Cdk8 in snRNA 3’ end formation: phosphorylation 
of the RNAPII CTD, or as an Integrator subunit kinase. Phosphorylation of Ser2 and Ser7 in 
the RNAPII CTD is reported to be specifically required for Integrator complex recruitment and 
activation of snRNA 3’ end processing, but the kinase responsible for Ser7 phosphorylation is 
not known yet. Cdk8 has been shown to phosphorylate the CTD of Rpb1 in vitro (Rickert et al. 
1999), so it is possible that Cdk8 may act as a RNAPII CTD Ser7 kinase to mediate snRNA 3’ 
end processing. Alternatively, CycC/Cdk8 may regulate an Integrator subunit through direct 
phosphorylation similar to the role it plays in the mediator complex where CycC/CDK8 
phosphorylates Mediator 13 (Knuesel et al. 2009).  
      In conclusion, the most remarkable feature of the Integrator complex is that an essential 
network of interactions is present making it intolerant to perturbation. In most cases, depletion 
of even a single subunit leads to inefficient snRNA 3’ end processing. Thus, characterization of 
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the functional interactions and identification of the role of each Integrator subunit in snRNA 3’ 
end formation represent the most compelling challenges in the field. 
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Chapter 4. Functional Analysis Identifies an Autonomous IntS12 microdomain 
Mediating Activation of the Drosophila Integrator Complex.  !! !
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INTRODUCTION!!
      The accurate production of snRNAs is an important bioprocess needed for efficient 
downstream RNA processing events including intron removal and histone mRNA 3’ end 
formation (reviewed in (Matera et al. 2007; Egloff et al. 2008)). With the exception of the U6 
snRNA, spliceosomal snRNAs are transcribed by RNA Polymerase II (RNAPII) and their 3’ 
ends are processed by the Integrator complex. Both the snRNA promoter and the 3’ box 
sequence element located downstream of the cleavage site have been established as features 
required for snRNA 3’ end formation in metazoans (Hernandez 1985; de Vegvar et al. 1986; 
Hernandez and Weiner 1986). Unlike the rigid requirements of the poly(A) signal (PAS) in 
protein coding genes or the histone downstream element (HDE) in histone mRNA processing, 
the snRNA 3’ box can be removed with only minor perturbation to snRNA biosynthesis (Ach 
and Weiner 1987; Ezzeddine et al. 2011). This demonstrates that the snRNA processing 
machinery is moderately tolerant to mutations within demarcating cis elements and that 
specificity of the RNA cleavage event is in part brought about through additional means. 
      Precise snRNA 3’ end cleavage is predicated on transcription being initiated from an 
snRNA promoter, with distinct RNAPII C-terminal domain (CTD) protein modifications found on 
transcription complexes active at snRNA loci. Phosphorylations within the CTD heptad repeat 
at serines 2 and 7 have been shown to be essential for Integrator recruitment and subsequent 
snRNA 3’ end formation (Egloff et al. 2007; Egloff et al. 2010). Replacement of native snRNA 
promoters with RNAPII promoters from protein-coding genes prevents snRNA 3’ end 
formation, consistent with Integrator being assembled onto the RNAPII complex early in the 
transcription cycle (de Vegvar et al. 1986; Hernandez and Weiner 1986; Ezzeddine et al. 
2011).  
     The initial biochemical identification of the Integrator complex, subsequent analyses of 
immunoprecipitates, and a recent genome-wide RNAi screen have identified fourteen 
members of the complex to date (IntS1 through IntS12, Asu/IntS13 and IntS14) (Baillat et al. 
2005; Malovannaya et al. 2010; Malovannaya et al. 2011; Chen et al. 2012). Each member of 
the human Integrator complex is conserved in Drosophila and RNAi-mediated depletion of 
nearly any Integrator subunit in S2 cells causes snRNA misprocessing (Ezzeddine et al. 
2011). This latter result suggests the existence of a network of interactions within the 
Integrator complex that is highly sensitive to disruption. 
      The only well-established protein-protein interaction among Integrator subunits is between 
IntS9 and IntS11 (Dominski et al. 2005b; Albrecht and Wagner 2012).  These two proteins 
contain highly conserved metallo-β-lactamase and β-CASP domains and likely represent the 
catalytic core of the complex (reviewed in (Dominski 2007)).  They form a highly stable 
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heterodimer in vivo and their association is mediated through conserved C-terminal domains 
on both proteins.  Formation of this heterodimer is required for snRNA 3’ end formation and 
likely is important to activate the endonuclease activity of IntS11 (Albrecht and Wagner 2012).  
The role of the remaining subunits in snRNA 3’ end formation has yet to be determined and 
functional domains within other subunits have yet to be experimentally identified. 
      There are several evolutionarily conserved motifs identifiable within Integrator subunits in 
addition to the conserved β-CASP/β-lactamase domains of IntS9/11 (reviewed in (Chen and 
Wagner 2010)).  These include the HEAT repeats within IntS4, a von-Willebrand factor type A 
(VWA) motif within IntS6, and a Plant Homeodomain (PHD) finger in IntS12. PHD fingers are 
typically ~60 amino acid motifs comprising a C4HC3 signature that coordinate two zinc ions 
(reviewed in (Bienz 2006; Musselman and Kutateladze 2011)). Proteins containing PHD 
fingers are almost exclusively found in the nucleus and are commonly present in protein 
complexes that govern transcriptional regulation. The PHD finger itself robustly interacts with 
N-terminal tails of histones, most commonly histone H3. Typically, PHD fingers exhibit 
preference toward unique chemical modifications of amino acids in histone H3 with a particular 
preference toward lysine methylation. These attributes make analysis of the role of the IntS12 
PHD finger in snRNA 3’ end formation an attractive entry point to further our understanding of 
Integrator subunit function. 
      Here, we investigate the role of Drosophila IntS12 in snRNA 3’ end formation using 
snRNA-specific GFP reporters to assess Integrator complex activity. To identify regions of 
IntS12 required for Integrator activity, we devised an RNAi-rescue strategy to re-express 
RNAi-resistant forms of IntS12 mRNA in cells depleted for endogenous IntS12 protein.  
Unexpectedly, we determined the PHD finger to be dispensable for IntS12 activity and instead 
identified a small microdomain at the N-terminus of IntS12 that is essential for activity. 
Surprisingly, the IntS12 microdomain by itself is sufficient to rescue the snRNA misprocessing 
defected from our reporters as well as endogenous snRNAs observed in IntS12 depleted cells.  
Moreover, the microdomain is sufficient to mediate interaction between Integrator subunits and 
a heterologous protein. We also show that the IntS12 microdomain interacts with IntS1 in the 
absence of other Integrator subunits and the stability of these two subunits requires their 
interaction.  Collectively, these results suggest a critical regulatory function for IntS1 and 
IntS12 required for Integrator activity in snRNA 3’ end formation. 
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RESULTS 
Development of an RNAi-rescue assay to study IntS12 function.   
      Previously, we developed a GFP-based reporter system for in vivo monitoring of U7snRNA 
3’ end formation in Drosophila cells (Ezzeddine et al. 2011; Chen et al. 2012). The advantage 
of the U7-GFP reporter as a method of monitoring Integrator complex activity is that loss of 
activity can be readily detected in vivo with high sensitivity via GFP fluorescence.  A potential 
limitation of this reporter is that it uses the U7 snRNA gene, which is somewhat atypical from 
the spliceosomal snRNA genes due to unique variations within its core promoter elements 
(Dominski et al. 2003; Hernandez et al. 2007). To control for potential experimental bias, we 
created a second analogous spliceosomal snRNA reporter based instead upon the Drosophila 
U4:39B snRNA gene. To test the functionality of this new reporter (U4-GFP), we treated S2 
cells with separate non-overlapping dsRNAs (IntS12#1 or IntS12#2) to induce RNAi-mediated 
depletion of IntS12. Cells were then transfected with either the U7-GFP or U4-GFP reporter to 
assess Integrator complex functionality (Figure 4.1A). Depletion of IntS12 resulted in robust 
levels of GFP expression from both reporters relative to control dsRNA (LacZ) treated cells.  
Western blot analysis of lysates prepared from treated cells confirmed both the loss of 
endogenous IntS12 expression and a consequential increase in GFP production from both 
reporters (Figure 4.1B).  While the overall sensitivity of the U4-GFP reporter is similar to that of 
the U7-GFP reporter, the U4-GFP reporter displayed greater specificity, as seen by the lower 
background GFP fluorescence in the control treated cells.  Finally, to confirm that dsRNA-
mediated depletion of IntS12 led to misprocessing of endogenous snRNAs, we isolated total 
RNA and performed qRT-PCR analysis using primers that specifically detect the misprocessed 
forms of the U1, U2, U4 and U5 snRNAs (Figure 4.1C).  Both dsRNAs directed against IntS12 
were found to increase the levels of misprocessed snRNA 2-4 fold, consistent with our 
previous observations (Ezzeddine et al. 2011). 
      To validate that the misprocessing of the U7 and U4-GFP reporters we observed is 
induced by depletion of the endogenous IntS12 protein, we set to rescue the phenotype by 
introducing back an IntS12 plasmid refractory to RNAi. As initial attempts to target the 
endogenous IntS12 mRNA 5′ or 3′ UTRs using dsRNA failed to generate adequate depletion, 
we developed a RNAi-resistant IntS12 expression construct containing 188 silent mutations 
within the region targeted by the IntS12#2 dsRNA (cDNA bases 1-418) (Figure 4.2A).  
Expression of this RNAi-resistant IntS12 cDNA (IntS12*) from a ubiquitin promoter yielded ~50 
kDa doublet of IntS12 protein, albeit at slightly reduced levels relative to the wild-type IntS12 
cDNA expressed under the same conditions.  Next we tested the ability of IntS12* to restore 
snRNA 3’ end processing in cells when endogenous IntS12 has been depleted. 
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Figure 4.1 Dual GFP reporters reveal snRNA misprocessing following IntS12 
knockdown in Drosophila S2 cells. S2 cells treated with dsRNA corresponding to bases 
418-719 (IntS12#1) and 1-418 (IntS12#2) of IntS12 mRNA, or control dsRNA (lacZ) were 
subsequently transiently transfected with either U7-GFP or U4-GFP 3’ cleavage reporter 
constructs. (A) Fluorescence and brightfield images of treated S2 cells and. (B) Western blot 
analysis of cell lysates using anti-GFP or anti-IntS12 antibodies. A nonspecific band that 
cross-reacts with the IntS12 antibody is shown as a loading control (C) Graphical 
representation of qRT-PCR quantification of snRNA misprocessing. Amplicons specific for 
non-processed snRNAs isolated from S2 cells treated with either IntS12#1 or IntS12#2 
dsRNAs. Data represent the average of triplicate independent experiments normalized to 
Rps17 mRNA and plotted as fold increase relative to LacZ-treated control cells. 
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Figure 4.2 RNAi-resistant IntS12* Rescues dsRNA-induced U4 and U7 snRNA 
Misprocessing. (A) Schematic of the features encoded in the Drosophila (CG5491) IntS12 
gene, showing the relative location of dsRNA#2 and the 188 silent site changes used to 
generate the IntS12* cDNA. (B) Western blot analysis of lysates from cells transfected with 
myc-tagged IntS12 (wild-type) cDNA or IntS12* cDNA using anti-myc antibodies. (C) Western 
blot analysis demonstrating dose-dependent rescue of the U7-GFP and U4-GFP 
misprocessing phenotype using the IntS12* cDNA following RNAi-mediated depletion.  Lanes 
2-7 are from S2 cells treated with IntS12 dsRNA#2 subsequently cotransfected with reporter 
plasmid and rescue plasmid DNAs. Doses of rescue plasmid (Res. P) are indicated in 
nanograms.  (D) Representative fluorescence images of S2 cells treated as described in panel 
(C). In all cases “VA” is the abbreviation for transfecting cells with vector alone. 
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To this end, we cotransfected either the U4-GFP or U7-GFP reporters with decreasing 
amounts of plasmid DNA encoding IntS12* into S2 cells depleted of endogenous IntS12 by 
treatment with dsRNA#2. Both fluorescence microscopy and Western blot analysis of lysates 
from transfected cells revealed a clear dose-dependent response between the amount of 
transfected IntS12* and the level of snRNA 3’ end processing as measured by both reporters 
(Figure 4.2C/D).  As 10 ng. of transfected IntS12* cDNA per 96-well was found to be the 
minimal amount required to achieve full rescue of IntS12 knockdown, this amount was used in 
all further experiments.  Collectively, these results demonstrate that depletion of endogenous 
IntS12 leads to measureable and reproducible GFP expression from both U4-GFP and U7-
GFP reporters and that dsRNA mediated knockdown of endogenous IntS12 can be fully 
rescued through the expression of an RNAi resistant IntS12* cDNA. 
 
The N-terminus is both Necessary and Sufficient for IntS12 Function.  
      Alignment of IntS12 protein sequences from multiple species identified two regions with 
significant homology (Figure 4.3).  The largest region includes the amino acids within the PHD 
finger known to be important for zinc coordination as well as several other residues known to 
be essential for maintaining PHD structure (Bienz 2006).  A smaller conserved region within 
the first 50 amino acids of the N-terminus bears no resemblance to any known motifs. Lastly, 
the C-terminal region consists of a poorly conserved serine rich region.  To investigate the 
functional contribution of these conserved features to snRNA 3’ end formation, we utilized the 
dual U7 or U4-GFP reporter together with the RNAi-rescue strategy we developed. To do this, 
we generated a series of RNAi-resistant deletion constructs derived from the IntS12* cDNA 
and tested their ability to rescue snRNA misprocessing in cells depleted of endogenous IntS12 
(Figure 4.4A). Constructs lacking various combinations of the N-terminus, centrally located 
PHD finger domain, or serine-rich C-terminus were myc-tagged and transfected into S2 cells. 
Western blot analysis using anti-myc antibodies confirmed protein expression from all 
constructs while some variability was observed (Figure 4.4B).  To determine the relative ability 
of these deletion mutants to restore snRNA processing after knockdown of endogenous 
IntS12, we co-transfected each mutant construct with either the U7-GFP or the U4-GFP 
reporter into cells pre-treated with IntS12 dsRNA#2.  Data obtained using GFP fluorescence 
imaging (Figure 4.4C) and Western blot analysis using anti-GFP antibodies were congruent 
(Figure 4.4D).  The results gathered using both GFP reporters were remarkably consistent 
and, to our surprise, demonstrated that the conserved PHD finger is not required for IntS12 to 
mediate snRNA 3’ end processing.  We found that constructs containing N-terminal amino 
acids (ΔC, NP, N, and ΔP) were as active as full-length (FL) protein in restoring reporter 3’ end 
processing after endogenous IntS12 knockdown. 
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Figure 4.3 Protein sequence alignment of IntS12 from four metazoan species. Vector NTI 
Advance (Invitrogen) is used to generate the sequence alignment graph. Four different 
species are selected: human (H.sapiens), chicken (G.gallus), zebrafish (D.rerio) and fly 
(D.melanogaster). Blue highlighted residues represent similar amino acids and yellow 
highlights represent identical residues. The highlighted red boxes denote the identified 
functional microdomain and the defined PHD finger. 
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Figure 4.4 The N-terminus of Drosophila IntS12 is required for snRNA 3’ end formation. 
(A) Schematic of IntS12* truncation and deletion constructs, which were designed based upon 
predicted domains. Relevant amino acid sequences are numbered. (B) Western blot analysis 
of cell lysates isolated from S2 cells transiently transfected with plasmids encoding myc-
tagged IntS12* proteins. (C) Representative fluorescence images of S2 cells treated with 
either control dsRNA or IntS12 dsRNA#2 followed by cotransfection of either the U4-GFP or 
U7-GFP reporters with the myc-tagged IntS12* cDNAs. (D) Western blot analysis of cell 
lysates from panel (C). (E) Schematic and Western blot analysis of three additional IntS12* 
deletion mutants cotransfected with the U4-GFP reporter. In all panels “VA” stands for empty 
vector transfection as a control. 
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Conversely, all mutants lacking the N-terminus (C, PC, ΔN, and P) were incapable of restoring 
Integrator activity.  These results indicate that the N-terminal 45 amino acids are required for 3’ 
end processing activity while the first 129 amino acids are sufficient, whereas the PHD domain 
was dispensable.  
 
Mutations within an N-terminal microdomain disrupt IntS12 Activity.   
      To further characterize the N-terminus of IntS12, we generated three more IntS12 
constructs derived from IntS12*. Two encode proteins harboring deletions of either the first 15 
or first 30 amino acids, whereas a third generated a truncated protein consisting of only the 
first 45 amino acids (Figure 4.4E, upper panel). The ΔN15 mutant was observed to function as 
well as full-length IntS12; however, deletion of the first 30 amino acids (ΔN30) abolished 
IntS12’s ability to rescue misprocessing of the U4-GFP reporter (Figure 4.4E, blot) despite 
being expressed at levels comparable to the FL protein.  In addition, expression of the first 45 
amino acids of IntS12 (N45) was sufficient to restore snRNA processing as effectively as the 
FL expression construct.  These data demonstrate that amino acids 16-45 are required for 
IntS12 activity and that the first 45 amino acids are sufficient to restore snRNA 3’ end 
processing after endogenous IntS12 knockdown. 
      Detailed examination of the evolutionary similarities within the N-terminal region of IntS12 
(Figure 4.5A) shows high conservation of the residues located within the region identified as 
required for IntS12 function.  The combination of evolutionary conservation and requirement in 
snRNA 3’ end processing implicates this region as forming a functional microdomain critical for 
IntS12 activity.  To achieve better resolution of the relative contribution of amino acids within 
this microdomain, we created a series of 6 mutant constructs (Mt1 through Mt6) spanning 
amino acids 16-45, each comprising 5 contiguous alanine substitutions in the context of the 
full-length IntS12* (Figure 4.5A).  In instances where alanine was encoded in the wild-type 
protein at a specific residue, no change was introduced. Therefore two of the mutants 
contained 4 amino acid changes (Mt2 and Mt6) and one (Mt4) contained only three 
substitutions. Western analysis confirmed each of these mutants to be expressed to similar 
levels at the wild-type IntS12 protein (Figure 4.5B), yet they displayed strikingly different 
abilities to promote snRNA 3’ end processing.  Mt1, Mt2, Mt4, and Mt6 were as capable as the 
wild-type IntS12 in restoring snRNA processing; however, both Mt3 and Mt5 were completely 
ineffective in abrogating GFP reporter gene expression (Figure 4.5B).  When this same 
mutation series was retested in the context of the “N” construct (Figure 4.3A) comprising the 
first 129 amino acids only, virtually identical results were obtained (data not shown).  These 
data define a highly conserved ~15 amino acid ‘core’ of a microdomain within the N-terminus  
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Figure 4.5 Mapping critical residues within the N-terminal IntS12 microdomain required 
for snRNA 3’ end formation. (A) Upper panel, alignment of several species’ IntS12 N-termini.  
Blue highlighted residues represent similar amino acids and yellow highlights represent 
identical residues. The highlighted red box denotes the identified functional microdomain; the 
labeled amino acids are the subject of six different alanine-scanning mutants. (B) Western blot 
analysis of cell lysates treated with either control dsRNA or IntS12 dsRNA#2 that were then 
cotransfected with U4-GFP reporter and IntS12* plasmids containing mutations as described 
in panel (A). 
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of IntS12 that is required for restoring snRNA 3’ end processing after endogenous IntS12 
knockdown. 
 
The IntS12 Microdomain is Necessary and Sufficient for Incorporation of IntS12 into the 
Integrator Complex.   
      Given the discrete and conserved nature of the IntS12 microdomain, we hypothesize that it 
may function as a protein-protein interaction motif required for association with other 
member(s) of the Integrator complex.  To test this possibility, we cloned full-length RNAi-
resistant IntS12* cDNAs encoding either full-length (FL), Mt3 or Mt5 proteins in frame with an 
N-terminal FLAG to facilitate immunoprecipitation studies.  Analogous constructs comprising a 
deletion of the first 45 amino acids of IntS12* (ΔN) or only the first 45 amino acids at the N-
terminus (N45) were also generated. We observed that different FLAG-tagged proteins 
restored 3’ end processing of both the U7-GFP and U4-GFP reporters in an identical fashion 
to the myc-tagged proteins described above (Figure 4.6 v.s. Figures 4.4 and 4.5).  We further 
determined the effect of these FLAG-tagged proteins on endogenous snRNA processing.  We 
generated stable cell lines expressing FLAG-tagged IntS12* constructs, treated them with 
dsRNA targeting either control LacZ or IntS12 and measured snRNA misprocessing using the 
qRT-PCR assay described in Figure 4.1C. We observed that in the control stable line 
expressing the FLAG only, depletion of IntS12 led to a 4-5 folds increase in the levels of 
misprocessed endogenous U2 or U5 snRNA. Consistent with the reporter observations, stably 
expressing FLAG-IntS12* or FLAG-N45 in IntS12 depleted cells rescued the misprocessed 
endogenous U2 and U5 snRNAs to similar basal levels. In contrast, depletion of IntS12 in 
stable lines expressing FLAG-tagged Mt3, Mt5 or ΔN led to a 3-5 folds increase in 
misprocessed levels of endogenous U2 or U5 snRNA (Figure 4.7A). These data demonstrate 
that functionally the IntS12 microdomain is necessary and sufficient to mediate the 3’ end 
formation of both reporter and endogenous snRNAs.  
      To test interactions of other Integrator subunits with the IntS12 microdomain, we generated 
nuclear extracts from these same stable cells lines and immunoprecipitated IntS12-associated 
proteins using anti-FLAG agarose beads (Figure 4.7B).  While we observed rescue of snRNA 
processing using the N45 Int12 cDNA, levels of this protein were markedly reduced relative to 
the other stably expressed Int12 proteins obscuring the ability to directly compare IP 
efficiencies.  Therefore, we initially compared the binding of endogenous Integrator subunits to 
the full length IntS12, Mt3, Mt5, and the ΔN. We observed robust and significant levels of 
endogenous IntS1 and IntS9 associating with FLAG-tagged full length (FL) IntS12 relative to 
control pulldowns (Figure 4.7B. lane 4 vs. 2). IntS12 protein expressed from Mt3- or Mt5-
containing constructs poorly associated with endogenous IntS1 or IntS9 and this association 
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Figure 4.6 FLAG-tagged IntS12 microdomain restores processing of U4 and U7 snRNA-
GFP reporters. Western blot analysis of cell lysates from S2 cells treated with either control 
dsRNA or IntS12 dsRNA#2 followed by cotransfection of FLAG-tagged rescue plasmids and 
either the U4- GFP or U7-GFP reporter. 
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was completely absent in cells expressing the ΔN IntS12 protein truncation (Figure 4.7B. lanes 
6, 8, & 10 versus lane 4).  These data demonstrate that mutations introduced into the IntS12 
N-terminal microdomain compromise Integrator activity in snRNA 3’ end processing by 
reducing the ability of IntS12 to interact with other Integrator subunits. 
      As the data presented in Figure 4.7A shows expression of only the first 45 amino acids of 
IntS12 is sufficient to rescue depletion of the endogenous protein, we next asked if the IntS12 
microdomain alone (N45) is sufficient to mediate interaction with endogenous Integrator 
subunits.   To circumvent the issue of low expression of the N45 peptide we generated stable 
cell lines expressing either FLAG-mCherry or FLAG-N45mCherry, where the first 45 amino 
acids of IntS12 was fused to the N-terminus of mCherry.  To confirm that fusion to mCherry did 
not generate any unintended effects, we transfected FLAG-mCherry, FLAG-N45mCherry, or 
full-length FLAG-IntS12* into cells pretreated with IntS12 dsRNA#2.  Western blot analysis 
determined that both FLAG-mCherry and FLAG-N45mCherry were expressed at comparable 
levels, however, only the FLAG-N45mCherry was capable of rescuing the snRNA processing 
defects associated with depletion of endogenous IntS12 (Figure 4.7C, lane 2 vs. 3).  FLAG-
tagged proteins from cell lines stably expressing these constructs were then 
immunoprecipitated utilizing anti-FLAG agarose and probed for their ability to pull-down 
endogenous IntS1 and IntS9.  We found robust levels of both these subunits interacting with 
the FLAG-N45mCherry relative to FLAG-mCherry control (Figure 4.7D, lane 2 vs. 4). We also 
noticed that the FLAG-N45mCherry was not as efficient as FLAG-tagged full-length IntS12 in 
interacting with either the IntS1 or IntS9 subunit suggesting that residues beyond the first 45 
amino acids are likely to contribute to the interactions between IntS12 and other members of 
the complex as well.  Nevertheless, the N-terminal 45 amino acid IntS12 microdomain is 
sufficient for binding to IntS1 and IntS9 and to restore snRNA 3’ end cleavage, either as a 
peptide (FLAG-N45) or in the context of a heterologous protein (FLAG-N45mCherry). 
 
IntS1 Binding to the IntS12 Microdomain is Essential for Maintaining IntS1 levels.  
      As co-depletion is commonly observed between interacting proteins and has been found to 
occur between several members of the histone pre-mRNA processing complex, including 
Symplekin and CPSF73 (Sullivan et al. 2009), we next asked whether expression of 
endogenous IntS12 is dependent on any other Integrator subunit. To do that, S2 cells were 
treated in duplicate with non-overlapping dsRNAs for each of the Integrator genes for which 
we had antibodies (IntS1, IntS9, IntS11, IntS12), or with a control dsRNA (LacZ). Depletion of 
Integrator subunits was equally effective with either dsRNAs relative to control dsRNA treated 
cells (Figure 4.8A).  In addition, both dsRNAs targeting IntS12 were as effective in depleting 
IntS1 protein level as were dsRNAs directly targeted IntS1, 
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Figure 4.7  Mutations in the IntS12 Microdomain causing loss of function disrupt IntS12 
interaction with endogenous Integrator subunits.  (A) Quantitative real-time PCR 
measuring levels of misprocessed endogenous U2 or U5 snRNA in cells treated with dsRNA 
targeting IntS12.  Control represents S2 cells expressing FLAG only while the cell lines treated 
with IntS12 dsRNA that are also stably expressing FLAG-tagged IntS12 proteins are labeled 
on the x-axis.  All results are plotted as fold increase relative to LacZ dsRNA treatment and 
normalized to RpS17 mRNA levels. (B) Western blot analysis of immunoprecipitations using 
anti-FLAG agarose from nuclear extracts prepared from cell lines stably expressing FLAG-
tagged IntS12* proteins. (C) Western blot analysis of cell lysates from S2 cells treated with 
either control dsRNA or IntS12 dsRNA#2 followed by cotransfection with U4-GFP and FLAG-
mCherry plasmids with or without the N-terminal 45 amino acids of IntS12. (D) Western blot 
analysis of immunoprecipitations using anti-FLAG agarose from nuclear extracts purified from 
cell lines stably expressing FLAG-tagged IntS12* proteins and FLAG-mCherry proteins with 
and without the IntS12 Microdomain (N45).  The upper panels are probed for endogenous 
IntS1/9 and the bottom panel is probed with anti-FLAG antibody to confirm pull down. 
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and reciprocally, dsRNAs targeting IntS1 were capable of co-depleting IntS12.  In contrast, 
IntS9 and IntS11 levels were unaffected by depletion of IntS1 or IntS12 and targeting either 
IntS9 or IntS11 did not impact on the levels of IntS1 or IntS12. We repeated these experiments 
in the cell lines stably expressing RNAi-resistant full-length IntS12*, Mt3-containing or Mt5-
containing full-length IntS12*, or the FLAG-N45mCherry proteins.  We observed that 
expression of the resistant full-length IntS12* blocked the codepletion of IntS1 in response to 
treatment of cells with IntS12#2 dsRNA whereas neither Mt3- or Mt5-containing constructs 
were effective in maintaining IntS1 stability (Figure 4.8B, lane 2 vs lanes 6, 7).  Consistent with 
the microdomain binding studies (Figure 4.7), stable expression of the first 45 amino acids of 
IntS12 was sufficient to stabilize IntS1 in cells when endogenous IntS12 had been depleted.  
Collectively, these data demonstrate that there is an interdependency of protein stability 
between IntS1 and IntS12 mediated by the IntS12 N-terminal microdomain and that amino 
acid substitutions in this microdomain that disrupt IntS12 activity and its association with 
endogenous Integrator subunits are also required to maintain endogenous IntS1 protein 
stability. 
      Finally, to examine the role of direct protein-protein interactions in Integrator complex 
composition and stability we utilized a directed yeast two-hybrid assay, since Saccharomyces 
cerevisiae does not encode any orthologous Integrator proteins. We expressed full-length 
Drosophila IntS12 fused to the Gal4 transcriptional activation domain (AD-IntS12) and all other 
members of the fly Integrator complex as individual fusions to the Gal4 DNA binding domain 
(BD-IntS1 through -IntS12). When individual BD fusions were coexpressed in cells along with 
AD-IntS12, only those expressing IntS1 and IntS10 supported growth on nutritional selection 
plates lacking histidine (Figure 4.9A).  However, in this system we were unable to conclusively 
determine the existence of an IntS10/12 association, as expression of the BD-IntS10 alone 
supported growth on media lacking histidine. To determine if the yeast two-hybrid interaction 
between IntS1 and IntS12 was sensitive to mutations within the N-terminal microdomain of 
IntS12, we expressed AD-fusions of full-length, ΔN, N45, Mt3- or Mt5-containing full length 
IntS12 in the presence of BD-Ints1.  We observed a total absence of growth on selective 
media lacking histidine for all IntS12 protein fusions that lacked or contained inactivating 
mutations within the N-terminus previously identified as unable to complement the effects of 
endogenous IntS12 knockdown (Figure 4.9B).  Importantly, Western blotting confirmed loss of 
growth was indicative of loss of interaction rather than loss of expression (Figure 4.9C).  
Lastly, we examined the binding of Gal4 fused to the N-terminal 45 amino acids of IntS12 and 
found that this small peptide, when fused to Gal4 was nearly as capable as the full-length 
protein in supporting growth on selective media. These results demonstrate that the IntS12  
 
! 78 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 Expression of Drosophila IntS1 and IntS12 is interdependent and stability of 
IntS1 requires an intact IntS12 Microdomain. (A) Western blot analysis of endogenous 
Integrator subunit expression from S2 cells treated with various dsRNA targeting IntSs. (B) 
Western blot analysis of endogenous IntS1 expression in S2 cells stably expressing FLAG-
tagged IntS12* proteins containing mutations within the IntS12 microdomain. 
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Figure 4.9 The IntS12 microdomain is required and sufficient to mediate interaction with 
IntS1 in the absence of other Integrator subunits. (A) S. cerevisiae (AH109) were 
cotransformed with plasmids encoding hybrid proteins containing IntS12 fused to the Gal4 
activation domain (AD-IntS12) and each of the other Integrator subunits fused to the Gal4 
DNA binding domain (BD-IntSs). A dilution series of overnight cultures was spotted on either 
SD/-Leu/-Trp plates or the same media without histidine to test interaction.  All BD constructs 
were tested for auto-activation. (B) Similar to panel A, except AH109 yeast were transformed 
with full-length IntS12 containing mutations 3, 5, or a deletion of the 45 N-terminal amino acids 
(DN), or the first 45 amino acids of IntS12 (N45). (C) Western Blot analysis confirming the 
expression of HA-tagged IntS12 constructs in yeast strain AH109. 
(The work for yeast-two-hybrid assay shown here is collaborating with Dr. Bill Warren’s group 
at James Cook University Australia, and I performed Western blot analysis to determine the 
expression of HA-tagged IntS12 constructs in yeast AH109.) 
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microdomain binds to IntS1 in the absence of other Integrators and that the first 45 amino 
acids are sufficient to support a stable and autonomous interaction with IntS1. 
 
DISCUSSION 
 
      Here we present a detailed functional analysis of the Drosophila IntS12 protein through 
characterizing its role in snRNA 3’ end formation. Unexpectedly, our investigations determined 
that the highly conserved PHD finger is dispensable for IntS12 to promote nascent snRNA 
processing (Figure 4.4).  Rather, we identified a small highly conserved ~30 amino acid 
microdomain near the N-terminus that is both necessary and sufficient for the restoration of 
Integrator function in IntS12 depleted cells (Figures 4.4-4.6). Residues within the IntS12 
microdomain are also required for interaction with other endogenous Integrator complex 
subunits, and when mutated disrupt their stable interaction (Figures 4.7-4.9).  These data 
establish a critical role for IntS12 in regulating the activity of the Integrator complex, mediated 
through binding to and stabilization of IntS1, the largest Integrator subunit.  Additionally, our 
approach using dual snRNA GFP reporters in combination with functional rescue through 
expression of RNAi-resistant cDNAs represents a powerful tool going forward to elucidate 
function of the other Integrator subunits. 
 
Functions of IntS12 microdomain.   
      Our results demonstrate a strong correlation between IntS12 microdomain binding to IntS1 
and its ability to promote snRNA 3’ end formation. This argues that this small interaction motif 
is critical for Integrator complex function. Moreover, results shown in Figures 4.7A and 4.7C 
reveal that the microdomain is nearly as effective as full-length IntS12 in restoring the 
processing of the reporter and endogenous snRNAs, thereby excluding a simple localization 
sequence function. However, as the FLAG-N45mCherry protein was not as effective at pulling 
down endogenous Integrator subunits as the full-length protein, other residues of IntS12 may 
play a minor role in achieving maximal stability of the IntS1/IntS12 complex (Figure 4.7D). 
      PSIPRED secondary structure prediction posits the IntS12 microdomain may form a helix-
coil-helix structure (Jones 1999; McGuffin et al. 2000; Buchan et al. 2010) similar to the 
hepatocyte nuclear factor 1-alpha dimerization domain and the dimerization domain required 
for the heterodimeric association of the SinR-SinI anti-repressor complex (Johnen and 
Kaufman 1997; Colledge et al. 2011).  In both of these cases, small helix-coil-helix domains 
act as crucial protein-protein interaction motifs that elicit dimerization.  Based upon these 
examples, we propose that the microdomain of IntS12 binds to an as-yet unidentified 
complementary domain within IntS1. This IntS1/IntS12 interaction is not only essential for 
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IntS1 function but also is required for the stability of both IntS1 and IntS12 (Figure 4.8).  In this 
respect, the IntS12 microdomain is behaving similar to the RNAse E microdomain that 
interacts with the glycolytic enzyme Enolase (Py et al. 1996; Chandran and Luisi 2006; 
Nurmohamed et al. 2010). RNAse E is the essential component of the Escherichia coli RNA 
degradosome and contains a N-terminal catalytic domain as well as a long C-terminal 
scaffolding domain (reviewed in (Carpousis 2007)).  The scaffold domain binds to the RhlB 
helicase, the phosphorolytic exoribonuclease polynucleotide phosphorylase, and Enolase.  
The RNAse E microdomain resides within the scaffolding section and consists of a ~28 amino 
acid conserved region that binds to a dimeric interface between two Enolase proteins to 
promote the decay of specific mRNAs in E. coli (Bernstein et al. 2002; Bernstein et al. 2004; 
Chandran and Luisi 2006; Nurmohamed et al. 2010).  Given the large size of IntS1, it may 
simultaneously interact with multiple other members of the Integrator complex in an analogous 
way to the scaffolding domain of RNAse E.  Our data support a model where binding of IntS12 
to IntS1 alters IntS1 confirmation allows further interaction(s) with other proteins and activation 
of the complex. 
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Chapter 5. Biochemical Analysis Identifies IntS12 as a Phosphoprotein and 
its Conserved PHD Finger Plays Roles in Histone H3 Interaction in vitro 
and Integrator Subunits Interaction in vivo 
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INTRODUCTION 
 
      The serendipitous biochemical purification of the twelve-member Integrator complex and 
the establishment of its role in snRNA 3’ end processing has expanded the existing repertoire 
of the 3’ end processing machinery for RNAPII transcripts (Baillat et al. 2005). The 
polyadenylated mRNA and poly(A)- histone mRNA use the same endonuclease CPSF73 for 
their 3’ end endonucleolytic cleavage (Reviewed in (Dominski 2007; Dominski 2010)). Unlike 
these two classes of RNAPII transcripts, a distinct endonuclease called IntS11 catalyzes the 3’ 
end processing of snRNA. IntS11 is homologous to CPSF73, and both proteins belong to the 
metallo-β-lactamase superfamily with a signature β-lactamase/ β-CASP domain (Weiner 2005) 
(See Figure 1.5 for a schematic representation of protein domain). In the Integrator complex, 
another Integrator subunit, IntS9, also has the MBL/β-CASP domain but with alterations in 
critical residues rendering it catalytically inactive. IntS9 shows significant homology with the 
mRNA 3’ -end processing factor CPSF100. Recent work from our lab shows that IntS9 and 
IntS11 form a heterodimer through a unique C-terminal domain and that the interaction 
between these two subunits is required for the cleavage activity of the Integrator complex 
(Albrecht and Wagner 2012). Besides these two subunits, no significant homology has been 
identified between subunits of the complex and other known proteins, making it difficult to 
predict their roles in snRNA 3’ end processing.  
     Most of Integrator subunits are conserved in metazoans and plants but absent in 
Saccharomyces cerevisiae (Baillat et al. 2005), which is consistent with the observation that 
yeast use a distinct Nrd1/Nab3/Sen1 complex to carry out the 3’ end processing of snRNAs. A 
careful protein domain analysis of the remaining ten Integrator subunits reveals the presence 
of HEAT repeats in IntS4, ARM repeats in IntS4 and IntS7, a von Willebrand factor type A 
(VWA) domain in IntS6 and a plant homeodomain (PHD) finger in IntS12. The HEAT and ARM 
repeats are from a common phylogenetic origin and both mediate protein-protein interactions 
(Andrade et al. 2001). The VWA domain is found in both intracellular and extracellular proteins 
and in both cases likely functions in protein-protein interactions (Whittaker and Hynes 2002). 
The PHD finger domain is a reader domain of chromatin modifications (Bienz 2006; 
Musselman and Kutateladze 2011), and the IntS12 PHD finger is the second most conserved 
domain after the MBL/β-CASP domain of IntS9/11. 
      Drosophila IntS12 is a 328-amino acid protein, consisting of a well-conserved central PHD 
finger, a conserved N-terminal motif and a less conserved C-terminal serine-rich region (See 
Figure 4.3). The PHD finger is a well-defined signature chromatin-associated motif that uses 
the Cys4–His–Cys3 motif to coordinate two zinc ions to form an intertwined topology (Sanchez 
and Zhou 2011). At the secondary structure level, it consists of a two-strand anti-parallel β-
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sheet and a C terminal α-helix (present in many PHDs). PHD fingers are commonly found in 
proteins that either possess catalytic activities or act as scaffolding proteins bridging 
multisubunit enzymatic complexes to specific genomic loci (Musselman and Kutateladze 2011; 
Sanchez and Zhou 2011). The biological outcome of an interaction for a particular PHD finger 
is usually determined by the function of the complex in which the PHD finger resides. It is 
widely accepted that PHD fingers are epigenetic effectors that recognize unique histone 
modifications present in the histone N -terminal tail, preferably the tail of histone H3 (Reviewed 
in (Musselman and Kutateladze 2011)). Recently, PHD fingers are also implicated in 
recognition of non-histone proteins where PHD finger acts as a protein-protein interaction motif 
to bind cofactors and further facilitate histone recognition (Hom et al. 2010; Miller et al. 2010). 
The Drosophila IntS12 PHD finger contains  ~55 amino acids and is phylogenetically 
conserved cross metazoan species. Its mouse homologue has been experimentally 
determined to adopt a typical PHD topology in solution (Figure 5.1A). Moreover, sequence 
alignment of IntS12 PHD finger to other known PHD fingers indicates that it is most closely 
related to a subgroup of PHD fingers that recognize unmodified histone H3 tail (Figure 
5.2A/B). Based on these evidence and the complex context that IntS12 PHD finger resides in, 
it is possible that IntS12 acts as an adaptor to bring the Integrator complex to snRNA genomic 
loci by recognition of unique chromatin modifications through its conserved PHD finger 
domain. Alternatively, given the emerging evidence that some PHD fingers have the ability to 
bind protein co-factors, it is also possible that IntS12 PHD finger works as a protein interacting 
motif to mediate Integrator complex assembly. 
      In this study, to test these possibilities mentioned above, we characterized several 
biochemical properties of IntS12 PHD finger and investigated their functional involvement in 
snRNA 3’ end processing. We also mapped a residue threonine 76 important for IntS12 
phosphorylation, and investigated the biochemical and cellular roles of this phosphorylation in 
Integrator interaction and snRNA 3’ end processing. Our data reveal that IntS12 PHD is able 
to bind histone H3 in vitro and enhance association with other Integrator subunits in vivo. 
However, functional analysis indicated that association with histone H3 or enhanced 
interaction with other Integrator subunits through the PHD finger is not essential for reporter 
snRNA 3’ end processing. We also demonstrate that IntS12 phosphorylation through T76 is 
functionally not required for snRNA 3’ end processing but may play a negative role in 
mediating protein-protein interaction between IntS12 and the other Integrator subunits. 
Collectively, these data characterized several features of IntS12 protein and demonstrate their 
function in Integrator protein interaction. We envision that a yet-to-be identified 
cellular/biological function for the Integrator complex besides snRNA biosynthesis may involve 
in the biochemical properties of IntS12 that we described here.  
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RESULTS 
The PHD finger of Integrator subunit 12 binds histone H3 in vitro 
      Recent studies show that PHD fingers have a general preference toward recognizing 
unmodified or modified N-terminal tail of histone H3 thereby involving them in fundamental 
cellular processes such as transcriptional regulation, nucleosome remodeling, and DNA 
recombination (Reviewed in (Musselman and Kutateladze 2011; Sanchez and Zhou 2011)). 
IntS12 has a central PHD finger that is conserved across different metazoan species (Figure 
5.1A, left panel). The Nuclear Magnetic Resonance (NMR) structure of the mouse IntS12 PHD 
finger (PDB id: 1wev) shows that this PHD finger adopts a typical PHD zinc finger structure 
consisting of an antiparallel beta-sheet and a α-helix in the C-terminus (Figure 5.1A, right 
panel). To determine whether the conserved IntS12 PHD finger is able to recognize specific 
histones, an in vitro glutathione S-transferase (GST) pull-down assay was performed by 
incubation of recombinant GST-tagged human IntS12 PHD finger, Drosophila IntS12 full 
length protein, or Drosophila IntS12 PHD finger with a purified mixture of histones 
(Worthington, NJ). Bound histones were co-precipitated with GST-tagged proteins by the 
glutathione agarose beads, and detected by Western blot analysis using histone antibodies. 
Both fly and human IntS12 PHD fingers as well as the full-length fly IntS12 protein were found 
to specifically bind histones even in the presence of 500mM NaCl in the incubation buffer 
(Figure 5.1B, left panel). Further analysis of the co-precipitates using individual histone 
antibodies revealed that histone H3 is specifically co-precipitated with IntS12 PHD finger 
(Figure 5.1B, right panel).  
     To further confirm the binding specificity of IntS12 PHD finger toward histone H3, ten 
IntS12 PHD finger point mutants were generated and used for the GST pull-down assay. 
These mutants were constructed by substituting highly conserved residues in IntS12 PHD 
fingers (Figure 5.1A, left panel) to alanine using site-directed mutagenesis. Two of these 
IntS12 PHD mutations (L145 and E147) were found to significantly reduce the levels of co-
precipitated histone H3 (Figure 5.1C), indicating their important roles in histone H3 interaction. 
Both residues were found to reside in the first β-strand of IntS12 PHD finger, which has been 
shown to play essential roles in recognition of histone H3 tails (Pena et al. 2006; Shi et al. 
2006). These results are highly similar to two previously well-characterized cases of 
recognition of tri-methyl Lysine 4 of histone H3 by the Inhibitor of Growth protein 2 (ING2) PHD 
finger and recognition of unmodified lysine 4 of histone H3 by the autoimmune regulator 
(AIRE) PHD finger (Pena et al. 2006; Org et al. 2008). In these instances, the first β-strand of 
PHD finger pairs with another β-strand from the histone H3 tail to form an antiparallel β-sheet 
to facilitate histone H3 tail binding (Figure 5.1D). Superimposition of the mIntS12 PHD finger 
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Figure 5.1 The plant homeodomain (PHD) finger of Integrator subunit 12 binds histone 
H3 in vitro. 
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Figure 5.1 The plant homeodomain (PHD) finger of Integrator subunit 12 binds histone 
H3 in vitro. 
(A)(left). Amino acid sequence alignment of IntS12 PHD finger across several different 
metazoan species. Green highlighted residues represent similar amino acids and yellow 
highlights represent identical residues. Blue stars on the bottom highlight the eight residues 
coordinating zinc atoms, and the dashed lines and solid arrows indicate residues forming the 
loops and β-strands secondary structures. (A)(right).  NMR structure of the mouse IntS12 PHD 
finger. Two zinc atoms are shown as balls, and zinc chelating cysteines and histidine are 
highlighted in yellow with side chain shown. (B)(left). GST pull-down assay was carried out 
using recombinant fly or human IntS12 PHD co-incubating with purified histone mixture. 
Glutathione beads bound GST-tagged proteins were visualized by Coomassie staining, and 
histones were detected by western blot analysis using a mixture of histone antibodies. (right). 
Co-precipitated histone proteins were detected by western blot using individual histone 
antibodies. (C). GST pull-down assay was performed using recombinant IntS12 PHD finger 
point mutants. Co-precipitated histone H3 were shown as two different exposures. (D). 3D-
structures of ING2 PHD finger recognition of H3K4me3 or AIRE PHD finger recognition of 
H3K4 (left, middle), Pymol 3D-superimposition of AIRE PHD finger with mIntS12 PHD finger 
(right). 
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on mING2 PHD finger or human AIRE PHD finger by using the molecular graphics tool PyMOL 
demonstrates that IntS12 PHD finger adopts a very similar tertiary structure to the PHD fingers 
tested with minor difference where mIntS12 PHD finger contains a significantly longer loop2 
region (Figure 5.1D). Collectively, all data indicate that the IntS12 PHD finger is structurally 
similar to those for histone H3 recognition, and is able to bind histone H3 in vitro. 
 
IntS12 PHD finger does not recognize canonical histone modifications  
      To further determine the specificity of IntS12 PHD finger toward unique histone 
modifications, the amino acid sequence of IntS12 PHD finger was first aligned to various 
subgroups of known PHD fingers using the homology-extended alignment and a predicted 
secondary structure algorithm. IntS12 PHD finger is most homologous and structurally similar 
to PHD fingers (AIRE-PHD1, CHD4-PHD2, TRIM24) that bind to unmodified histone H3 lysine 
4 (H3K4me0) rather than those (DPF3-PHD1) that bind acetylated histone H3 lysine 
(H3K14ac)  or those that bind (Pygo1, MLL1-PHD3, BPTF, ING2) tri-methylated histone H3 
lysine 4 (H3K4me3) as shown by both sequence alignment (Figure 5.2A) and tree 
representation (Figure 5.2B). However, a distinct characteristic of IntS12 PHD finger compared 
to the H3K4me0-recognition PHD fingers is the presence of two much longer loop regions, a 
feature that is also observed in two PHD fingers (Pygo1, MLL1-PHD3) capable of binding non-
histone proteins (Figure 5.2A). Overall, in silico data analysis indicates that IntS12 PHD finger 
is likely to recognize either an unmodified histone H3K4me0 marker or bind to a non-histone 
protein.  
      To experimentally determine the potential unique histone modification recognized by the 
IntS12 PHD finger, a biotinylated histone peptide pull-down assay was performed. In brief, 
GST-tagged IntS12 PHD finger recombinant proteins were incubated with an array of biotin-
labeled, 21-23 amino acid-long peptide corresponding to different regions of the N-terminal 
histone tails with each containing a unique lysine methylation (H3, 1-21; H3, 22-44; H3, 66-88; 
H4, 1-25; H3K4, K9, K27, K36, K79 and H4K20 mono-, di- or tri- methylated peptide). Bound 
IntS12 PHD finger proteins were co-precipitated with biotin-labeled histone peptides by using 
streptavidin agarose beads, and were detected by Western blot analysis using anti-GST 
antibodies. The PHD finger of lysine demethylase PHF2 was used as a positive control in this 
study, which recognizes di- and tri-methylated histone H3K4. As a proof-of-principle, PHF2 
PHD finger was shown to specifically bind di-methylated H3K4 under both salt conditions 
tested in our biotinylated pull-down assay (Figure 5.2C, top panel). We followed this with 
systematic biotinylated pull-down analysis, however, this revealed that neither the human nor 
Drosophila IntS12 PHD finger was able to be co-precipitated with any of the biotin-labeled 
histone peptide used for this study (Figure 5.2C, bottom panel), suggesting that either IntS12 
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Figure 5.2 IntS12 PHD finger does not recognize canonical histone H3 modifications. 
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Figure 5.2 IntS12 PHD finger does not recognize canonical histone H3 modifications. 
(A). Representation of conserved amino acids from structure-based alignments of PHD finger 
sequences using PRALINE. The absolutely conserved Zinc-coordinating residues are shown 
in red, and the two core β-strands are shown in gray. Residues are colored according to 
sequence conservation. The residue numbers corresponding to the PHD finger in the full-
length protein are shown in parentheses on the right. (B). Tree representation of structure-
based alignments of representative PHD finger sequences using PRALINE. The score 
indicates the similarity between two close PHD fingers (the higher, the more similar), and the 
distance from the branch (+) to the right side indicates similarity as well. Two PHD fingers in 
the same branch indicate a similar structure, and the closer the branch on the right, the more 
similarity present in the two groups of PHD fingers within the same branch. (C). Biotinylated 
histone peptides were unable to pulldown GST-tagged recombinant IntS12 PHD finger. Biotin-
labeled histone peptides each containing a single unique modification were incubated with 
recombinant IntS12 PHD finger or PHF2 PHD finger (positive control), and were precipitated 
by streptavidin agarose beads. Co-precipitated recombinant PHD fingers were detected by 
western blot analysis using anti-GST antibodies. PHF2 input and pulldown are separated on 
two blots.  
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PHD finger recognizes a histone modification marker that is not tested here or it may require 
other co-factors for histone recognition similar to the property observed in Pygo1 and MLL1. 
 
IntS12 is a phosphoprotein and Threonine 76 residue is responsible for IntS12 
phosphorylated. 
      IntS12 migrates as a doublet in SDS-PAGE gel detected by Western blot analysis, 
suggesting that this protein may be phosphorylated (Figure 5.3A, left panel). To formally test 
that hypothesis, phosphatase treatment and site-directed mutagenesis analysis of IntS12 were 
performed. Briefly, cell lysates from untransfected S2 cells or cells transfected with Myc-
tagged IntS12 were treated with alkaline phosphatase (AP) or lambda protein phosphatase 
(λPP), and the migration shift of IntS12 proteins was detected by Western blot analysis using 
anti-IntS12 or anti-myc antibodies. Both endogenous and myc-tagged exogenous IntS12 were 
found to migrate faster (lower band) after phosphatase treatment (Figure 5.3A, Middle and 
right panels), indicating that IntS12 is a phosphoprotein. To narrow down the phosphorylated 
region, six myc-tagged IntS12 deletion mutants (N, NP, C, ΔP, PC, P) were generated and 
tested for migration profile after phosphatase treatment. IntS12 N-terminal containing deletion 
mutants (N, NP, ΔP) were found to both migrate as doublets and faster after phosphatase 
treatment (Figure 5.3B, lane 2, 4), indicating that the phosphorylation is present in the N-
terminus. To further map the position of the phosphorylated residue, potential phosphorylation 
sites within IntS12 N-terminus were predicted using the Kinase-specific Phosphorylation Sites 
Prediction Tool GPS 2.0 (Xue et al. 2008). Eight potential phosphorylation sites (S2829, S33, 
T56, T60, T76, T91, S93) were predicted, and substituting of these sites with alanine did not 
affect myc-tagged IntS12 N-terminus migration with the exception of the Threonine 76 (Figure 
5.3 C). The T76A mutation lost its doublet migration pattern and instead ran as a clear single 
faster migration (Figure 5.3C, let panel lane 5).The single band was completely inert to 
phosphatase treatment (Figure 5.3C, right panel lane 5, 6), strongly indicating that the T76 is 
an important residue responsible for IntS12 phosphorylation. A close examination of the amino 
acid sequence context of the phosphorylation shows the presence of a consensus cyclin-
binding motif (RXL) and a distinct threonine-proline (TP) phosphorylation motif for mitogen-
activated protein kinase (MAPK) or CDK, suggesting that it is a potential substrate either of 
these two protein kinases. Our previous genome-wide RNAi screen identified CycC/Cdk8 as 
an important factor required for snRNA 3’ end formation. It is possible that Cdk8 is involved in 
snRNA 3’ end formation through post-translational modification of IntS12 activity. However, 
mutation of the potential consensus cyclin-binding motif or depletion of CycC or Cdk8 protein 
in cells did not affect IntS12 phosphorylation pattern (data not shown), suggesting other Cdk 
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Figure 5.3 IntS12 is a phosphoprotein and the residue threonine 76 is important for 
IntS12 phosphorylation. 
(A)(left). IntS12 is observed to migrate as doublets by Western blot detection. (Middle, right). 
Alkaline phosphatase  or lambda protein phosphatase treatment of IntS12 resulted in a 
downshift for both endogenous and myc-tagged exogenous IntS12 as detected by Western 
blot. (B)(left top). Schematic representation of IntS12 deletion constructs for mapping 
phosphorylation region. (Left bottom, right top). Myc-tagged IntS12 deletion mutants 
expressed in S2 cells were detected by Western blot before and after alkaline phosphatase 
treatment. The star labeled band represents cross-reactant from the alkaline phosphatase to 
the anti-myc antibodies. (C)(top). Representation of potential phosphorylation sites in IntS12 
N-terminus predicted by GPS 2.0. (bottom). Western blot analysis of cell lysates from cells 
transfected with potential phosphorylation site point mutants before and after alkaline 
phosphatase treatment. 
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kinases may be responsible for IntS12 phosphorylation. Taken together, the data presented 
here show the threonine 76 is responsible for Drosophila IntS12 phosphorylation in cells. 
 
IntS12 PHD finger enhances interaction between IntS12 microdomain and other 
Integrator subunits. 
      We described in last chapter that the 45 amino acid IntS12 microdomain is fully functional 
for reporter snRNA 3’ end formation, however, the interactions between IntS12 microdomain 
and IntS1, IntS9 were not as strong as that observed for full-length Integrator IntS12. This 
prompted us to test whether other parts of IntS12, especially the conserved PHD finger, is 
involved in biochemical association between IntS12 and other Integrator subunits. To test that 
possibility, S2 stable cell lines expressing FLAG-tagged mCherry (Ch, negative control), full-
length IntS12 (IntS12), C-terminal fused mCherry of IntS12 N-terminal 1-130 a.a. (12NCh), C-
terminal fused mCherry of IntS12 NP 1-185 a.a. (12NPCh) and N-terminal fused mCherry of 
IntS12 C-terminus 185-328 a.a. (Ch12C) were generated (Figure 5.4A). Then, anti-FLAG 
immunoprecipitation assays using nuclear extracts prepared from these stable cells were 
conducted. Consistent with previous pull-down results (Figure 4.7B/D), significant amount of 
endogenous IntS1 and IntS9 were found to be co-precipitated with full-length IntS12 (Figure 
5.4B, lane 4 v.s. lane 2). We surprisingly found that the IntS12 C-terminal truncation mutant 
(12NPCh) was able to pulldown the endogenous IntS1 and IntS9 at the levels equivalent to 
full-length IntS12 (Figure 5.4B, lane 10 v.s. lane 4), and significantly better than N-terminus 
only (12NCh) or C-terminus only (Ch12C) (Figure 5.4B, lane 10 v.s. lane 6,14). These results 
suggest that IntS12 PHD finger plays an important role in biochemical interaction between 
IntS12 and other Integrator subunits, though it was found dispensable for snRNA 3’ end 
formation in our snRNA-GFP reporter assay.  
      Since we characterized an important residue T76 for the IntS12 phosphorylation and 
specific interaction of IntS12 and histone H3 in vitro, here we wanted to biochemically test the 
involvement of these features of IntS12 with other Integrators. To accomplish this, two S2 
stable cell lines expressing FLAG-tagged C-terminal fused mCherry of IntS12 N-terminal 
phosphorylation mutant 1-130 a.a. (12NT76ACh) and a C-terminal fused mCherry of IntS12 
NP histone binding-deficient mutant 1-185 a.a. (12NPLACh) were generated, and were tested 
for interactions by anti-FLAG immunoprecipitation assays. I found that the N-terminal 
phospho-mutant (12NT76ACh) was able to significantly increase the co-precipitated 
endogenous IntS1 and IntS9 to the levels similar to full-length IntS12 compared to the deletion 
mutant containing IntS12 N-terminus (Figure 5.4B, lane 8 v.s. lane 4, 6), suggesting that the 
T76-mediated phosphorylation is likely to negatively regulate IntS12 association with other 
Integrators. In contrast, the L145 mutation in the IntS12 C-terminal deletion mutant 
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Figure 5.4 IntS12 PHD finger enhances association between IntS12 microdomian and 
other Integrator subunits. 
(A). Schematic representation of IntS12 mCherry fusion constructs for study of IntS12 
domains important for Integrator interaction. The star within two of the constructs represents a 
point mutation being introduced. (B). Western blot analysis of immunoprecipitates using anti-
FLAG agarose from nuclear extracts purified from cell lines stably expressing FLAG-tagged 
mCherry-fused IntS12* proteins.  The upper panels are probed for endogenous IntS1/9 and 
the bottom panel is probed with anti-FLAG antibody to confirm pull down. Two different 
exposures were presented. 
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(12NPLACh) was found to significantly reduce the pull-down levels of IntS1 and IntS9 
compared to that observed for IntS12 C-terminal deletion mutant (12NPCh) (Figure 5.4B, lane 
12 v.s. lane 10), indicating that the L145 residue, which has been determined to be important 
for in vitro histone H3 binding, is important for in vivo Integrator interaction as well. Taken 
together, these data presented here suggest that besides interacting with histone H3 in vitro, 
the IntS12 PHD finger is also likely to play an important role in enhancing interaction between 
IntS12 microdomain and other Integrators in vivo and that this interaction might be modulated 
by the T76-related phosphorylation. 
 
IntS12 PHD finger and T76-related phosphorylation are not required for reporter snRNA 
3’ end processing. 
      To further test the functional requirement of the IntS12 T76-related phosphorylation and 
histone or Integrator interaction mediated through the PHD finger in snRNA 3’ end formation, a 
functional RNAi rescue assay was performed as described previously (See Chapter 2 RNAi-
rescue/snRNAGFP reporter for details).  S2 cells were treated with either control dsRNA 
(LacZ) or IntS12 dsRNA and co-transfected with U4-GFP reporter (See Chapter 2 Materials 
and Methods section for details) and IntS12 constructs described in the pulldown assay. Cells 
were imaged and subsequently lysed for Western blot analysis for GFP expression. In IntS12 
depleted cells, the mCherry vector (mChe) and mCherry fused IntS12 C-terminus only 
(mChe12C) completely failed to restore proper 3’ end processing of U4-GFP reporter as 
significant GFP fluorescence was observed (Figure 5.5A/B). For the remaining constructs, we 
observed reduced GFP fluorescence to background level in IntS12 depleted cells (Figure 
5.5A/B), indicating that all of these constructs were fully functional in restoring proper reporter 
snRNA 3’ end processing. The phosphorylation mutant (12NT76AmChe) and the histone H3 
binding mutants (12NP(EA)mChe, 12NP(LA)mChe) fully restored reporter snRNA 3’ end 
formation, implying that IntS12 T76-mediated phosphorylation and binding to histone H3 are 
dispensable events for processing of the reporter snRNA 3’ end. 
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Figure 5.5 IntS12 PHD finger and a phosphorylation are not required for reporter snRNA 
3’ end processing. 
(A). Representative fluorescence images of S2 cells treated with either control dsRNA (LacZ) 
or IntS12 dsRNA#2 followed by cotransfection of the U4-GFP reporter with the FLAG-tagged 
mCherry-fused IntS12* cDNAs. (B). Western blot analysis of cell lysates from panel A. 
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Discussion 
 
      In this chapter we presented the biochemical characterization of IntS12 and investigated 
the functional involvement of these features in snRNA 3’ end formation. The IntS12 PHD finger 
was determined to bind histone H3 in vitro (Figure 5.1) and enhance Integrator protein 
interaction in vivo (Figure 5.4). The former result is consistent with the prevailing findings that 
PHD fingers have the ability to recognize a variety of histone modification markers 
(Musselman and Kutateladze 2011; Sanchez and Zhou 2011). However, the latter result 
indicates that IntS12 PHD may also contribute to protein-protein interactions, which is 
supported by two recently reported findings demonstrating that the PHD finger from Pygo1/2 
or MLL1 is able to recognize non-histone proteins (Hom et al. 2010; Miller et al. 2010). Our 
data presented here support both non-exclusive models for IntS12 PHD action: act as a 
histone reader to bring the Integrator complex to specific genomic loci or to work as a protein-
protein interacting domain for Integrator complex assembly. Further experiments need to be 
conducted to better understand these potential working mechanisms. We also determined that 
T76 is responsible for IntS12 phosphorylation, and our data suggest the phosphorylation is 
likely a negative regulator for Integrator protein interaction. Nevertheless, snRNA-GFP reporter 
combined with RNAi-rescue assay indicates that all of these biochemical features of IntS12 
protein are dispensable for snRNA 3’ end processing, making the roles of these characterized 
features unknown. It is very likely that these features we identified here contribute to a yet-to-
be characterized cellular process. 
  
Why has evolution selected for the central IntS12 PHD finger?   
      The central PHD finger region of IntS12 is one of the few domains found among the 
Integrator subunits whose function can be readily inferred from sequence conservation aside 
from the conserved MBL/β-CASP domains of IntS9/11. Members of the PHD finger family of 
proteins are involved in a diverse range of biological functions; yet typically bind to specific 
histone H3 posttranslational modifications (reviewed in (Bienz 2006; Musselman and 
Kutateladze 2011)). IntS12 PHD finger forming a canonical PHD finger topology is supported 
by NMR structure analysis of the mouse IntS12 PHD finger (pdbid:1WEV; He F, Muto Y, Inoue 
M, Kigawa T, Shirouzu M, Terada T, Yokoyama S, unpublished). Here we have also 
experimentally confirmed that recombinant Drosophila and Human IntS12 PHD finger proteins 
bind histone H3 in vitro.  While nascent transcription from an snRNA promoter is essential for 
Integrator function, a central role for chromatin in 3’ end formation has not been established 
(de Vegvar et al. 1986; Hernandez and Weiner 1986; Cazalla et al. 2011; Ezzeddine et al. 
2011).  Although the presence of a stable nucleosome located between the DSE and PSE in 
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human cells has been reported by several groups (Stunkel et al. 1997; Boyd et al. 2000; Zhao 
et al. 2001; Pavelitz et al. 2008), the preponderance of evidence argues for a general 
deficiency of histones within snRNA genes, with the snRNA promoter establishing a perpetual 
“open” transcription state (Pavelitz et al. 2008; Egloff et al. 2009).  In Drosophila, the lack of a 
DSE (Hernandez 2001) and our own observations that the Proximal Sequence Element A 
(PSEA) from the snRNA gene promoter alone is sufficient to impart Integrator sensitivity to our 
actin 5C promoter driven reporters (JC, EJW, unpublished), suggests there is not likely a 
stable nucleosome present at fly snRNA promoters. These data together with our observations 
that the PHD domain is dispensable for snRNA 3’ end processing argues against the IntS12 
PHD finger coupling the Integrator complex to the snRNA promoter via histone binding.   
      We cannot exclude the possibility that, the IntS12 PHD finger is involved in recruiting the 
Integrator complex to chromatin at non-snRNA genes, though there is presently no indication 
that the Integrator complex functions elsewhere in the genome. Whether the endogenous 
target of the IntS12 PHD finger is indeed histone H3 in vivo has also yet to be determined.  
There are numerous examples of PHD fingers that associate with non-histone substrates 
(Musselman and Kutateladze 2011) including the MLL1 methyltransferase PHD3 finger bound 
to the RNA recognition motif (RRM) of nuclear cyclophilin Cyp33 (Fair et al. 2001).  The IntS12 
PHD finger may behave similarly and interact with a non-histone partner.  
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OVERVIEW, SUMMARY AND FUTURE DIRECTIONS 
 
      As the functional snRNPs are well known for their role in removal of introns from pre-
mRNA, it is predictable that any event disturbing the snRNP biogenesis pathway is likely to 
affect downstream mRNA maturation, which in turn may have a significant impact on the 
biological outcomes. One such well-documented case is SMA, which is caused by reduced 
expression of the SMN due to mutations in the gene (Burghes and Beattie 2009; Coady and 
Lorson 2011; Workman et al. 2012). The SMN complex plays critical roles in snRNP 
biogenesis in that it is responsible for loading the Sm core onto the snRNA Sm site and 
facilitates subsequent snRNP nuclear import (Figure 1.3A). Though it is still unclear how 
exactly a mutation in SMN causes motor neuron death, it has been well documented that 
snRNP maturation and mRNA splicing are both significantly affected in SMA patients and 
mouse models (Gabanella et al. 2007; Zhang et al. 2008). Currently, the most tantalizing 
model for the cause of motor neuron dysfunction and death in SMA patients is that inadequate 
expression of SMN protein leads to insufficient snRNP assembly, which in turn affects critical 
pre-mRNA splicing events that are essential for motor neurons. The results from SMA 
research vividly demonstrate the importance of the snRNP biogenesis pathway in human 
health. 
      The biogenesis of RNAPII-transcribed snRNA encounters a sophisticated nuclear and 
cytoplasmic life cycle where they begin as snRNA precursors through a transcription-coupled 
3’ -end processing event. Therefore, the nuclear 3’ end cleavage of snRNAs is an integral part 
for snRNP maturation, and this event is brought about by the poorly understood Integrator 
complex (Baillat et al. 2005). Twelve different polypeptides were initially thought to be present 
in the Integrator complex, which associates with the C-terminal domain of RNAPII largest 
subunit Rpb1. Analogous to the SMN complex, the Integrator complex is also essential for 
snRNP biogenesis, and disruption of the Integrator complex is expected to affect downstream 
cellular processes and biological outcomes where a functional snRNP is required, such as the 
pre-mRNA splicing. Indeed, analysis of the RNA-sequencing data from cells depleted of the 
catalytic subunit of the Integrator complex (IntS11) revealed a global defect in pre-mRNA 
splicing, manifested by prevalent exon skipping and intron retention (Wagner lab, unpublished 
data). It was also reported in Zebrafish that disruption of Integrator subunit 5 leads to a specific 
red blood cell differentiation defect that is caused by missplicing of genes essential for the 
hematopoiesis signaling pathway (Tao et al. 2009). Moreover, studies from several different 
groups also show a requirement for the Integrator complex in mouse and fly development, 
where it is likely to function through regulation of the snRNP biogenesis (Rutkowski and 
Warren 2009; Ezzeddine et al. 2011). While these data contribute to understanding of the 
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significance of the Integrator Complex, the molecular details of the 3’ end processing of the 
RNAPII transcribed snRNAs are far from understood.     
     The existing working model for transcription-coupled 3’ end processing of snRNA is 
described in Figure 6.1. The key questions to be addressed are how the Integrator Complex is 
recruited to snRNA genes and also how it recognizes nascent transcripts to cleave them at the 
cleavage site. Studies of the other two RNAPII transcripts (polyadenylated mRNA and 
nonpolyadenylated histone mRNA) have established the requirements of two different RNA-
binding proteins/protein complexes through recognition of two conserved cis-regulatory 
sequence elements present in each transcript. These binding events serve to recruit the 
catalytic core to the cleavage site and position it for proper 3’ end processing (Figure 1.4). 
Interestingly, two functionally important 3’ end elements, a conserved 3’ box element and a 
less conserved 3’ stem loop element have been identified in snRNAs (Hernandez 1985; 
Ezzeddine et al. 2011), however, the factors responsible for recognition of these elements are 
not known yet. An added challenge to identify these factors is that no identifiable RNA-binding 
domains are found in the known Integrator complex (Figure1.5). Moreover, analogous to 3’ 
end formation of polyadenylated mRNA, the snRNA 3’ end formation is a transcription-coupled 
process. The RNAPII CTD serine 5 phosphatase Ssu72 has been reported to serve as an 
adaptor to bridge the RNAPII CTD and the cleavage/polyadenylation factor Symplekin (Pta1 in 
yeast), thus coupling the mRNA transcription and subsequent 3’ end cleavage and 
polyadenylation (He et al. 2003). During the period of this work, another RNAPII CTD serine 5 
phosphatase RNA Pol II-associated protein 2 (RPAP2) has been proposed to play an 
analogous role of Ssu72 to bridge the RNAPII CTD to the Integrator complex by specific 
recognition of the pSer7 marker on the RNAPII CTD. RPAP2 is then thought to be important 
for the recruitment of Integrator complex to RNAPII CTD (Egloff et al. 2012). Confounding this 
result, however, is the subsequent observation that the RPAP2 yeast homolog Rtr1, lacked a 
phosphatase catalytic domain and was devoid of dephosphorylation activity toward RNAPII 
CTD in vitro (Xiang et al. 2012). These results do not rule out a model where RPAP2 serves 
as an adaptor between RNAPII CTD and the Integrator complex but reduce the possibility that 
RPAP2 exhibits any catalytic activity. Finally, the identity of the Integrator subunit that would 
behave analogously to the mammalian cleavage/polyadenylation factor Symplekin to couple 
transcription and 3’ end formation is still not determined yet. 
      The studies described in this dissertation are aiming to probe these biologically important 
questions. To address these questions, I first identified missing protein factors that are 
functionally required for snRNA 3’ end processing through a functional RNAi screen in 
Drosophila S2 cells in Chapter 3. This was followed by a detailed structural and functional 
analysis of one Integrator subunit that has the potential to lay the foundation to address the  
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above-mentioned questions. Below, I reflect on the significance of these two efforts and 
expand on what I believe to be their meaning and future implications. 
 
Functional RNAi screen identifies protein factors required for snRNA 3’ end formation. 
      In Chapter 3, I described a genome-wide RNA interference (RNAi) screen in Drosophila S2 
cells to identify important genes required for snRNA 3’ end formation by utilization of an 
snRNA-GFP reporter. The U7-GFP is a sensor of the U7 snRNA 3’ end formation, and only 
knockdown of a gene causing U7 snRNA 3’ end cleavage defect will result in expression of 
GFP in cells. Using this reporter, the screen identified 21 genes that when depleted leads to 
strong or moderate levels of GFP expression in cells. This screen determined that 10 out of 
the 12 known Integrator proteins (not IntS3 or IntS10) are functionally required for snRNA 3’ 
end formation. Interestingly, 11 novel factors were identified in our screen as well. These 
genes encoding protein factors are involved in a variety of cellular functions, including protein 
ubiquitination, phosphorylation, transport, DNA replication and others. More importantly, I also 
revealed that Asunder and CG4785 are two additional core Integrator proteins in the Integrator 
complex as both are functionally required for snRNA 3’ end formation and biochemically 
associate with the known Integrator complex. Moreover, the CycC/Cdk8 kinase was 
determined to be required for proper snRNA 3’ end formation where the kinase activity of 
CdK8 is involved but is likely working through a pathway independent of the Mediator complex. 
At this stage, it is still unclear how exactly these four factors carry out their function in snRNA 3’ 
end formation.  
     The Asu/IntS13 was originally identified to be a regulator of mitotic cell cycle and 
Drosophila development (Stebbings et al. 1998), and recently was found to regulate the 
perinuclear dynein localization during Drosophila spermatogenesis (Anderson et al. 2009). 
Asu/IntS13 was also identified as a regulator of small RNA biogenesis in a S2 cell RNAi 
screen (Zhou et al. 2008). Here we reported a novel function for Asu/IntS13 in snRNA 3’ end 
formation. Whether the reported different function of Asu/IntS13 could be ascribed to the same 
pathway in cells is not clear, but it is possible that Asu/IntS13 may function in multiple 
pathways as the reported Asu/IntS13 associated processes take place in different cellular 
compartments consistent with its bimodal localization observed in our study (Chen et al. 2012). 
The Asu/IntS13 is a conserved protein across metazoan species and belongs to the cell cycle 
regulator Mat89Bb family that contains a well-conserved but functionally unknown DUF2151 
domain (Figure 6.2). It would be interesting to determine the functional domain(s) mediating 
the differential roles of Asu/IntS13, especially in snRNA 3’end processing by using the 
powerful RNAi/rescue/snRNA-GFP reporter system described in Chapter 4. An effort to 
characterize the potential direct Integrator binding partner of Asu by directed Y2H assay failed
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Figure 6.2 Schematic representation of protein domains of Asu/IntS13 and 
IntS14/CG4785.  
Protein domain search is conducted by using Pfam analysis, and protein domains are labeled 
in black. The species used for conservation analysis are human, cow, chicken, Drosophila and 
zebrafish. Abbreviations: DUF, domain of unknown function; VWA, von Willebrand factor type 
A domain; IntS, Integrator subunit. 
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to score any known Integrator protein, leaving the functioning details of Asu in snRNA 3’ end 
formation an open question to be addressed. 
     IntS14/CG4785 is a protein with much less known and there is a weakly defined von 
Willebrand factor type A (VWA) domain in its N-terminal (Figure 6.2). A previous RNAi screen 
in S2 cells for protein factors involved in small RNA (miRNA/siRNA) pathways also scored 
IntS14 as a positive regulator (Zhou et al. 2008), implying that IntS14 may function in sRNA 
biogenesis in Drosophila.  
     The identification of CycC/Cdk8 kinase in our screen was unexpected as it is predominantly 
present in the Mediator Complex of the RNAPII, which is likely separated from the Integrator 
Complex (Baillat et al. 2005; Galbraith et al. 2010). In eukaryotic cells, Cdk8 is a cell-cycle 
dependent protein kinase but has not been observed to oscillate throughout nor affect the cell 
cycle. CycC/Cdk8 is most characterized as part of the kinase module that interacts with the 
Mediator Complex  and consists of CycC, Cdk8, Mediator 12 (Med12) and Med13. This 
module plays an important role in transcriptional regulation of gene expression as a means of 
cellular adaptation to different environmental cues. Our results (Figure 3.4D, Figure 6.3) 
demonstrate that the CycC/Cdk8 but not other Cdks are specifically required for U7 reporter 
snRNA 3’ end formation, and its kinase activity in particular is involved in this process. This is 
the first report that implicates the function of CycC/Cdk8 in snRNA 3’ end formation, and the 
underlying mechanism of this reaction is not known yet. Our results also rule out the possibility 
that CycC/Cdk8 contributes to snRNA 3’ end processing through transcriptional control of 
Integrator expression as depletion of CycC or Cdk8 in cells did not affect expression of the 
Integrator subunit mRNA or protein (Figure 3.5). We believe that the function of these two 
proteins may be analogous to their role in the RNAPII-associated Mediator Complex, where 
the Mediator Cdk8 module can phosphorylate the Rpb1 CTD as well as a specific Mediator 
subunit (Knuesel et al. 2009). In the case of the Integrator Complex, CycC/Cdk8 may 
phosphorylate the Rpb1 CTD or Integrator subunit. Indeed, our results showed that 
CycC/Cdk8 functions independent of the Mediator Cdk8 module as depletion of the other two 
essential components of the Mediator Cdk8 module Med12 and Med13 did not affect the 
snRNA 3’ end processing (Figure 3.7A/B). Furthermore, a small fraction of CycC/Cdk8 was 
found to associate with Integrator subunits but neither Med12 nor Med13 was found to 
associate with the Integrator Complex(Figure 3.7C/D). Taken together, all of the existing data 
support the presence of an Integrator Cdk8 module where the CycC/Cdk8 phosphorylates 
either the RNAPII CTD or the Integrator subunit to regulate the transcription-coupled snRNA 3’ 
end formation. Since phosphorylation of the Ser2 and Ser7 in the Rpb1 CTD has been 
determined to be essential events for the Integrator complex recruitment as shown that 
mutation in these two residues abolished integrator complex association with RNAPII in vitro 
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Figure 6.3 Specific involvement of Cdk8 and CycC in snRNA 3’ end formation. 
(A). Fluorescence image of S2 cells treated with cyclin or Cdk dsRNA followed by transient 
transfection with U7-GFP reporters measuring snRNA 3’ end formation. Two representative 
images were shown for each dsRNA treatment. (B). Western blot analysis of cell lysates from 
panel (A). 
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as well as occupancy on snRNA gene in vivo, which in turn affected the snRNA 3’ end 
formation (Egloff et al. 2007; Egloff et al. 2010), it would be tempting to test whether 
CycC/Cdk8 can serve as a Ser7 kinase or a redundant Ser2 kinase besides Cdk9. Indeed, 
previous study has shown that Drosophila Cdk8 is able to phosphorylate RNAPII CTD in vitro 
(Leclerc et al. 1996), a more specific in vitro kinase assay using recombinant proteins or an in 
vivo assay to determine the phosphorylation alternations using RNAPII CTD phosphorylation-
specific antibodies in CycC/Cdk8 depleted cells will provide more details on CycC/Cdk8 
function mechanism in snRNA 3’ end formation. 
      Finally, in addition to the “strong hits” analyzed above, our screen also identified 7 
“medium hits”, including a WD40 repeat-containing uncharacterized protein CG9945 and a 
zinc-finger containing protein CG11247. Recent study of the Gemin5, a component of the 
SMN complex, determined that the WD repeat is a previously undescribed RNA-binding 
domain that specifically binds snRNA sequence (Lau et al. 2009). Results from recent studies 
of zinc-finger proteins also showed that they are able to bind single-stranded RNA as well 
expanding the canonical roles in DNA recognition and protein-protein interaction (Burdach et 
al. 2012). Therefore, to functionally validate these two proteins and to determine their potential 
for snRNA recognition and Integrator association may lead to the discovery of the elusive RNA 
binding proteins in the snRNA 3’ end processing machinery. 
       
Structural and functional analysis of the PHD finger-containing Integrator subunit 
IntS12  
      It has been well established that chromatin states control gene transcription, and emerging 
evidence from recent studies suggest that chromatin states also play important roles in exon 
definition as well as pre-mRNA alternative splicing (Luco et al. 2010; Shukla et al. 2011). In 
both cases, the epigenetic effectors are critical readers that transmit the chromatin pattern to 
biological outcomes. While no study has been reported to implicate the chromatin architecture 
in the 3’ end processing of pre-RNA, it is possible that such chromatin reader mediated 
recognition may be involved. The plant homeodomain (PHD) finger is a reader domain of the 
chromatin that preferentially recognizes modified or unmodified histone lysine markers 
(Reviewed in (Musselman and Kutateladze 2011; Sanchez and Zhou 2011)), and it was found 
to be the most conserved domain with a well-defined function in the Integrator proteins 
besides the MBL/β-CASP domain present in IntS9/11 (Figure 1.5). It is possible that the 
Integrator complex is recruited through recognition of specific chromatin markers present at 
the 5’ or 3’ end of snRNA genes via the PHD finger present in Integrator subunit 12 (IntS12). 
This provides the basis for our structural/functional study of IntS12. 
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      Chapter 4 and 5 described our biochemical and functional characterization of IntS12 to 
understand how this PHD finger-containing Integrator protein functions in snRNA 3’ end 
formation. Since IntS12 contains a chromatin reader domain, we tested the chromatin 
recruitment of Integrator complex model by determination of the interaction between the 
IntS12 PHD finger and histones. As expected, GST-pulldown assay established a specific 
interaction between IntS12 PHD finger and the histone H3 (Figure 5.1B/C). However, 
subsequent functional analysis clearly demonstrates that neither the conserved IntS12 PHD 
nor the characterized interaction with histone H3 is required for mediating the U7 or U4 
reporter snRNA 3’ –end formation (Figure 4.4C/D, Figure 5.5). To our surprise, systemic 
analysis of IntS12 functional domain identified an N-terminal 30 amino acid long microdomain 
that resides in a conserved region that is predicted to form a helix-coil-helix fold (Figure 
4.4C/D/E, Figure 4.5A, Figure 6.4). This IntS12 microdomain functions autonomously as 
shown functionally the microdomain by itself is able to mediate both reporter and endogenous 
snRNA 3’ end formation (Figure 4.6, 4.7A). Further, biochemically it is sufficient to stabilize the 
largest Integrator subunit IntS1 through a potential direct binding (Figure 4.7, 4.8, 4.9). This 
study provided the first detailed functional analysis of one of the Integrator subunits and 
established a working model for IntS12 in snRNA 3’ end formation where the N-terminal region 
of IntS12 binds IntS1 to stabilize the putative scaffold protein to facilitate further complex 
assembly (Figure 6.5). IntS1 has been determined to play important roles in snRNA 3’ end 
formation and animal development. Depletion of IntS1 in S2 cells causes accumulation of 
significant amount of premature snRNAs (Figure 3.3A) and disruption of IntS1 in mouse 
causes misprocessing of snRNAs and eventually leads to embryonic lethality (Hata and 
Nakayama 2007). The expression of IntS1 was found to be dependent on the expression of 
several other Integrator subunits as shown in our co-depletion assay (Figure 6.6), further 
supporting a scaffolding role of IntS1 in the Integrator complex. The functional microdomain of 
IntS12 is predicted to adopt a helix-coil-helix fold that has been shown to serve as a protein-
protein dimerization surface (Johnen and Kaufman 1997; Colledge et al. 2011). However, an 
effort to determine the structure of the IntS12 microdomain by nuclear magnetic resonance 
(NMR) spectroscopy revealed that solution structure of the recombinant microdomain is likely 
to be intrinsically disordered (data not shown). One possible explanation for the disparity is 
that the correct folding for IntS12 microdomain requires the presence of its binding partner 
(potentially IntS1). It would be interesting to determine which region of IntS1 is recognized by 
IntS12 microdomain that will further advance our understanding on the function of the IntS12 
microdomain in snRNA 3’ end formation. 
      Our results from the study of the IntS12 functional domain disfavors our initial model for 
chromatin recruitment of Integrator complex to snRNA genes through the conserved PHD  
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                 Figure 6.4 Secondary structure prediction of IntS12 m
icrodom
ain by Jpred3 predicts a helix-coil-helix fold.  
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Figure 6.5 Schematic working model of IntS12-IntS1 interaction in Integrator complex 
assembly. 
When IntS12 interacts with putative scaffolding Integrator subunit IntS1, it stabilizes IntS1 
protein in cells, which serves as a platform for other Integrator binding and the complex 
assembly. If this interaction is disrupted by either sequestering IntS12 or promoting its 
degradation, IntS1 in cells will be destabilized and subject to degradation. Loss of the putative 
scaffolding protein eventually will disassemble the Integrator complex. IntS12 is schematically 
shown to have three features: an N-terminal microdomain (crescent), a PHD finger (pentagon) 
and a phosphorylation at the Thr 76 residue. 
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Figure 6.6 The stability of IntS1 in cells is dependent upon the expression of many other 
Integrator subunits.  
S2 cells were treated with dsRNA targeting either control PTB mRNA or different Integrator 
mRNA for three days, and cell lysates were prepared from these cells on the fifth day. Lysates 
were then subjected to Western blot analysis using antibodies specific for IntS1, IntS9, IntS11 
and IntS12. NT, cells not treated with any dsRNA; IntS, Integrator subunit; a cross-reacting 
band with IntS1 antibodies was used as a loading control. 
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finger containing protein IntS12 to mediate proper 3’ end formation. This then generates the 
question of what is the function of the IntS12 PHD finger?  While we did observe that the 
IntS12 microdomain can function autonomously, it exhibited lower efficiency in interaction with 
other Integrators (Figure 4.7A/D). So there is a possibility that IntS12 PHD may contribute to 
full interaction between IntS12 and other Integrators. Our results from the co-IP support this 
idea as the PHD finger retaining IntS12 N-terminal fragment exhibited significantly stronger 
interaction with other Integrators to a level equivalent to the full-length IntS12 protein (Figure 
5.4B, lane 10 v.s. 2, 4). These results await follow-up experiments to determine whether the 
observed enhanced Integrator interaction contributes to endogenous snRNA 3’ end formation.  
     Though here we focus our research interest on the Integrator Complex in snRNA 3’ end 
formation, there are also sporadic reports that suggest Integrator subunits function in 
processes beyond snRNA 3’ end formation (Reviewed in (Chen and Wagner 2010)). Recently 
genome-wide CHIP-Seq studies of the SNAP protein and endonuclease IntS11 suggest that 
the Integrator complex is potentially recruited to the genomic loci distinct from snRNA genes  
((Baillat et al. 2012); Baillat & Shiekhattar, unpublished data). More interestingly, a statistical 
analysis of Drosophila Integrator proteins scored in the public screens also suggests that the 
Integrator complex may function in a variety of cellular and biological pathways. These 
pathways include: notch signaling (Mourikis et al. 2010), mitogen-activated protein kinase 
(MAPK) signaling, protein aggregate formation (Zhang et al. 2010) and cell morphology control 
(Kiger et al. 2003) (Table 6.1). Thus, we can envision that the conserved IntS12 PHD may 
contribute to these yet-to-be identified/confirmed cellular and biological processes. 
      Finally, this thesis project provides a powerful tool for characterization of functional 
domains present in other Integrator subunits that are required for snRNA 3’ end formation. The 
unique Drosophila RNAi rescue system we presented here combined with our snRNA-GFP 
reporters enables us to ultimately validate the candidate genes and dissect any functional 
domains present in the validated factors. The Drosophila RNAi system uses ~500bp dsRNAs 
to elicit depletion of endogenous proteins, which makes it difficult to generate an RNAi-
resistant cDNA. This, in turn, makes any RNAi-rescue structure/function analysis intrinsically 
more challenging. Two common methods to do RNAi rescue in fly cells are: (1) design dsRNA 
targeting the UTRs of the endogenous mRNA and rescue by the wild-type cDNA open reading 
frame (ORF) of the targeted gene; (2) dsRNA targeting the coding sequence and rescue with 
an ortholog cDNA (i.e. some other Drosophilids) of the targeted gene. The limitation for the 
first method is that many of the Drosophila genes have short UTR regions that when targeted 
elicit limited levels of reduction of endogenous proteins. Significant effort was wasted to 
determine that this was the case for the IntS12 3’UTR (~70 nt) (Data not shown). The limitation 
for the second method lies in that it rescues with a different protein, which may function  
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different from the wild-type protein. Here we described another way to do the RNAi rescue in 
fly cells by using dsRNA targeting the coding sequence while rescue is conducted with an 
RNAi-resistant cDNA that encodes the same wild-type protein. This RNAi-resistant cDNA is 
generated by chemical synthesis of a DNA sequence with all of the possible silent mutations 
introduced to the cDNA region targeted by the dsRNA. This RNAi rescue method in fly cells 
can circumvent the obstacles generated by using the other two methods, and theoretically it is 
applicable to any gene in fly cells. With the development of synthetic biology, the cost using 
this technique will continue to decrease. 
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CONCLUDING REMARKS 
      This dissertation has contributed to the field of metazoan snRNA processing by providing 
detailed functional analysis of the snRNA 3’ end processing machinery, the Integrator 
Complex. Specifically, this work has redefined the Integrator complex to comprise of fourteen 
core subunits and a regulatory kinase through a genome-wide functional RNAi screen. 
Moreover, this work also provides the first detailed functional domain analysis of one Integrator 
subunit IntS12, and reveals IntS12 mediates the function of Integrator complex in snRNA 3’ 
end formation through stabilization of the putative scaffold protein in the complex. 
      Finally, the work presented in dissertation provides the basis for further elucidating the 
biochemical, cellular and biological function of the conserved IntS12 PHD finger, and for 
identification of those elusive RNA-binding proteins in the Integrator complex for snRNA 
sequence element recognition.  The research into the Integrator Complex is only beginning 
and this thesis has contributed to laying foundation for future work. 
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Appendix. IntS12 is Preferentially Recruited to Promoter Region of snRNA Genes. 
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INTRODUCTION 
 
      Integrator Complex is the 3’ end processing machinery for RNAPII-transcribed snRNAs in 
metazoan species that associates with the CTD of RNAPII, and IntS11 is the MBL/β-CASP 
superfamily endonuclease that cleaves 3’ end of the nascent primary snRNA transcripts from 
the elongating polymerase (Baillat et al. 2005). Subsequent functional analysis of the 
Integrator complex has determined that all twelve subunits except IntS3 and IntS10, are 
required for snRNA 3’ end formation in Drosophila cells (Ezzeddine et al. 2011). Several 
Integrator subunits (IntS2, 9,10,11) have also been determined to recruit to U1 and U2 snRNA 
genes but not the Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) encoding gene or 
the histone H3 gene (Baillat et al. 2005), supporting a specific functional requirement for 
Integrator Complex in snRNA biosynthesis. For the other two RNAPII transcripts, the poly(A) 
mRNA and histone mRNA, the shared cleavage factor including CPSF73, CPSF100 and 
Symplekin, is found to enrich at 3’ end of both types of genes in vivo (Sullivan et al. 2009), 
supporting its cleavage role for both types of transcripts. 
      It has well documented that snRNA 3’ end formation is a transcription-coupled process that 
requires transcription initiation from an snRNA promoter (de Vegvar et al. 1986; Hernandez 
and Weiner 1986; Ezzeddine et al. 2011). This is analogous to the poly(A) mRNA 3’ end 
cleavage/polyadenylation process but is distinct from the histone mRNA 3’ end formation. The 
pre-mRNA 3’ end processing factors have been observed to be present at both 5’ and 3’ end 
of coding genes (He et al. 2003; Glover-Cutter et al. 2008), supporting the model for 
recruitment of processing factors to the promoter for coupling transcription and 3’ end 
processing. Compared to mRNA encoding gene, the snRNA gene is very short with an 
average size of ~ 200 bp, which makes it difficult to discriminate the occupancy of Integrator 
proteins on the snRNA genomic loci by the Chromatin immunoprecipitations (CHIP) assay. 
The original study showed that four Integrator subunits tested occupied both ends of U1 and 
U2 snRNA genes in HEK293T cells (Baillat et al. 2005). However, the author described that 
due to the low resolution of CHIP, it was difficult to conclude the exact occupying loci of the 
Integrator proteins on snRNA genes. 
      Here I tried to develop a high-resolution CHIP assay for detection of Integrator proteins on 
snRNA genes in Drosophila S2 cells. This assay could be used to determine the accurate 
occupancy of Integrator proteins on snRNA genes (Promoter or 3’ region), and combined with 
RNAi, it could be used to determine critical subunit for recruitment of Integrator complex to 
snRNA promoter or 3’ end region, which will significantly advance our understanding for 
Integrator Complex function in snRNA 3’ end formation. I started optimizing the CHIP 
conditions by study of the IntS12 occupancy on snRNA genes (U7, U1, U2, U4). I determined 
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the optimal chromatin fragmentation condition and screened good qPCR amplicons of various 
regions of the snRNA genes in S2 cells. By using the developed CHIP assay, I have found that 
IntS12 is preferentially recruited to the promoter region of U7 snRNA gene whereas the 
RNAPII is enriched across the whole gene region. Then I also tested the requirement of the 
conserved PHD and the T76 phosphorylation for IntS12 occupancy on promoter region of the 
U7 snRNA gene. 
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RESULTS 
 
Optimization of Chromatin Immunoprecipitation (CHIP) Conditions in S2 Cells 
      A high resolution CHIP profile is important for determining the in vivo genomic occupancy 
of a protein under investigation, and several key factors are prerequisites to achieve that, 
including the qualities of CHIP antibodies, chromatin fragments, qPCR amplicons. Figure A.1A 
shows the standard procedure for CHIP assay, and the detailed procedure is described in the 
Chapter 2 Materials and Methods section. Here I evaluated all the factors required for 
development of a high resolution CHIP on snRNA genes. I purified the IntS12 polyclonal 
antibodies by affinity purification using the recombinant GST-IntS12 (1-163 a.a.) antigen-
conjugated column, and showed that the antigen-purified IntS12 polyclonal antibodies can 
specifically recognize endogenous IntS12 proteins in S2 cells (Figure A.1B). The size of the 
fragmented chromatin is a critical determinant of the resolution of the CHIP assay. I tested 
different sonication conditions and determined the optimal program to be 4 times of 30 sec 
on/2.5 min off using the Ultrasonic Converter C5749. Under this condition, the major 
population of the chromatin fragments was distributed ~ 300-400 bp (Figure A.1C). I also 
tested qPCR primers for amplification of different regions upstream and downstream 1.6kb of 
the U7 snRNA gene (Figure A.1D), and determined seven amplicons (~200 bp) that could be 
specifically amplified across the U7 genomic loci (Figure A.1D). Collectively, I determined the 
optimal CHIP conditions for test IntS12 occupancy on U7 snRNA genes in S2 cells by 
controlling the quality of the antibodies, chromatin fragment size and amplicons. 
 
IntS12 is preferentially occupying the U7 snRNA promoter region 
      Once optimized the CHIP condition in S2 cells, I tested the occupancy of IntS12 on U7 
snRNA genomic loci. 1X108 S2 cells were used for the CHIP assay. DNA-proteins were 
crosslinked, sonicated, immunoprecipitated, and precipitated DNA-protein were reverse 
crosslinked and DNA was purified for qPCR analysis. Antibodies for RNAPII, IntS11 and 
IntS12 were used for immunoprecipitation, and Guinea pig (GP) IgG were used as control for 
pulldown. The RNAPII was observed to enrich in both the promoter and 3’ region of the U7 
snRNA gene (Figure A.2d,e), and IntS12 was highly enriched in the U7 snRNA promoter 
(Figure A.2d). In contrast, the endonuclease IntS11 was found to be present across the whole 
region measured, with the highest occupancy in the 3’ end region of the U7 snRNA gene 
(Figure A.2). This result indicates that there might be a sequential recruitment of different 
Integrator subunit onto specific region of the U7 snRNA gene. 
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Figure A.1 Optimization of CHIP conditions on Drosophila U7 snRNA gene. 
(A). Schematic representation of the standard procedure for CHIP assay. (B). Western blot 
analysis of S2 cell lysates using the antigen-purified IntS12 polyclonal antibodies. (C). Reverse 
crosslinked total DNA was run on agarose gel and stained with Ethidium bromide. (D). top 
panel, schematic representation of amplicon location relative to the U7 snRNA gene; bottom 
panel, amplicons from qPCR were run on agarose gel and stained with Ethidium bromide.  
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Figure A.2 CHIP profiles of IntS11, IntS12 and RNAPII on the U7 snRNA gene. 
S2 cell CHIP DNA was prepared by following the optimized protocol described above, and 
RNAPII, IntS11 and IntS12 antibodies were used for immunoprecipitations with GP IgG as 
negative control. Purified DNA was used for qPCR analysis using primers described above. 
Data were presented as percentage of input with the IgG background subtracted. 
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DISSCUSSION 
 
      Chromatin Immunoprecipitation is a technique used to determine the occupancy of a 
protein factor on specific genomic region in vivo. Information garnered from CHIP assay is an 
important complementation for understanding the cellular function of nuclear acid associated 
proteins. Integrator proteins were found to recruit to U1 and U2 snRNA genes and catalyze the 
3’ end formation of RNAPII-transcribed snRNAs. However, it is still not clear whether it is 
recruited to the promoter or the 3’ end region of snRNA. Both cases are possible as Integrator 
complex are determined to couple the snRNA transcription and 3’ end formation as well as 
cleave the nascent primary transcripts (de Vegvar et al. 1986; Hernandez and Weiner 1986; 
Baillat et al. 2005). A high resolution CHIP assay will help answering these biologically 
important questions. In this study, I developed a CHIP assay for detection of the occupancy of 
IntS12 protein on U7 snRNA gene in vivo. The IntS12 proteins were found to preferentially 
occupy the promoter region of the U7 snRNA gene. 
      In Chapter 4 and 5, we have comprehensively investigated the domain functions of IntS12 
protein, and characterized an N-terminal microdomain that is essential for snRNA 3’ end 
formation. We also determined the roles of the T76 phosphorylation and the conserved PHD 
finger domain of IntS12 in Integrator interactions. It would be interesting to know whether 
these characterized features are important for IntS12 occupancy on the U7 snRNA promoter 
or not. To test that, we have generated S2 cell stable lines expressing FLAG-tagged PHD 
deletion or point mutants, T76 point mutant or the N-terminal microdomain point mutants. 
CHIP analysis using anti-FLAG antibodies in these stable cell lines gave ambiguous results 
that are hard to interpret (data not shown). One potential caveat to do the CHIP analysis using 
these stable lines is the uneven expression of tagged proteins in these cells, which makes the 
CHIP signal hard to compare between different cell lines. To circumvent this problem, it will be 
worth selecting the monoclonal S2 stable cell lines that give similar levels of expression for the 
tagged proteins or to generate isogenic cells that harbor only a single copy of gene insertion at 
a specific genomic site. 
      Nevertheless, using the CHIP assay we developed on snRNA genes combined with RNAi-
mediated depletion of Integrator subunits, it will provide more details of Integrator function in 
snRNA 3’ end formation, such as the promoter recruitment of Integrator complex and the 3’ 
end cleavage of snRNA, through study of the occupancy of all other Integrator subunits on 
snRNA promoter and 3’ end region. 
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